+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

List of PDF Full Texts available from EurekaMag Chapter 57528

Chapter 57528 contains a list of PDF Full Texts available from EurekaMag.





Ernstsson, O.; Gyllensten, H.; Alexanderson, K.; Tinghög, P.; Friberg, E.; Norlund, A., 2017:
Cost of Illness of Multiple Sclerosis - A Systematic Review

Luther, G.Aman.; Murthy, P.; Blazar, P.E., 2016:
Cost of Immediate Surgery Versus Non-operative Treatment for Trigger Finger in Diabetic Patients

Zalis'ka, O.; Leleka, M.; Kosyachenko, K.; Zaliskyy, O., 2014:
Cost of Influenza and Acute Respiratory Infections Treatment in Ukraine

Cardones, A.R.; Hall, R.P., 2018:
Cost of Inpatient Care of Patients With Pemphigus in the United States: Translating Dollars and Cents Into Improved Patient Care

Kale, M.S.; Mhango, G.; Bonomi, M.; Federman, A.; Sigel, K.; Rosenzweig, K.E.; Wisnivesky, J.P., 2018:
Cost of Intensity-modulated Radiation Therapy for Older Patients with Stage III Lung Cancer

Nadendla, R., 2015:
Cost of Medication Nonadherence in Patients with Diabetes Mellitus

Czilli, T.; Tan, J.; Knezevic, S.; Peters, C., 2016:
Cost of Medications Recommended by Canadian Acne Clinical Practice Guidelines

Dinh, H.T.; Nguyen, T.T.T., 2014:
Cost of Non Small Cell Lung Cancer by Vietnamese and European Treatment Standards in Vietnam

Tangka, F.K.L.; Subramanian, S.; Beebe, M.Cole.; Weir, H.K.; Trebino, D.; Babcock, F.; Ewing, J., 2018:
Cost of Operating Central Cancer Registries and Factors That Affect Cost: Findings From an Economic Evaluation of Centers for Disease Control and Prevention National Program of Cancer Registries

Mokiou, S.; de Cock, E.; Standaert, B., 2015:
Cost of Paediatric Vaccine Administration in the United Kingdom (UK): a Time and Motion (T&M) Study

Tachfouti, N.; Najdi, A.; Alonso, S.; Sicuri, E.; Laamrani El Idrissi, A.; Nejjari, C.; Picado, A., 2017:
Cost of Pediatric Visceral Leishmaniasis Care in Morocco

Szafraniec-Burylo, S.; Orlewska, E., 2014:
Cost of Pharmacotherapy in Polish Patients With Rheumatoid Arthritis

Östensson, E.; Fröberg, M.; Leval, A.; Hellström, A-Cathrin.; Bäcklund, M.; Zethraeus, N.; Andersson, S., 2016:
Cost of Preventing, Managing, and Treating Human Papillomavirus (HPV)-Related Diseases in Sweden before the Introduction of Quadrivalent HPV Vaccination

Cognet, M.; Druais, S.; Gervais, F.; Gauthier, A.; Abrams, K.R., 2014:
Cost of Previously Treated Chronic Lymphocytic Leukemia (CLL) and Indolent Non-Hodgkin's Lymphoma (INHL) in the United Kingdom (UK)

Prioli, K.M.; Pizzi, L.T.; Karp, J.Katz.; Galanis, T.; Herman, J.H.; Fanikos, J.; Pollack, C.; Roseff, S.; Rubin, R.; Vogenberg, F., 2017:
Cost of Purchased Versus Produced Plasma from Donor Recruitment Through Transfusion

Perrier, L.; Nechba, A.; Perol, O.; Perol, M.; Fayette, J.; Rebattu, P.; Bonnand, S.; Philip, T.; Charbotel, B.; Fervers, B., 2015:
Cost of Questionnaire-Based Process to Identify Occupational Exposures Among Patients with Lung Cancer

Schubert, A.; Nielsen, A.T.; El Khoury, A.; Kamal, A.; Taieb, V., 2015 :
Cost of Reaching Defined HbA1c Target Using Canagliflozin Compared to Dapagliflozin as Add-On to Metformin in Patients with Type 2 Diabetes Mellitus (T2DM) in the United Arab Emirates (UAE)

Barbosa, C.; Cowell, A.J.; Landwehr, J.; Dowd, W.; Bray, J.W., 2016:
Cost of Screening, Brief Intervention, and Referral to Treatment in Health Care Settings

Czech, M.; Jaron, N.; Pietrzyk, A.; Franek, E., 2014:
Cost of Severe Hypoglycaemia in Hospitalized Patients In Poland- Is It Financed and Reported in a Right Way?

Baggett, T.P.; Rigotti, N.A.; Campbell, E.G., 2016:
Cost of Smoking among Homeless Adults

Culme-Seymour, E.J.; Mason, K.; Vallejo-Torres, L.; Carvalho, C.; Partington, L.; Crowley, C.; Hamilton, N.J.; Toll, E.C.; Butler, C.R.; Elliott, M.J.; Birchall, M.A.; Lowdell, M.W.; Mason, C., 2016:
Cost of Stem Cell-Based Tissue-Engineered Airway Transplants in the United Kingdom: Case Series

Turner, I.; Minhas, Z.; Kennedy, J.; Morris, S.; Crockard, A.; Choi, D., 2016:
Cost of Surgery for Symptomatic Spinal Metastases in the United Kingdom

Martsolf, G.R.; Kandrack, R.; Gabbay, R.A.; Friedberg, M.W., 2017:
Cost of Transformation among Primary Care Practices Participating in a Medical Home Pilot

Kruse, M.M.; Wildner, R.; Barnes, G.; Martin, M.; Mueller, U.; Lo Coco, F.; Leyman, S.; Pathak, A., 2014:
Cost of Treating Acute Promyelocytic Leukemia (APL) Patients in Italy

Menzie, A.M.; Daskiran, M.; Abbott, T.A., 2014:
Cost of Treating Hip Fractures With Cephalomedullary Nails: A Retrospective Claims Database Review

Kahler, Z.P.; Beam, D.M.; Kline, J.A., 2016 :
Cost of Treating Venous Thromboembolism With Heparin and Warfarin Versus Home Treatment With Rivaroxaban

Abouzaid, S.; Gibson, C.; Nagarwala, Y., 2016:
Cost of Treatment for Relapsed/Refractory Multiple Myeloma

Karabay, O.; Ogutlu, A.; Guclu, E., 2015:
Cost of Treatment in HBeAg-Negative Chronic Hepatitis B Patients with 10-Years Projection Analysis

Cheikh, A.; Rachid, R.; Jehanne, A.; Adil, A.; Ali, B.; Cherrah, Y.; Amine, E.Hassani.; Abdeljalil, E.Quessar., 2016:
Cost of Treatment of Cerebral Aneurysm Embolization: Study of Associated Factors

Charbonnel, B.; Dallongeville, J.; Simon, D.; Bureau, I.; Leproust, S.; Levy-Bachelot, L.; Gourmelen, J.; Detournay, B., 2015:
Cost of Type 2 Diabetes According to Glucose-Lowering Medications in France

Chevalier, P.; De Beule, J.; Lamotte, M.; Hunsche, E.; Régulier, E., 2014:
Cost of a Pulmonary Arterial Hypertension-Related Hospitalization in Belgium

Weiss, R., 2016:
Cost of a lymphedema treatment mandate-10 years of experience in the Commonwealth of Virginia

Hussain, S.; Moorman, L.; Moorman, J.Randall.; DiMarco, J.P.; Malhotra, R.; Darby, A.; Bilchick, K.; Mangrum, J.Michael.; Ferguson, J.D.; Mason, P.K., 2015:
Cost of a recall of a single-center experience managing the Riata defibrillator lead

Dwivedi, P.; Wang, W.; Hudiburg, T.; Jaiswal, D.; Parton, W.; Long, S.; DeLucia, E.; Khanna, M., 2015:
Cost of abating greenhouse gas emissions with cellulosic ethanol

Parmar, D.; Leone, T.; Coast, E.; Murray, S.Fairley.; Hukin, E.; Vwalika, B., 2015:
Cost of abortions in Zambia: A comparison of safe abortion and post abortion care

Hampson, N.B., 2016:
Cost of accidental carbon monoxide poisoning: A preventable expense

Ali, A.N.; Howe, J.; Abdel-Hafiz, A., 2016:
Cost of acute stroke care for patients with atrial fibrillation compared with those in sinus rhythm

Smith, K.A.; Orlandi, R.R.; Rudmik, L., 2015:
Cost of adult chronic rhinosinusitis: A systematic review

Ludbrook, A., 2016:
Cost of alcohol: better data will be justified if it is put to better use

Kosar, C.; Steinberg, K.; de Silva, N.; Avitzur, Y.; Wales, P.W., 2017:
Cost of ambulatory care for the pediatric intestinal failure patient: One-year follow-up after primary discharge

Ross, R.K.; Hersh, A.L.; Kronman, M.P.; Newland, J.G.; Gerber, J.S., 2016:
Cost of antimicrobial therapy across US children's hospitals

Whittaker, G.; Barnhart, B.L.; Srinivasan, R.; Arnold, J.G., 2015:
Cost of areal reduction of gulf hypoxia through agricultural practice

Lo, T.K.T.; Parkinson, L.; Cunich, M.; Byles, J., 2016:
Cost of arthritis: a systematic review of methodologies used for direct costs

Arrospide, A.; Soto-Gordoa, M.; Acaiturri, T.; López-Vivanco, G.; Abecia, L.Carlos.; Mar, J., 2015:
Cost of breast cancer treatment by clinical stage in the Basque Country, Spain

Ward, R.L.; Laaksonen, M.A.; van Gool, K.; Pearson, S-Anne.; Daniels, B.; Bastick, P.; Norman, R.; Hou, C.; Haywood, P.; Haas, M., 2016:
Cost of cancer care for patients undergoing chemotherapy: The Elements of Cancer Care study

Cavallo, M.Caterina.; Gugiatti, A.; Fattore, G.; Gerzeli, S.; Barbieri, D.; Zanini, R.; Mosca, F.; Picciolini, O.; Visentin, S.; Battajon, N.; Di Nunzio, M.Lucia.; Ramacciato, F.; Barberis, L.; Mastretta, E.; Anna, S.; Zanini, R.; Carli, G.; Bordigato, M.Alfiero.; Chiandotto, V.; Boiti, C.; Litta, R.; Minelli, G.; Napolitano, M.; Arco, A.; Martino, G.; Mammoliti, P.; Fortini, C.; Tagliabue, P.; Quartulli, L.; Motta, G.; Introvini, P.; Grigorio, R.; Mussini, P.; Pomero, G.; Poggiani, C.; Bauchier, 2016:
Cost of care and social consequences of very low birth weight infants without premature- related morbidities in Italy

Goldstein, E.; Ho, C-Xing.; Hanna, R.; Elinger, C.; Yaremchuk, K.L.; Seidman, M.D.; Jesse, M.T., 2015:
Cost of care for subjective tinnitus in relation to patient satisfaction

Haque, A.; Siddiqui, N-ur-.Rehman.; Kumar, R.; Hoda, M.; Lakahni, G.; Hooda, K., 2015:
Cost of care in a paediatric intensive care unit of a tertiary-care university hospital of Pakistan

Handa, S.; Jain, N.; Narang, T., 2015:
Cost of care of atopic dermatitis in India

Rejani, P.P.; Sumesh, T.P.; Shaji, K.S., 2015:
Cost of care: a study of patients hospitalized for treatment of psychotic illness

Weycker, D.; Malin, J.; Glass, A.; Oster, G., 2016:
Cost of chemotherapy-related febrile neutropenia

Danese, M.; Gleeson, M.; Reyes, C.; Pao, M.; Knopf, K.B., 2016:
Cost of chronic lymphocytic leukemia (CLL) in Medicare patients

Moon, C., 2012:
Cost of competition proving greater than we imagined

Serra-Arbeloa, P.; Rabines-Juárez, Á.O.; Álvarez-Ruiz, M.S.; Guillén-Grima, F., 2016:
Cost of Cutaneous Melanoma by Tumor Stage: A Descriptive Analysis

Sørensen, M.; Arneberg, F.; Line, T.M.; Berg, T.J., 2016:
Cost of diabetes in Norway 2011

Schirr-Bonnans, Sène.; Costa, Nège.; Derumeaux-Burel, Hélène.; Bos, Jérémy.; Lepage, Bît.; Garnault, Vérie.; Martini, J.; Hanaire, Hélène.; Turnin, M-Christine.; Molinier, L., 2016:
Cost of diabetic eye, renal and foot complications: a methodological review

Romero-Aroca, P.; de la Riva-Fernandez, S.; Valls-Mateu, A.; Sagarra-Alamo, R.; Moreno-Ribas, A.; Soler, N.; Puig, D., 2017:
Cost of diabetic retinopathy and macular oedema in a population, an eight year follow up

Zambrowski, J-Jacques., 2018:
Cost of dialysis in France

Mushi, L.; Krohn, M.; Flessa, S., 2015:
Cost of dialysis in Tanzania: evidence from the provider's perspective

Brown, M.G., 2015:
Cost of disease-modifying therapies for multiple sclerosis

Coutinho, E.Silva.Freire.; Bahia, L.; Barufaldi, L.Augusta.; Abreu, G.de.Azevedo.; Malhão, Tá.Alves.; Pepe, C.Ribeiro.; Araujo, D.Vianna., 2017:
Cost of diseases related to alcohol consumption in the Brazilian Unified Health System

Holden, S.E.; Currie, C.J.; Lennon, M.; Reynolds, A.V.; Moots, R.J., 2016:
Cost of dose escalation in people with rheumatoid arthritis treated with tumour necrosis factor inhibitors across Europe

Inoue, K.Cristina.; Matsuda, L.Misue., 2017:
Cost of dressings for prevention of sacral pressure ulcers

Emara, K.Mohamed.; Diab, R.Ahmed.; Ghafar, K.Abd.El., 2015:
Cost of external fixation vs external fixation then nailing in bone infection

Mayordomo, J.I.; López, A.; Viñolas, N.; Castellanos, J.; Pernas, S.; Alonso, J.D.; Frau, A.; Layola, M.; Gasquet, J.A.; Sánchez, J., 2016:
Cost of febrile neutropenia management in cancer patients in Spain

Goyens, J.; Van Wassenbergh, S.; Dirckx, J.; Aerts, P., 2016:
Cost of flight and the evolution of stag beetle weaponry

Gleeson, M.; Carolina, R.; Danese, M.; Knopf, K.B., 2016:
Cost of follicular lymphoma (FL) in Medicare patients

Hu, J.; He, Z., 2016:
Cost of general anesthesia during radical gastrectomy using different specifications of propofol: cost-minimization analyses

Lazcano-Gomez, G.; Ramos-Cadena, Mía.de.Los.Angeles.; Torres-Tamayo, M.; Hernandez de Oteyza, A.; Turati-Acosta, M.; Jimenez-Román, Jús., 2017:
Cost of glaucoma treatment in a developing country over a 5-year period

Aras, D.; Aydoğdu, S.; Bozkurt, E.; Çavuşoğlu, Yüksel.; Eren, M.; Erol, Çetin.; Güleç, S.; Kızılırmak, Pınar.; Öngen, Z.; Özdemir, O.; Saylan, M.; Tokgözoğlu, L.; Yeter, E.; Yılmaz, M.Birhan., 2018:
Cost of heart failure management in Turkey: results of a Delphi Panel

Zhang, S.; Palazuelos-Munoz, S.; Balsells, E.M.; Nair, H.; Chit, A.; Kyaw, M.H., 2017:
Cost of hospital management of Clostridium difficile infection in United States-a meta-analysis and modelling study

Tripathy, J.P.; Prasad, B.M.; Shewade, H.D.; Kumar, A.M.V.; Zachariah, R.; Chadha, S.; Tonsing, J.; Harries, A.D., 2016:
Cost of hospitalisation for non-communicable diseases in India: are we pro-poor?

Tchamdja, T.; Balaka, A.; Tchandana, M.; Agbétra, A., 2016:
Cost of hospitalization by the Activity Based Costing method in the neonatal department of Principal Hospital of Dakar

Oksuz, E.; Malhan, S.; Sonmez, B.; Numanoglu Tekin, R., 2016:
Cost of illness among patients with diabetic foot ulcer in Turkey

Vervoort, V.M.; Vriezekolk, J.E.; Olde Hartman, T.C.; Cats, H.A.; van Helmond, T.; van der Laan, W.H.; Geenen, R.; van den Ende, C.H., 2016:
Cost of illness and illness perceptions in patients with fibromyalgia

Pavel, M.Sadik.; Chakrabarty, S.; Gow, J., 2018:
Cost of illness for outpatients attending public and private hospitals in Bangladesh

Adebayo, E.Taiwo., 2015:
Cost of illness in patients with mandibular fracture

Akhiwu, B.I.; Suleiman, H.H.; Muktar, M.; Amole, I.O., 2015:
Cost of illness in patients with mandibular fracture following road traffic crash and its socioeconomic implications in KANO STATE, NIGERIA

Matsumoto, K.; Haga, K.; Kitazawa, T.; Seto, K.; Fujita, S.; Hasegawa, T., 2016:
Cost of illness of breast cancer in Japan: trends and future projections

Rencz, F.; Kovács, Ágnes.; Brodszky, V.; Gulácsi, László.; Németh, Zán.; Nagy, Gábor.János.; Nagy, János.; Buzogány, Ián.; Böszörményi-Nagy, Géza.; Majoros, A.; Nyirády, Péter., 2016:
Cost of illness of medically treated benign prostatic hyperplasia in Hungary

Ni Riordain, R.; Christou, J.; Pinder, D.; Squires, V.; Hodgson, T., 2017:
Cost of illness of oral lichen planus in a U.K. population--a pilot study

Hayata, E.; Seto, K.; Haga, K.; Kitazawa, T.; Matsumoto, K.; Morita, M.; Hasegawa, T., 2016:
Cost of illness of the cervical cancer of the uterus in Japan--a time trend and future projections

Kitazawa, T.; Matsumoto, K.; Fujita, S.; Seto, K.; Hanaoka, S.; Hasegawa, T., 2016:
Cost of illness of the prostate cancer in Japan--a time-trend analysis and future projections

Hasoumi, M.; Nasehi, M.; Khakian, M.; Mohseni, M.; Ziaiifar, H.; Keykale, M.Safi., 2015:
Cost of illness of tuberculosis in tehran in the year 2011

Tugendhaft, A.; Manyema, M.; Veerman, L.J.; Chola, L.; Labadarios, D.; Hofman, K.J., 2018:
Cost of inaction on sugar-sweetened beverage consumption: implications for obesity in South Africa

Wijeratna, M.D.; McRoberts, J.; Porteous, M.J., 2015:
Cost of infection after surgery for intracapsular fracture of the femoral neck

Joo, H.; Fang, J.; Losby, J.L.; Wang, G., 2015:
Cost of informal caregiving for patients with heart failure

Saronga, H.Pius.; Dalaba, M.Ayindenaba.; Dong, H.; Leshabari, M.; Sauerborn, R.; Sukums, F.; Blank, A.; Kaltschmidt, J.; Loukanova, S., 2016:
Cost of installing and operating an electronic clinical decision support system for maternal health care: case of Tanzania rural primary health centres

Baly, A.; Toledo, M.Eugenia.; Lambert, I.; Benítez, E.; Rodriguez, K.; Rodriguez, E.; Vanlerberghe, V.; Stuyft, P.Van.der., 2017:
Cost of intensive routine control and incremental cost of insecticide-treated curtain deployment in a setting with low Aedes aegypti infestation

Kruger, S.J.; DuBois, L.; Becker, E.R.; Morrison, D.; Wilson, L.; Wilson, M.Edward.; Lambert, S.R., 2015:
Cost of intraocular lens versus contact lens treatment after unilateral congenital cataract surgery in the infant aphakia treatment study at age 5 years

Franklin, H.; Rajan, M.; Tseng, C-Lin.; Pogach, L.; Sinha, A.; Mph, M., 2015:
Cost of lower-limb amputation in U.S. veterans with diabetes using health services data in fiscal years 2004 and 2010

Goljo, E.; Dang, R.; Iloreta, A.M.; Govindaraj, S., 2016:
Cost of management in epistaxis admission: Impact of patient and hospital characteristics

Ellenga Mbolla, B.F.; Matingou, A.R.; Ikama, M.S.; Mongo-Ngamami, S.F.; Kouala Landa, C.M.; Gombet, T.R.; Kimbally-Kaky, S.G., 2018:
Cost of management of nonvalvular atrial fibrillation in Brazzaville (Congo): preliminary findings

Zhang, S.; Sammon, P.M.; King, I.; Andrade, A.Lucia.; Toscano, C.M.; Araujo, S.N.; Sinha, A.; Madhi, S.A.; Khandaker, G.; Yin, J.Kevin.; Booy, R.; Huda, T.M.; Rahman, Q.S.; El Arifeen, S.; Gentile, A.; Giglio, N.; Bhuiyan, M.U.; Sturm-Ramirez, K.; Gessner, B.D.; Nadjib, M.; Carosone-Link, P.J.; Simões, E.Af.; Child, J.A.; Ahmed, I.; Bhutta, Z.A.; Soofi, S.B.; Khan, R.J.; Campbell, H.; Nair, H., 2018:
Cost of management of severe pneumonia in young children: systematic analysis

Wendorf, K.A.; Kay, M.; Ortega-Sanchez, I.R.; Munn, M.; Duchin, J., 2016:
Cost of measles containment in an ambulatory pediatric clinic

Rahman, R.; Lesser, A.; Mboera, L.; Kramer, R., 2016:
Cost of microbial larviciding for malaria control in rural Tanzania

Diel, R.; Nienhaus, A.; Lampenius, N.; Rüsch-Gerdes, S.; Richter, E., 2015:
Cost of multi drug resistance tuberculosis in Germany

Ruiz-Moreno, J.M.; Roura, M., 2017:
Cost of myopic patients with and without myopic choroidal neovascularisation

Brandt, S.; Perez, L.; Künzli, N.; Lurmann, F.; Wilson, J.; Pastor, M.; McConnell, R., 2015:
Cost of near-roadway and regional air pollution-attributable childhood asthma in Los Angeles County

Bhattarai, R.; Carabin, Hélène.; Proaño, J.V.; Flores-Rivera, J.; Corona, T.; Flisser, A.; Budke, C.M., 2015:
Cost of neurocysticercosis patients treated in two referral hospitals in Mexico City, Mexico

Rello, J.; Bin, C., 2016:
Cost of nosocomial pneumonia: the example of vancomycin versus linezolid-shorter stay or fewer complications?

Bishara, H.; Ore, L.; Vinitsky, O.; Bshara, H.; Armaly, N.; Weiler-Ravell, D., 2016:
Cost of nurse-managed latent tuberculous infection treatment among hard-to-reach immigrants in Israel

Ruiz, P.Buck.de.Oliveira.; Perroca, M.Galan.; Jericó, M.de.Carvalho., 2016:
Cost of nursing turnover in a Teaching Hospital

Nickman, N.A.; Ye, X.; Gaffney, D.K.; Barney, R.B.; Biskupiak, J.E.; Okano, G.J.; Lee, V.C.; Arellano, J., 2015:
Cost of palliative external beam radiotherapy (EBRT) use for bone metastases secondary to prostate cancer

Akhavan Hejazi, S.Majid.; Mazlan, M.; Abdullah, S.Jeffery.Freddy.; Engkasan, J.Patrick., 2016:
Cost of post-stroke outpatient care in Malaysia

Maurice, J., 2016:
Cost of protection against pandemics is small

Prata, N.; Downing, J.; Bell, S.; Weidert, K.; Godefay, H.; Gessessew, A., 2017:
Cost of providing injectable contraceptives through a community-based social marketing program in Tigray, Ethiopia

Vanholder, R.; Lameire, N.; Annemans, L.; Van Biesen, W., 2017:
Cost of renal replacement: how to help as many as possible while keeping expenses reasonable?

Riewpaiboon, A.; Shin, S.; Le, T.Phuong.Mai.; Vu, D.Thiem.; Nguyen, T.Hien.Anh.; Alexander, N.; Dang, D.Anh.; Tho, L.; Thuy, V.; Chan, T.; Viet, P.; Nguyet, N.; Hoa, L., 2017:
Cost of rotavirus diarrhea for programmatic evaluation of vaccination in Vietnam

Wasan, H.S., 2015:
Cost of selective internal radiation therapy versus other modalities

Stirbulov, R.; Lopes da Silva, N.; Maia, S.Cristina.Oliveira.Machado.; Carvalho-Netto, E.; Angelini, L., 2017:
Cost of severe asthma in Brazil-systematic review

Jakubczyk, Mł.; Lipka, I.; Pawęska, J.; Niewada, M.; Rdzanek, Eżbieta.; Zaletel, J.; Ramírez de Arellano, A.; Doležal, Táš.; Chekorova Mitreva, B.; Nagy, B.; Petrova, G.; Šarić, T.; Yfantopoulos, J.; Czech, M., 2017:
Cost of severe hypoglycaemia in nine European countries

Pereira, J.; Body, J-J.; Gunther, O.; Sleeboom, H.; Hechmati, G.; Maniadakis, N.; Terpos, E.; Acklin, Y.P.; Finek, J.; von Moos, R., 2017:
Cost of skeletal complications from bone metastases in six European countries

Ogola, G.O.; Shafi, S., 2016:
Cost of specific emergency general surgery diseases and factors associated with high-cost patients

Misra, U.K.; Kalita, J.; Bhoi, S.K.; Dubey, D., 2016:
Cost of status epilepticus in a tertiary care hospital in India

Kortland, L-Marie.; Knake, S.; Rosenow, F.; Strzelczyk, A., 2015:
Cost of status epilepticus: A systematic review

Martínez, H.R.; Rangel-Guerra, R.A.; Marfil-Rivera, A.; Muñiz, C.E.; Sagastegui, A., 1995:
Cost of stroke in Mexico

Jennum, P.; Iversen, H.K.; Ibsen, R.; Kjellberg, J., 2016:
Cost of stroke: a controlled national study evaluating societal effects on patients and their partners

Nguyen, H.; Ivers, R.; Jan, S.; Pham, C., 2015:
Cost of surgery and catastrophic expenditure in people admitted to hospital for injuries: estimates from a cohort study in Vietnam

Löfgren, J.; Mulowooza, J.; Nordin, Pär.; Wladis, A.; Forsberg, B.C., 2015:
Cost of surgery in a low-income setting in eastern Uganda

Kaynar, A.Murat.; Bakalov, V.; Laverde, S.Martinez.; Cambriel, Aélie.I.F.; Lee, B-Hoon.; Towheed, A.; Gregory, A.D.; Webb, S.A.R.; Palladino, M.J.; Bozza, F.A.; Shapiro, S.D.; Angus, D.C., 2016:
Cost of surviving sepsis: a novel model of recovery from sepsis in Drosophila melanogaster

Granados-García, Víctor.; Flores, Y.N.; Pérez, R.; Rudolph, S.E.; Lazcano-Ponce, E.; Salmerón, J., 2017:
Cost of the Cervical Cancer Screening Program at the Mexican Social Security Institute

Ocansey, S.; Kyei, S.; Diafo, A.; Darfor, K.Nkansah.; Boadi-Kusi, S.Bert.; Aglobitse, P.B., 2017:
Cost of the medical management and prescription pattern for primary open angle glaucoma (POAG) in Ghana-a retrospective cross-sectional study from three referral facilities

Varley, I.; Kumar, A., 2016:
Cost of training in oral and maxillofacial surgery: beyond the second degree

Andrade, C., 2015 :
Cost of treatment as a placebo effect in psychopharmacology: importance in the context of generic drugs

Jönsson, L.; Justo, N.; Musayev, A.; Krishna, A.; Burke, T.; Pellissier, J.; Judson, I.; Staddon, A.; Blay, J.Y., 2017:
Cost of treatment in patients with metastatic soft tissue sarcoma who respond favourably to chemotherpy. The SArcoma treatment and Burden of Illness in North America and Europe (SABINE) study

Sicras-Mainar, A.; Rejas-Gutiérrez, J.; Pérez-Páramo, Mía.; Navarro-Artieda, R., 2016:
Cost of treatment of peripheral neuropathic pain with pregabalin or gabapentin in routine clinical practice: impact of their loss of exclusivity

Henry, N.; Schlueter, M.; Lowin, J.; Lekander, I.; Filonenko, A.; Trussell, J.; Skjeldestad, F.Egil., 2016:
Cost of unintended pregnancy in Norway: a role for long-acting reversible contraception

Burki, T.Khan., 2018:
Cost of unused cancer drugs in the USA

Totten, C.F.; Davenport, D.L.; Ward, N.D.; Roth, J.Scott., 2017:
Cost of ventral hernia repair using biologic or synthetic mesh

Ene, G.; Garcia Raso, Aánzazu.; Gonzalez-Dominguez Weber, A.; Hidalgo-Vega, Álvaro.; Llamas, P., 2016:
Cost of vitamin K antagonist anticoagulant treatment in patients with metallic prosthetic valve in mitral position

Xue, Y.; Chappel, A.R.; Freund, D.A.; Aiken, L.H.; Noyes, K., 2016:
Cost outcomes of supplemental nurse staffing in a large medical center

Pilon, D.; Queener, M.; Lefebvre, P.; Ellis, L.A., 2017:
Cost per median overall survival month associated with abiraterone acetate and enzalutamide for treatment of patients with metastatic castration-resistant prostate cancer

Cox, H.; Ramma, L.; Wilkinson, L.; Azevedo, V.; Sinanovic, E., 2015:
Cost per patient of treatment for rifampicin-resistant tuberculosis in a community-based programme in Khayelitsha, South Africa

Bonafede, M.; Johnson, B.H.; Princic, N.; Shah, N.; Harrison, D.J., 2016:
Cost per patient-year in response using a claims-based algorithm for the 2 years following biologic initiation in patients with rheumatoid arthritis

Toor, K.; Druyts, E.; Jansen, J.P.; Thorlund, K., 2016:
Cost per remission and cost per response with infliximab, adalimumab, and golimumab for the treatment of moderately-to-severely active ulcerative colitis

Spitz, G.; McKenzie, D.; Attwood, D.; Ponsford, J.L., 2016:
Cost prediction following traumatic brain injury: model development and validation

Berelavichus, S.V.; Kriger, A.G.; Titova, N.L.; Smirnov, A.V.; Poljakov, I.S.; Kaldarov, A.R.; Son, A.I., 2015:
Cost price of robot-assisted and laparoscopic operations

Noblett, K.L.; Dmochowski, R.R.; Vasavada, S.P.; Garner, A.M.; Liu, S.; Pietzsch, J.B., 2016:
Cost profiles and budget impact of rechargeable versus non-rechargeable sacral neuromodulation devices in the treatment of overactive bladder syndrome

Kelleher, K.J.; Cooper, J.; Deans, K.; Carr, P.; Brilli, R.J.; Allen, S.; Gardner, W., 2015:
Cost saving and quality of care in a pediatric accountable care organization

Devos, S.; Cox, B.; Dhondt, S.; Nawrot, T.; Putman, K., 2015:
Cost saving potential in cardiovascular hospital costs due to reduction in air pollution

Moore, D.C.; McVey, G.Neal., 2016:
Cost savings analysis and toxicity audit of a bevacizumab dose rounding policy at a community cancer center

Powers, B.W.; Makar, M.; Jain, S.H.; Cutler, D.M.; Obermeyer, Z., 2016:
Cost savings associated with expanded hospice use in Medicare

Geyer, B.C.; Peak, D.A.; Velmahos, G.C.; Gates, J.D.; Michaud, Y.; Petrovick, L.; Lee, J.; Yun, B.J.; White, B.A.; Raja, A.S., 2016:
Cost savings associated with transfer of trauma patients within an accountable care organization

Pobre, M.A.; Espallardo, O.; Alfonso, J.L.; Pinyol, C., 2014:
Cost savings for the use of antibacterial sutures in spanish hospitals. Budget impact model

Carpelan, A.; Kauhanen, S., 2016:
Cost savings in outpatient versus inpatient reduction mammaplasty

Roblin, X.; Attar, A.; Lamure, M.; Savarieau, B.; Brunel, P.; Duru, Gérard.; Peyrin-Biroulet, L., 2015:
Cost savings of anti-TNF therapy using a test-based strategy versus an empirical dose escalation in Crohn's disease patients who lose response to infliximab

Halla, M.; Pruckner, G.J.; Schober, T., 2018:
Cost savings of developmental screenings: Evidence from a nationwide program

Touati, M.; Lamarsalle, L.; Moreau, Séphane.; Vergnenègre, Fçoise.; Lefort, S.; Brillat, C.; Jeannet, L.; Lagarde, A.; Daulange, A.; Jaccard, A.; Vergnenègre, A.; Bordessoule, D., 2016:
Cost savings of home bortezomib injection in patients with multiple myeloma treated by a combination care in Outpatient Hospital and Hospital care at Home

Johnson, T.J.; Patel, A.L.; Bigger, H.R.; Engstrom, J.L.; Meier, P.P., 2016:
Cost savings of human milk as a strategy to reduce the incidence of necrotizing enterocolitis in very low birth weight infants

Quinlivan, A.; Thakkar, V.; Stevens, W.; Morrisroe, K.; Prior, D.; Rabusa, C.; Youssef, P.; Gabbay, E.; Roddy, J.; Walker, J.G.; Zochling, J.; Sahhar, J.; Nash, P.; Lester, S.; Rischmueller, M.; Proudman, S.M.; Nikpour, M., 2016:
Cost savings with a new screening algorithm for pulmonary arterial hypertension in systemic sclerosis

Arrieta, A.; García-Prado, A., 2015:
Cost sharing and hospitalizations for ambulatory care sensitive conditions

Baicker, K.; Levy, H., 2015:
Cost sharing as a tool to drive higher-value care

Wilkin, M., 2015:
Cost shifting and the quality use of medicines

Jaime-Pérez, Jé.Carlos.; Heredia-Salazar, A.Carlos.; Cantú-Rodríguez, O.G.; Gutiérrez-Aguirre, H.; Villarreal-Villarreal, César.Daniel.; Mancías-Guerra, C.; Herrera-Garza, Jé.Luís.; Gómez-Almaguer, D., 2016:
Cost structure and clinical outcome of a stem cell transplantation program in a developing country: the experience in northeast Mexico

Wyld, M.L.R.; Lee, C.M.Y.; Zhuo, X.; White, S.; Shaw, J.E.; Morton, R.L.; Colagiuri, S.; Chadban, S.J., 2016:
Cost to government and society of chronic kidney disease stage 1-5: a national cohort study

Dalaba, M.Ayindenaba.; Akweongo, P.; Aborigo, R.Akawire.; Saronga, H.Pius.; Williams, J.; Aninanya, G.Apiung.; Sauerborn, R.; Loukanova, S., 2016:
Cost to households in treating maternal complications in northern Ghana: a cross sectional study

Wodchis, W.P.; Arthurs, E.; Khan, A.I.; Gandhi, S.; MacKinnon, M.; Sussman, J., 2016:
Cost trajectories for cancer patients

von Wyl, V.; Telser, H.; Weber, A.; Fischer, B.; Beck, K., 2015:
Cost trajectories from the final life year reveal intensity of end-of-life care and can help to guide palliative care interventions

Sangchan, A.; Chaiyakunapruk, N.; Supakankunti, S.; Pugkhem, A.; Mairiang, P., 2014:
Cost utility analysis of endoscopic biliary stent in unresectable hilar cholangiocarcinoma: decision analytic modeling approach

Scangas, G.A.; Su, B.M.; Remenschneider, A.K.; Shrime, M.G.; Metson, R., 2017:
Cost utility analysis of endoscopic sinus surgery for chronic rhinosinusitis

Scangas, G.A.; Remenschneider, A.K.; Su, B.M.; Shrime, M.G.; Metson, R., 2016:
Cost utility analysis of endoscopic sinus surgery for chronic rhinosinusitis with and without nasal polyposis

Yepes, C.; Orozco, J.J.; Valencia, J., 2015:
Cost utility analysis of spinal cord stimulation vs. Reoperation in the treatment of failed back surgery syndrome in colombia

Hahn-Pedersen, J.; Worm, M.; Green, W.; Andreasen, J.Nørgaard.; Taylor, M., 2016:
Cost utility analysis of the SQ(®) HDM SLIT-tablet in house dust mite allergic asthma patients in a German setting

Kunkle, C.M.; Hallock, J.L.; Hu, X.; Blomquist, J.; Thung, S.F.; Werner, E.F., 2016:
Cost utility analysis of urethral bulking agents versus midurethral sling in stress urinary incontinence

Mari, K.; Dégieux, P.; Mistretta, F.; Guillemin, F.; Richette, P., 2016:
Cost utility modeling of early vs late total knee replacement in osteoarthritis patients

Njei, B.; McCarty, T.R.; Varadarajulu, S.; Navaneethan, U., 2016:
Cost utility of ERCP-based modalities for the diagnosis of cholangiocarcinoma in primary sclerosing cholangitis

Von Bargen, E.; Patterson, D., 2016:
Cost utility of the treatment of stress urinary incontinence

Brauer, D.G.; Hawkins, W.G.; Strasberg, S.M.; Brunt, L.Michael.; Jaques, D.P.; Mercurio, N.R.; Hall, B.L.; Fields, R.C., 2016:
Cost variation in a laparoscopic cholecystectomy and the association with outcomes across a single health system: implications for standardization and improved resource utilization

Kennedy, R.S.; Starker, R.A.; Feldman, K.A.; Tashiro, J.; Perez, E.A.; Mendoza, F.G.; Sola, J.E., 2016:
Cost varies with procedure type in pediatric GI foreign bodies

Dalton, C.Marsh.; Warren, P.L., 2018:
Cost versus control: Understanding ownership through outsourcing in hospitals

Warren, B., 2016:
Cost versus investment: how does the C-suite view the security function?

Capitanescu, F.; Rege, S.; Marvuglia, A.; Benetto, E.; Ahmadi, A.; Gutiérrez, T.Navarrete.; Tiruta-Barna, L., 2017:
Cost versus life cycle assessment-based environmental impact optimization of drinking water production plants

Ramos, M.; Haughney, J.; Henry, N.; Lindner, L.; Lamotte, M., 2016:
Cost versus utility of aclidinium bromide 400 µg plus formoterol fumarate dihydrate 12 µg compared to aclidinium bromide 400 µg alone in the management of moderate-to-severe COPD

Rawlins, M.D., 2016:
Cost, Effectiveness, and Value: How to Judge?

Myers, N.; Wehrwein, P., 2015:
Cost, Outcomes Mixed for Tele-ICU

Schoen, M.E.; Xue, X.; Wood, A.; Hawkins, T.R.; Garland, J.; Ashbolt, N.J., 2016:
Cost, energy, global warming, eutrophication and local human health impacts of community water and sanitation service options

Bazzoli, F., 2016:
Cost- Effective Imaging

Grekova, D.; Dimitrova, M.; Andreevska, K.; Petkova, V.; Madzharov, V.; Gueorguiev, S.; Petrova, G., 2014:
Cost- Effectiveness of Real Life Asthma Pharmacotherapy

Petrov, M.K.; Dimitrova, M.; Petrova, G.I., 2014:
Cost- Minimization Analysis of the Direct Costs of Sevelamer Carbonate and Lanthanum Carbonate in the Treatment of Ckd-Nd Patients

Gerson, L.B., 2016:
Cost-Analyses Studies in Barrett's Esophagus: What Is Their Utility?

Tatar, M.; Senturk, A.; Ergin, G.; Tuna, E.; Mat, C.; Bulbul, B.E.; Artuz, F.; Gurer, M.A.; Atakan, N.; Inaloz, S.; Sezen, S.; Keskinaslan, A.; Saylan, M., 2014:
Cost-Analysis of Chronic Idiopathic Urticaria Disease

Dik, J-Willem.H.; Dinkelacker, A.G.; Vemer, P.; Lo-Ten-Foe, J.R.; Lokate, Mëtte.; Sinha, B.; Friedrich, A.W.; Postma, M.J., 2016:
Cost-Analysis of Seven Nosocomial Outbreaks in an Academic Hospital

Wu, H.; Shi, Q., 2015:
Cost-Benefit Analysis Of Yindanxintai Dropping Pills In The Treatment Of Angina Pectoris Caused By Coronary Heart Disease

Paine, T.D.; Millar, J.G.; Hanks, L.M.; Gould, J.; Wang, Q.; Daane, K.; Dahlsten, D.L.; Mcpherson, E.G., 2016:
Cost-Benefit Analysis for Biological Control Programs That Targeted Insect Pests of Eucalypts in Urban Landscapes of California

Špačková, O.; Straub, D., 2015:
Cost-Benefit Analysis for Optimization of Risk Protection Under Budget Constraints

Ma, J.; Liu, G.; Yao, Y.; Xu, F.; Lv, N., 2014:
Cost-Benefit Analysis of Bacterial Lysates for Chronic Obstructive Pulmonary Disease in China

Liu, W.; Chen, W.; Feng, Q.; Peng, C.; Kang, P., 2016:
Cost-Benefit Analysis of Green Infrastructures on Community Stormwater Reduction and Utilization: A Case of Beijing, China

Brown, P.; Daigneault, A., 2015:
Cost-Benefit Analysis of Managing the Papuana uninodis (Coleoptera: Scarabaeidae) Taro Beetle in Fiji

Rogers-Vizena, C.R.; Sporn, S.Flath.; Daniels, K.M.; Padwa, B.L.; Weinstock, P., 2016:
Cost-Benefit Analysis of Three-Dimensional Craniofacial Models for Midfacial Distraction: A Pilot Study

Balbinotto, G.; Rodriguez, S.; BrandÃo, A., 2015:
Cost-Benefit Analysis of Whole Body Bone Scintilography in the Pre-Trasnplant Assesment of Adult Patients Beares of Hepatocellular Carcinoma in a Liver Tranaplant List in the South of Brazil

Naunheim, M.R.; Kozin, E.D.; Sethi, R.K.; Ota, H.Gregory.; Gray, S.T.; Shrime, M.G., 2016:
Cost-Benefit Analysis of an Otolaryngology Emergency Room Using a Contingent Valuation Approach

Kolstad, C.; Zavras, A.; Yoon, R.K., 2017:
Cost-Benefit Analysis of the Age One Dental Visit for the Privately Insured

Joliat, Gëtan-Romain.; Labgaa, Iïl.; Hübner, M.; Blanc, C.; Griesser, A-Claude.; Schäfer, M.; Demartines, N., 2017:
Cost-Benefit Analysis of the Implementation of an Enhanced Recovery Program in Liver Surgery

Beresniak, A.; Schmidt, A.; Proeve, J.; Bolanos, E.; Patel, N.; Ammour, N.; Sundgren, M.; Ericson, M.; De Moor, G.; Kalra, D.; Dupont, D., 2014:
Cost-Benefit Assessment of the Electronic Health Records for Clinical Research (EHR4CR) European Project

Praet, C.; D'Oca, K., 2014:
Cost-Benefit Model of Varying Nexplanon and Other Long-Acting Reversible Contraceptive (Larc) Methods: Uptake Compared to the Oral Contraceptive Pill: UK Perspective

Franch-Arcas, Gán.; González Sánchez, Mía.del.Carmen., 2016:
Cost-Benefit Study of Ventral Hernia Repair and My Problems With Arithmetics

Hübner, C.; Hübner, N.O.; Kramer, A.; Flessa, S., 2014:
Cost-Benefit-Analysis of a Targeted Hospital Wide Pcr-Based Admission Screening for Mrsa in a German University Hospital - Consideration of a Six-Year Time Period

Hakimoglu, S.; Hancı, V.; Karcıoglu, M.; Tuzcu, Kım.; Davarcı, Iıl.; Kiraz, H.Ali.; Turhanoglu, S., 2015:
Cost-Conscious of Anesthesia Physicians: An awareness survey

Benson, M.K., 2016:
Cost-Consciousness in Teaching Hospitals

Simoncelli, Mève.; Samson, J.; Bussières, J-François.; Lacroix, J.; Dorais, M.; Battista, R.; Perreault, S., 2015:
Cost-Consequence Analysis of Nitisinone for Treatment of Tyrosinemia Type I

Rosti, G.; Ravasio, R., 2014:
Cost-Consequence Analysis of an Aprepitant Regimen Versus a Standard Antiemetic Regimen for the Prevention of Highly Emetogenic Chemotherapy-Induced Nausea and Vomiting in Italy

Peral, C.; Rejas, J.; Ramos, J.; Sanchez-Ballester, F.; Garcia-Mediero, J.M., 2015:
Cost-Consequences Analysis Of Fesoterodine At Flexible-Dose In The Therapy Of Overactive Bladder In Routine Medical Practice

Cipolla, A.; Cultrera, D.; Teruzzi, C.; Mantuano, M., 2014:
Cost-Consequences Analysis of the Long-Term Prophylaxis In A Type 1 Von Willebrand Disease Patient With Recurrent Bleedings In Italy

Pape, H-Christoph.; Neugebauer, E.; Ridley, S.A.; Chiara, O.; Nielsen, T.G.; Christensen, M.C., 2009:
Cost-Drivers in Acute Treatment of Severe Trauma in Europe: A Systematic Review of Literature

Fast, S.M.; González, M.C.; Markuzon, N., 2016:
Cost-Effective Control of Infectious Disease Outbreaks Accounting for Societal Reaction

Singh, A.; Brooks, M.M.; Voorhees, R.E.; Potter, M.A.; Roberts, M.S.; Luther, J.F.; Wisniewski, S.R., 2016:
Cost-Effective Drug Switch Options After Unsuccessful Treatment With an SSRI for Depression

Saleem, K.; Derhab, A.; Orgun, M.A.; Al-Muhtadi, J.; Rodrigues, J.J.P.C.; Khalil, M.Sayim.; Ali Ahmed, A., 2016:
Cost-Effective Encryption-Based Autonomous Routing Protocol for Efficient and Secure Wireless Sensor Networks

Pozo, L.; Paladio-Hernández, Já., 2015:
Cost-Effective Evaluation of Pirfenidone for Treating Idiopathic Pulmonary Fibrosis in Mexico

Moral, M.; Son, W-J.; Sancho-García, J.C.; Olivier, Y.; Muccioli, L., 2015:
Cost-Effective Force Field Tailored for Solid-Phase Simulations of OLED Materials

Yang, C-Hsien.; Hsu, C-Ping.; Lee, S-Long.; Wang, K-Wen.; Chang, J-Kuei., 2016:
Cost-Effective Hierarchical Catalysts for Promoting Hydrogen Release from Complex Hydrides

Ramírez-Pérez, M.; Röttgers, Rüdiger.; Torrecilla, E.; Piera, J., 2015:
Cost-Effective Hyperspectral Transmissometers for Oceanographic Applications: Performance Analysis

Fletcher, G.John.; Anantharam, R.; Radhakrishnan, K.; Karunakaran, A.; Abraham, P., 2016:
Cost-Effective In-House Neutralization Assay for the Confirmation of HBeAg

Prakash, L.; Himaja, M.; Ramakrishna Yadav, B.; Maheshwara Reddy, A., 2016:
Cost-Effective Isolation of a Process Impurity of Pregabalin

Wu, P-Yuan.; Fang, C-Chen.; Chang, J.Morris.; Kung, S-Yuan., 2016:
Cost-Effective Kernel Ridge Regression Implementation for Keystroke-Based Active Authentication System

Gormley, A.M.; Forsyth, D.M.; Wright, E.F.; Lyall, J.; Elliott, M.; Martini, M.; Kappers, B.; Perry, M.; McKay, M., 2016:
Cost-Effective Large-Scale Occupancy-Abundance Monitoring of Invasive Brushtail Possums (Trichosurus Vulpecula) on New Zealand's Public Conservation Land

Oinonen, S.; Hyytiäinen, K.; Ahlvik, L.; Laamanen, M.; Lehtoranta, V.; Salojärvi, J.; Virtanen, J., 2016:
Cost-Effective Marine Protection--A Pragmatic Approach

Chatterjee, R.; Chatterjee, S., 2016:
Cost-Effective Recruitment need for 24x7 Paediatricians in the State General Hospitals in Relation to the Reduction of Infant Mortality

Schneider, B.A., 2016:
Cost-Effective Solutions to Mental Health Barriers Attributable to Budgetary and Qualified Personnel Inefficiencies

Arkadopoulos, N.; Gemenetzis, G.; Danias, N.; Kokoropoulos, P.; Koukopoulou, I.; Bartsokas, C.; Kostopanagiotou, G.; Smyrniotis, V., 2017:
Cost-Effective Surgical Management of Liver Disease Amidst a Financial Crisis

Lipparini, F.; Gauss, Jürgen., 2016:
Cost-Effective Treatment of Scalar Relativistic Effects for Multireference Systems: A CASSCF Implementation Based on the Spin-free Dirac-Coulomb Hamiltonian

Phothong, N.; Akaraviputh, T.; Chinswangwatanakul, V.; Methasate, A.; Trakarnsanga, A., 2015:
Cost-Effective and Potential Benefits in Three-Port Hand-Assisted Laparoscopic Sigmoidectomy

Kang, D.Won.; Lim, K.Soo.; Lee, K.Jin.; Lee, J.Hyeon.; Lee, W.Ram.; Song, J.Hwa.; Yeom, K.Hyun.; Kim, J.Young.; Hong, C.Seop., 2016:
Cost-Effective, High-Performance Porous-Organic-Polymer Conductors Functionalized with Sulfonic Acid Groups by Direct Postsynthetic Substitution

Lorenzoni, V.; Pierotti, F.; Bellelli, S.; Neglia, D.; Rovai, D.; Turchetti, G., 2014:
Cost-Effectiveness (CE) of Imaging-Guided Strategies for the Diagnosis of Coronary Artery Disease (CAD): Results From the Evinci Study

Bregman, C.; Paubel, P.; Levy, P.; Doutriaux, A.; Gauthier, A.; Cognet, M., 2015:
Cost-Effectiveness Analyses In France, England And Canada: Comparative Analysis Of Structural Choices, Results And Perspectives

Raymakers, A.J.N.; Mayo, J.; Lam, S.; FitzGerald, J.Mark.; Whitehurst, D.G.T.; Lynd, L.D., 2017:
Cost-Effectiveness Analyses of Lung Cancer Screening Strategies Using Low-Dose Computed Tomography: a Systematic Review

Si, L.; Winzenberg, T.M.; Wang, L.; Palmer, A.J., 2014:
Cost-Effectiveness Analyses of Screening and Treatment Strategies for Postmenopausal Osteoporosis in Chinese Women

Penner, M.; Rayar, M.; Bashir, N.; Roberts, S.Wendy.; Hancock-Howard, R.L.; Coyte, P.C., 2016:
Cost-Effectiveness Analysis Comparing Pre-diagnosis Autism Spectrum Disorder (ASD)-Targeted Intervention with Ontario's Autism Intervention Program

Greenberg, D.; Neumann, P.J., 2018:
Cost-Effectiveness Analysis Expands its Reach Worldwide

Franco Figueira, S.; Cachoeira, C.V.; Petry Hasegawa, A.C.; Kano, B.Y.; Souza, F.H.; Poulios, N., 2015:
Cost-Effectiveness Analysis For Cervical Cancer Screening Using Hpv Tests In Brazil

Franco Figueira, S.; Cachoeira, C.V.; Souza, F.H.; Kano, B.Y.; Silva, M.; Poulios, N., 2015:
Cost-Effectiveness Analysis For Cervical Cancer Screening Using Hpv Tests In Chile

Iannazzo, S.; Colombatto, P.; Bonino, F.; Brunetto, M.R., 2014:
Cost-Effectiveness Analysis Of A Personalized Therapy For Genotype 1, Naive, Chronic Hepatitis C Patients In Italy

Berdunov, V.; Avery, A.J.; Elliott, R.A., 2015:
Cost-Effectiveness Analysis Of Alternative Strategies Of Monitoring For Amiodarone-Related Thyroid Toxicity In Uk Primary Care

Palka-Santini, M.; Motrunich, A.; Maunoury, F., 2014:
Cost-Effectiveness Analysis Of An Antimicrobial Transparent Dressing For Protecting Central Vascular Accesses In Critically Ill Patients Versus Standard Transparent Dressings In France: A Comparison Of Two Modeling Approaches: Decision-Tree Versus Non-Homogeneous Markov Model

Pyadushkina, E.; Avxentyeva, M.; Omelyanovsky, V.V.; Treur, M.; Westerhout, K.Y., 2014:
Cost-Effectiveness Analysis Of Antiviral Pharmacotherapies For Treatment Of Chronic Hepatitis C Virus Infection In Russia

Aguirre, A.; Carlos, F.; Naranjo, M.; Fernandez, C., 2015:
Cost-Effectiveness Analysis Of Bemiparin Used As Acute Treatment For Deep Venous Thrombosis Without Pulmonary Embolism

Dozsa, C.; Malbaski, N.; Borcsek, B., 2015:
Cost-Effectiveness Analysis Of Capsule Endoscopy Using For Diagnosing Small Bowel Crohn's Disease

Suarez, J., 2015:
Cost-Effectiveness Analysis Of Cetuximab And Panitumumab For First Line Treatment Of Metastatic Colorectal Cancer (Mcrc) In Wt Ras Patients In Spain

Zhu, S.; Yao, G.; Halligan, S.; Atkin, W.; Dadswell, E.; Wooldrage, K.; Lilford, R.J., 2014:
Cost-Effectiveness Analysis Of Computed Tomographic Colonography Versus Double Contrast Barium Enema For Investigation Of Patients With Symptoms Of Colorectal Cancer: Economic Evaluation Alongside The Siggar Trial

Malbaski, N.; Balazs, T.; Dozsa, C.; Zima, E., 2015:
Cost-Effectiveness Analysis Of Continuous Remote Monitoring Of Heart Failure Patients With Cardiac Electronic Implantable Device

Kourlaba, G.; Gourzoulidis, G.; Aravantinos, G.; Athanasiadis, I.; Lyman, G.H.; Villa, G.; Papagiannopoulou, V.; Tritaki, G.; Maniadakis, N., 2015:
Cost-Effectiveness Analysis Of Granulocyte Colony-Stimulating Factors For The Prophylaxis Of Chemotherapy-Induced Febrile Neutropenia In Patients With Breast Cancer In Greece

Gourzoulidis, G.; Kourlaba, G.; Apostolidis, J.; Lyman, G.H.; Villa, G.; Papagiannopoulou, V.; Tritaki, G.; Maniadakis, N., 2015:
Cost-Effectiveness Analysis Of Granulocyte Colony-Stimulating Factors For The Prophylaxis Of Chemotherapy-Induced Febrile Neutropenia In Patients With Non-Hodgkin's Lymphoma In Greece

Coretti, S.; Codella, P.; Romano, F.; Ruggeri, M.; Cicchetti, A., 2016:
Cost-Effectiveness Analysis Of Herpes Zoster Vaccination In Italian Elderly Persons

Fernandez, d.Bobadilla.J.; Gonzalez, F.O.; Lopez, d.Sa.E.; Lopez-Sendon, J.L., 2014:
Cost-Effectiveness Analysis Of Ivabradine In Heart Failure With Reduced Left Ventricular Ejection Fraction In Spain

Pradelli, L.; Bellone, M.; Era, S.; Campagnoli, E., 2015:
Cost-Effectiveness Analysis Of Neo-Adjuvant Pertuzumab Therapy In Women With Locally Advanced, Inflammatory, Or Early Her2-Positive Breast Cancer In Italy

Paquete, A.; Miguel, L.S.; Pereira, C.; Pinto, C.G., 2015:
Cost-Effectiveness Analysis Of Obinutuzumab For Previously Untreated Chronic Lymphocytic Leukemia (Cll) In Portuguese Patients That Are Unsuitable For Full-Dose Fludarabine Based Therapy

Yagudina, R.; Kulikov, A.; Babiy, V.V., 2015:
Cost-Effectiveness Analysis Of Obinutuzumab/Chlorambucil Vs Rituximab/Chlorambucil In Treatment Of Chronic Lymphocytic Leukemia

Vargas-Valencia, J.; Garcia Perlaza, J., 2015:
Cost-Effectiveness Analysis Of Panitumumab + Folfox Compared To Cetuximab + Folfiri As First-Line Treatment For Patients With Wild-Type (Wt) Ras (Exons 2, 3, And 4 Of Kras And Nras) Metastatic Colorectal Cancer (Mcrc) In Colombia

Tange, C.; Kunisawa, S.; Maeda, S.; Shimozuma, K., 2015:
Cost-Effectiveness Analysis Of Pertuzumab For Metastatic Her2-Positive Breast Cancer In Japan

Correia, V.; André, S.; Van de Velde, N., 2015:
Cost-Effectiveness Analysis Of Phid-Cv Routine Vaccination Programme Compared To Pcv-13 In Portugal

Geitona, M.; Kousoulakou, H.; Kalogeropoulou, M.; Mitsiki, E.; Panitti, E.; Steiropoulos, P., 2015:
Cost-Effectiveness Analysis Of The Fixed Combination Indacaterol/Glycopyrronium Vs. Tiotropium And Salmeterol/ Fluticasone In The Management Of Copd In Greece

Wu, D.B.C.; Lee, B.S.C.; Lee, K.K.C., 2014:
Cost-Effectiveness Analysis Of Ticagrelor In Treating Patients With Acute Coronary Syndrome In Hong Kong

Karbusicka, M.; Kolek, M.; Vothova, P.; Duba, J.; Kralikova, E.; Rublee, D.; Doleckova, J., 2015:
Cost-Effectiveness Analysis Of Tobacco Dependence Treatment In The Czech Republic

Ruiz-Antorán, B.; Pascasio, J.M.; Gea, F.; Barcena, R.; Larrubia, J.; Pérez, Álvarez.R.; Sousa, J.; Romero, Gómez.M.; Solá, R.; de, l.Revilla.J.; Crespo, J.; Navarro, J.; Arenas, J.; Delgado, M.; Fernández, Ríguez.C.; Planas, R.; Buti, M.; Forns, X.; Calleja, J.L., 2014:
Cost-Effectiveness Analysis Of Triple Therapy With Peginterferon, Ribavirin, And Boceprevir For The Treatment Of Chronic Hepatitis C Virus Genotype 1 With Severe Fibrosis Under "Real-Life" Conditions

Rochau, U.; Vukicevic, D.; Schmidt, S.; Stenehjem, D.; Brixner, D.; Radich, J.; Gastl, G.; Siebert, U., 2015:
Cost-Effectiveness Analysis on Starting Patients with Chronic Myeloid Leukemia on a Highly Potent Tyrosine Kinase Inhibitor and Early Switching to Imatinib

de Pouvourville, G., 2015:
Cost-Effectiveness Analysis for The Use of The Ccp Score In The Management of Early Low Risk Prostate Cancer In The French Context

Williams, C.; Lewsey, J.D.; Briggs, A.H.; Mackay, D.F., 2016:
Cost-effectiveness Analysis in R Using a Multi-state Modeling Survival Analysis Framework: A Tutorial

Ttc, N.; Ttt, N., 2014:
Cost-Effectiveness Analysis of 1-Year Adjuvant Trastuzumab Therapy of Early-Stage Her2-Positive Breast Cancer

Stawowczyk, E.; Kawalec, Pł.; Pilc, A., 2017:
Cost-Effectiveness Analysis of 1-Year Treatment with Golimumab/Standard Care and Standard Care Alone for Ulcerative Colitis in Poland

Martínez-Cerón, E.; García, A.; Casitas, R.; Galera, R.; García-Río, F., 2016:
Cost-Effectiveness Analysis of 3 Methacholine Challenge Tests: Importance of Simplified Protocols

Obando, C.A.; Desanvicente-Celis, Z.; Gonzalez, L.; Muschett, D.; Gonzalez, F.; Goldberg, P., 2014:
Cost-Effectiveness Analysis of Abiraterone Acetate Treatment Compared With Cabacitaxel in Costa Rica, in Patients with Metastatic Castration-Resistant Prostate Cancer That Have Failed to Chemotherapy with Docetaxel

Obando, C.A.; Desanvicente-Celis, Z.; Gonzalez, L.; Muschett, D.; Gonzalez, F.; Goldberg, P., 2014:
Cost-Effectiveness Analysis of Abiraterone Acetate Treatment Compared with Cabacitaxel in Dominican Republic, in Patients With Metastatic Castration-Resistant Prostate Cancer that Have Failed to Chemotherapy with Docetaxel

Obando, C.A.; Desanvicente-Celis, Z.; Gonzalez, L.; Muschett, D.; Gonzalez, F.; Goldberg, P., 2014:
Cost-Effectiveness Analysis of Abiraterone Acetate Treatment Compared with Cabacitaxel in the Republic of Panama, in Patients with Metastatic Castration-Resistant Prostate Cancer that Have Failed to Chemotherapy with Docetaxel

Soni, A.; Aspinall, S.L.; Zhao, X.; Good, C.B.; Cunningham, F.E.; Chatta, G.; Passero, V.; Smith, K.J., 2016:
Cost-Effectiveness Analysis of Adjuvant Stage III Colon Cancer Treatment at Veterans Affairs Medical Centers

Valero, A.; Westerhout, K.Y.; van de Wetering, G.; Pérez-Alcántara, F.; Azpeitia, A.; Najib, M., 2014:
Cost-Effectiveness Analysis of Allergen Immunotherapy in Patients With Grass Pollen-Induced Allergic Rhinitis in Spain

Bermingham, S.L.; Hughes, R.; Fenu, E.; Sawyer, L.M.; Boxall, E.; T Kennedy, P.; Dusheiko, G.; Hill-Cawthorne, G.; Thomas, H., 2016:
Cost-Effectiveness Analysis of Alternative Antiviral Strategies for the Treatment of HBeAg-Positive and HBeAg-Negative Chronic Hepatitis B in the United Kingdom

Soto, M.H.; Díaz, Mínez.J.P.; Escobar, Járez.Y.; Fernández, D.Valle.C., 2014:
Cost-Effectiveness Analysis of Amfepramone (Diethylpropion) for the Obesity Treatment In Mexico

Visco, A.G.; Zyczynski, H.; Brubaker, L.; Nygaard, I.; Xu, X.; Lukacz, E.S.; Paraiso, M.Fidela.; Greer, J.; Rahn, D.D.; Meikle, S.F.; Honeycutt, A.A., 2017:
Cost-Effectiveness Analysis of Anticholinergics Versus Botox for Urgency Urinary Incontinence: Results From the Anticholinergic Versus Botox Comparison Randomized Trial

Yagudina, R.; Kulikov, A.; Babiy, V., 2014:
Cost-Effectiveness Analysis of Autocoded and Manually Coded Blood Glucose Meters In Diabetes Treatment

Vallejo-Aparicio, L.A.; Díaz-Cerezo, S.; Parrondo, J.; García-Aparicio, A.M., 2014:
Cost-Effectiveness Analysis of Belimumab In the Treatment of Adult Systemic Lupus Erythematosus (Sle) Patients With Positive Biomarkers In Spain

Mlcoch, T.; Klimes, J.; Kruntoradova, K.; Mandelikova, M.; Dolezal, T., 2014:
Cost-Effectiveness Analysis of Bendamustin-Rituximab Compared to Chop-Rituximab in the Treatment of Indolent Follicular Non-Hodgkin Lymhoma in the Czech Republic

Sabater, E.; López-Guillermo, A.; Rueda, A.; Salar, A.; Oyagüez, I.; Collar, J.Manuel., 2017:
Cost-Effectiveness Analysis of Bendamustine Plus Rituximab as a First-Line Treatment for Patients with Follicular Lymphoma in Spain

Garcia Lopez, J.L.; Rodriguez, B.J.M.; Puig-Junoy, J.; Carrato, M.A., 2014:
Cost-Effectiveness Analysis of Bevacizumab, Fotemustine and Extended-Dose Temozolomide in Patients with Recurrent Glioblastoma in Spain

Tran, T.T.H.; Nguyen, T.T.T., 2014:
Cost-Effectiveness Analysis of Bevacizumab- Paclitaxel-Carboplatin (PC) Versus PC in First-Line Therapy of Advanced Non-Small Cell Lung Cancer from Patients' Perspective in Vietnam

Golestani, M.; Eshghi, P.; Rasekh, H.Reza.; Cheraghali, A.Majid.; Salamzadeh, J.; Naderi, M.; Managhchi, M.Reza.; Hoorfar, H.; Toogeh, G.Reza.; Imani, A.; Khodayari, M.Taghi.; Habibpanah, B.; Hantooshzadeh, R., 2016:
Cost-Effectiveness Analysis of Biogeneric Recombinant Activated Factor VII (AryoSeven™) and Activated Prothrombin Complex Concentrates (FEIBA™) to Treat Hemophilia A Patients with Inhibitors in Iran

Yagudina, R.; Kulikov, A.; Ugrekhelidze, D., 2015:
Cost-Effectiveness Analysis of Botulinum Toxin Type a Treatment for Cerebral Palsy

Zehtab, N.; Jafari, M.; Barooni, M.; Nakhaee, N.; Goudarzi, R.; Larry Zadeh, M.Hassan., 2017:
Cost-Effectiveness Analysis of Breast Cancer Screening in Rural Iran

Razdan, S.N.; Cordeiro, P.G.; Albornoz, C.R.; Ro, T.; Cohen, W.A.; Mehrara, B.J.; McCarthy, C.M.; Disa, J.J.; Pusic, A.L.; Matros, E., 2016:
Cost-Effectiveness Analysis of Breast Reconstruction Options in the Setting of Postmastectomy Radiotherapy Using the BREAST-Q

Yagudina, R.; Kulikov, A.; Pochuprina, A., 2015:
Cost-Effectiveness Analysis of Canacinumab In The Treatment of Patients Suffering From Systemic Juvenile Idiopathic Arthritis In Russian Federation

Chayakulkeeree, M.; Numuang, K.; Lerdlitruangsin, S.; Itzler, R., 2014:
Cost-Effectiveness Analysis of Caspofungin Compared to Conventional Amphotericin B (C-AMB) for Empirical Antifungal Therapy in Febrile Neutropenic Patients in Thailand

Kawaguchi, I.; Kamae, I.; Soen, S.; Sakamoto, C., 2014:
Cost-Effectiveness Analysis of Celecoxib In the Treatment of Patients With Chronic Pain In Japan

Kulikov, A.; Abdrashitova, G., 2015:
Cost-Effectiveness Analysis of Cerebrolysin In The Treatment of Patients With Acute Ischemic Stroke Moderate and Severe Degrees of Severity In The Russian Federation

Sher, D.J.; Fidler, M.Jo.; Tishler, R.B.; Stenson, K.; al-Khudari, S., 2016:
Cost-Effectiveness Analysis of Chemoradiation Therapy Versus Transoral Robotic Surgery for Human Papillomavirus-Associated, Clinical N2 Oropharyngeal Cancer

Drees, L.; Theidel, U.; Campbell, C.M.; Popelar, B.V.; O'Day, K.; Mittendorf, T., 2014:
Cost-Effectiveness Analysis of Coffee Consumption for Prevention of All-Cause Mortality in Germany

Zaytsev, A.; Makarevich, A.; Kondratyeva, T., 2014:
Cost-Effectiveness Analysis of Community-Acquired Pneumonia Treatment

Zhao, M.; Feng, W.; Zhang, L.; Ke, X.; Zhang, W.; Xuan, J., 2015:
Cost-Effectiveness Analysis of Conbercept Versus Ranibizumab For The Treatment of Age-Related Macular Degeneration In China

Kawamoto, Y.; Mouri, M.; Taira, T.; Iseki, H.; Masamune, K., 2017:
Cost-Effectiveness Analysis of Deep Brain Stimulation in Patients with Parkinson's Disease in Japan

Gasche, D.; Restovic, G.; Casado, V.; Ramírez-Boix, P.; Martínez Lopez, J., 2015:
Cost-Effectiveness Analysis of Delayed-Release Dimethyl Fumarate for The Treatment of Relapsing Remitting Multiple Sclerosis In Spain

Furneri, G.; Santoni, L.; Marchesi, C.; Iannazzo, S.; Cortesi, P.; Piacentini, P.; Caputi, A.; Mantovani, L.G., 2015:
Cost-Effectiveness Analysis of Delayed-Release Dimethyl-Fumarate In The Treatment of Relapsing-Remitting Multiple Sclerosis In Italy

Neidell, M.; Shearer, B.; Lamster, I.B., 2017:
Cost-Effectiveness Analysis of Dental Sealants versus Fluoride Varnish in a School-Based Setting

Chen, Y-Erh.; Kao, S-Shuo.; Chung, R-Hua., 2017:
Cost-Effectiveness Analysis of Different Genetic Testing Strategies for Lynch Syndrome in Taiwan

Tantitamit, T.; Termrungruanglert, W.; Oranratanaphan, S.; Niruthisard, S.; Tanbirojn, P.; Havanond, P., 2016:
Cost-Effectiveness Analysis of Different Management Strategies for Detection CIN2+ of Women with Atypical Squamous Cells of Undetermined Significance (ASC-US) Pap Smear in Thailand

Riesco-Martínez, M.Carmen.; Berry, S.R.; Ko, Y-Joung.; Mittmann, N.; Giotis, A.; Lien, K.; Wong, W.W.L.; Chan, K.K.W., 2017:
Cost-Effectiveness Analysis of Different Sequences of the Use of Epidermal Growth Factor Receptor Inhibitors for Wild-Type KRAS Unresectable Metastatic Colorectal Cancer

Granados-García, Víctor.; Contreras, A.M.; García-Peña, C.; Salinas-Escudero, G.; Thein, H-Hla.; Flores, Y.N., 2017:
Cost-Effectiveness Analysis of Different Testing Strategies that Use Antibody Levels to Detect Chronic Hepatitis C in Blood Donors

Sun, L.; Dong, H.; Sun, J.; Wang, Y.; Shi, W.; Zhao, X.; Wu, J., 2014:
Cost-Effectiveness Analysis of Different Therapeutic Regimens in Treatment of Community-Acquired Pneumonia in China

Hren, R.; Refoios Camejo, R., 2014:
Cost-Effectiveness Analysis of Dolutegravir for HIV Patients in Slovenia

Acevedo, J.R.; Fero, K.E.; Wilson, B.; Sacco, A.G.; Mell, L.K.; Coffey, C.S.; Murphy, J.D., 2016:
Cost-Effectiveness Analysis of Elective Neck Dissection in Patients With Clinically Node-Negative Oral Cavity Cancer

Parrondo, J.; Rincón, Ríguez.D.; Romero, Gómez.M.; Sola, L.R.; Roldán, C., 2014:
Cost-Effectiveness Analysis of Eltrombopag As Support Treatment In Chronic Hcv Infected Patients With Thrombocytopenia To Enable Interferon-Based Regimens

Chang, H.Won.; Shin, S.Hun.; Suh, S.Hyun.; Kim, B-Soo.; Rho, M.Ho., 2016:
Cost-Effectiveness Analysis of Endovascular Coiling versus Neurosurgical Clipping for Intracranial Aneurysms in Republic of Korea

Mateus, C.; Moura, A., 2014:
Cost-Effectiveness Analysis of Etanercept in the Treatment of Rheumatoid Arthritis In Portugal

Deng, J.; Gu, S.; Shao, H.; Dong, H.; Zhao, Y.; Shi, L., 2015:
Cost-Effectiveness Analysis of Exenatide Twice Daily (BID) Versus Insulin Glargine Once Daily (QD) as Add-on Therapy in Chinese Patients with Type 2 Diabetes Mellitus Inadequately Controlled by Oral Therapies

Luca, N.J.; Burnett, H.F.; Ungar, W.J.; Moretti, M.E.; Beukelman, T.; Feldman, B.M.; Schwartz, G.; Bayoumi, A.M., 2016:
Cost-Effectiveness Analysis of First-Line Treatment With Biologic Agents in Polyarticular Juvenile Idiopathic Arthritis

Permsuwan, U.; Chaiyakunapruk, N.; Nathisuwan, S.; Sukonthasarn, A., 2014:
Cost-Effectiveness Analysis of Fondaparinux Versus Enoxaparin in Non-St Elevation Acute Coronary Syndrome in Thailand

Permsuwan, U.; Chaiyakunapruk, N.; Nathisuwan, S.; Sukonthasarn, A., 2016:
Cost-Effectiveness Analysis of Fondaparinux vs Enoxaparin in Non-ST Elevation Acute Coronary Syndrome in Thailand

Krysanov, I.; Krysanova, V., 2014 :
Cost-Effectiveness Analysis of Fulvestrant in the Treatment of Metastatic Breast Cancer in Second-Line Chemotherapy

Zhang, L.; Chen, W.; Wang, Y.; Ma, R.; Du, M.; Xu, X., 2015:
Cost-Effectiveness Analysis of Gestational Diabetes Mellitus Screening in Urban Chinese Setting

Kruntoradova, K.; Mandelikova, M.; Mlcoch, T.; Dolezal, T., 2015:
Cost-Effectiveness Analysis of Ginkgo Biloba Extract (Egb761® - Tanakan®) for The Treatment of Dementia In The Czech Republic

Han, X.; Ni, W., 2015:
Cost-Effectiveness Analysis of Glybera for The Treatment of Lipoprotein Lipase Deficiency

Menegueti, M.Goncalves.; Auxiliadora-Martins, M.; Nunes, A.Aparecido., 2016:
Cost-Effectiveness Analysis of Heat and Moisture Exchangers in Mechanically Ventilated Critically Ill Patients

Lee, D.; Park, S.Min., 2016:
Cost-Effectiveness Analysis of Hepatitis B Vaccination Strategies to Prevent Perinatal Transmission in North Korea: Selective Vaccination vs. Universal Vaccination

Lee, C.; You, J., 2015:
Cost-Effectiveness Analysis of Herpes Zoster Vaccination In Hong Kong

Zaytsev, A.; Makarevich, A., 2014:
Cost-Effectiveness Analysis of High-Dose Levofloxacin Therapy of Patients With Community-Acquired Pneumonia

Lévesque, R.; Marcelli, D.; Cardinal, Héloïse.; Caron, M-Line.; Grooteman, M.P.C.; Bots, M.L.; Blankestijn, P.J.; Nubé, M.J.; Grassmann, A.; Canaud, B.; Gandjour, A., 2016:
Cost-Effectiveness Analysis of High-Efficiency Hemodiafiltration Versus Low-Flux Hemodialysis Based on the Canadian Arm of the CONTRAST Study

Hove-Musekwa, S.D.; Nyabadza, F.; Mambili-Mamboundou, H.; Chiyaka, C.; Mukandavire, Z., 2014 :
Cost-Effectiveness Analysis of Hospitalization and Home-Based Care Strategies for People Living with HIV/AIDS: The Case of Zimbabwe

Soto, H.; Sanchez, K.; Escobar, Járez.Y.; Constanzo, A.; Fernandez, Z.; Melendez, C., 2014:
Cost-Effectiveness Analysis of Hydralazine and Magnesium Valproate LP Associated With Treatment for Adult Patients with Metastatic Recurrent or Persistent Cervical Cancer in Mexico

Pérez, A.; Mezquita Raya, P.; Ramírez de Arellano, A.; Briones, T.; Hunt, B.; Valentine, W.J., 2015:
Cost-Effectiveness Analysis of Incretin Therapy for Type 2 Diabetes in Spain: 1.8 mg Liraglutide Versus Sitagliptin

Granell, M.; Giovanna, M.; Paz, S.; Betoret, I., 2014:
Cost-Effectiveness Analysis of Indacaterol/Glycopirronium (QVA149) as a Maintenance Bronchodilator Treatment in Adult Patients With Chronic Obstructive Pulmonary Disease in Spain

Lambertenghi-Deliliers, G.; Oriani, A.; Pioltelli, P.; Pogliani, E.M.; Capri, S., 1991:
Cost-Effectiveness Analysis of Induction Regimens Containing Anthracyclines in Adult Acute Myelogenous Leukemia

Di Matteo, S.; Colombo, G.L.; Pellacani, G.; Bruno, G.M., 2014:
Cost-Effectiveness Analysis of Ingenolo Mebutato Verse Imiquimod in the Treatment of Actinic Keratoses in the Perspective of the Italian Health System

Morales, Cóbal.; de Luis, D.; de Arellano, A.Ramírez.; Ferrario, M.Giovanna.; Lizán, L., 2015:
Cost-Effectiveness Analysis of Insulin Detemir Compared to Neutral Protamine Hagedorn (NPH) in Patients with Type 1 and Type 2 Diabetes Mellitus in Spain

Ramírez, d.Arellano.A.; Lizán, L.; Prades, M.; Morales, C.; De, L.D., 2014:
Cost-Effectiveness Analysis of Insulin Detemir Versus Insulin Neutral Protamine Hagedorn (Nph) In Patients With Type 1 Diabetes Mellitus In Spain

Richard, P.; Phillips, M.; Smith, W.; Davidson, D.; Kim, E.; Kane, G., 2017:
Cost-Effectiveness Analysis of Intensity Modulated Radiation Therapy Versus 3-Dimensional Conformal Radiation Therapy for Preoperative Treatment of Extremity Soft Tissue Sarcomas

Murra Anton, Z.A., 2015:
Cost-Effectiveness Analysis of Intravitreal Aflibercept Compared with Ranibizumab-Prn in Patients with wet Age-Related Macular Degeneration (Wamd)

Castelo Branco, A.; Eriksson, M.; Nilsson, J., 2015:
Cost-Effectiveness Analysis of Intravitreal Aflibercept In Diabetic Macular Oedema In Sweden

Kourlaba, G.; Tzanetakos, C.; Datseris, J.; Rouvas, A.; Arzoumanidou, D.; Maniadakis, N., 2015:
Cost-Effectiveness Analysis of Intravitreal Aflibercept In The Treatment of Neovascular Age-Related Macular Degeneration In Greece

O'Day, K.; Levy, W.C.; Johnson, M.; Jacobson, A.F., 2017:
Cost-Effectiveness Analysis of Iodine-123 Meta-Iodobenzylguanidine Imaging for Screening Heart Failure Patients Eligible for an Implantable Cardioverter Defibrillator in the USA

Lee, D.; Porter, J.; Hatswell, A.J.; Hertel, N.; Walker, A., 2014:
Cost-Effectiveness Analysis of Ipilimumab in Previously Untreated Patients With Unresectable Malignant Melanoma in Scotland

Harrington, R.; Lee, E.; Yang, H.; Wei, J.; Messali, A.; Azie, N.; Wu, E.Q.; Spalding, J., 2016:
Cost-Effectiveness Analysis of Isavuconazole vs. Voriconazole as First-Line Treatment for Invasive Aspergillosis

Lee, Y.; Park, D.J.; Ko, S.K., 2014:
Cost-Effectiveness Analysis of Latanoprost Compared with Dorzolamide/Timolol Fixed Combination for the Treatment of Open-Angle Glaucoma and Ocular Hypertension Patients in Korea

Tilden, E.L.; Lee, V.R.; Allen, A.J.; Griffin, E.E.; Caughey, A.B., 2016:
Cost-Effectiveness Analysis of Latent versus Active Labor Hospital Admission for Medically Low-Risk, Term Women

Tzanetakos, C.; Melidonis, A.; Verras, C.; Kourlaba, G.; Maniadakis, N., 2014:
Cost-Effectiveness Analysis of Liraglutide Versus Sitagliptin or Exenatide in Patients With Inadequately Controlled Type 2 Diabetes On Oral Antidiabetic Drugs In Greece

Pereira, C.; Rubio, T.C.; Rubio, Ríguez.D., 2014:
Cost-Effectiveness Analysis of Maintenance Treatment With Rituximab In Patients With Follicular Lymphoma Responding To First Line Induction Therapy In Portugal

Jethwa, P.R.; Patel, T.D.; Hajart, A.F.; Eloy, J.Anderson.; Couldwell, W.T.; Liu, J.K., 2016:
Cost-Effectiveness Analysis of Microscopic and Endoscopic Transsphenoidal Surgery Versus Medical Therapy in the Management of Microprolactinoma in the United States

Bortoletto, P.; Einerson, B.D.; Miller, E.S.; Milad, M.P., 2015:
Cost-Effectiveness Analysis of Morcellation Hysterectomy for Myomas

Walker, B.; Powers-Fletcher, M.V.; Schmidt, R.L.; Hanson, K.E., 2016:
Cost-Effectiveness Analysis of Multiplex PCR with Magnetic Resonance Detection versus Empiric or Blood Culture-Directed Therapy for Management of Suspected Candidemia

Vennera, Mía.Del.Carmen.; Valero, A.; Uría, E.; Forné, C.; Picado, César., 2016:
Cost-Effectiveness Analysis of Omalizumab for the Treatment of Severe Persistent Asthma in Real Clinical Practice in Spain

Tolentino, A.C.; Schutz, V.; Peregrino, A.A., 2015:
Cost-Effectiveness Analysis of One-Piece Drainable Pouch Versus Two-Piece Drainable Pouch For Colostomates Under The Perspective of Patient's Out-of-Pocket Expenses, In Brazil

Hren, R., 2015:
Cost-Effectiveness Analysis of Opioid Substitution Treatment in Slovenia

Soto, M.H.; Sanchez, K.; Escobar, Járez.Y.; Constanzo, A.; Fernandez, Z.; Melendez, C., 2014 :
Cost-Effectiveness Analysis of Oxycodone Lp An Opioid Analgesic for Patients With Moderate To Severe Pain Secondary To Cancer In Mexico

Graham, C.N.; Hechmati, G.; Hjelmgren, J.; De Liège, F.; Lanier, J.; Knoof, A.; Knox, H.; Barber, B.; de Pouvourville, G., 2014:
Cost-Effectiveness Analysis of Panitumumab Plus Mfolfox6 Versus Bevacizumab Plus Mfolfox6 for First-Line Treatment of Patients with Wild-Type Ras Metastatic Colorectal Cancer

Kourlaba, G.; Boukovinas, I.; Saridaki, Z.; Papagiannopoulou, V.; Tritaki, G.; Maniadakis, N., 2014:
Cost-Effectiveness Analysis of Panitumumab+Mfolfox over Bevacizumab+Mfolfox as a First-Line Treatment for Metastatic Colorectal Cancer Patients with Wild-Type Ras in Greece

Iannazzo, S.; Santoni, L.; Saleri, C.; Puma, E.; Vestri, G.; Giuliani, L.; Canonico, P.L.; Centonze, D., 2015:
Cost-Effectiveness Analysis of Peginterferon Beta-1a In Italian Relapsing Remitting Multiple Sclerosis Management

Hernandez, L.; Guo, S.; Toro-Diaz, H.; Carroll, S.; Syed Farooq, S.F., 2015:
Cost-Effectiveness Analysis of Peginterferon Beta-1a In The Treatment of Relapsing-Remitting Multiple Sclerosis In Ireland

Hernandez, L.; Guo, S.; Toro-Diaz, H.; Carroll, S.; Syed Farooq, S.F., 2015:
Cost-Effectiveness Analysis of Peginterferon Beta-1a In The Treatment of Relapsing-Remitting Multiple Sclerosis In Scotland

Ono, Y.; Osuga, K.; Takura, T.; Nakamura, M.; Shibamoto, K.; Yamamoto, A.; Fujiwara, H.; Mimura, H.; Tomiyama, N., 2017:
Cost-Effectiveness Analysis of Percutaneous Sclerotherapy for Venous Malformations

Iannazzo, S.; McGarry, L.; Chiroli, S., 2015:
Cost-Effectiveness Analysis of Ponatinib In The Treatment of Chronic-Phase Chronic Myeloid Leukemia (Cp-Cml) In Sweden

Belousov, D.; Afanasieva, E., 2015:
Cost-Effectiveness Analysis of Pramipexole Extended Release Monotherapy In Early Parkinson`S Disease

Karbusicka, M.; Kolek, M.; Duba, J.; Vothova, P.; Dolec Kova, J., 2015:
Cost-Effectiveness Analysis of Pregabalin In The Treatment of Central Neuropathic Pain

Fust, K.; Li, X.; Maschio, M.; Villa, G.; Parthan, A.; Barron, R.; Weinstein, M.C.; Somers, L.; Hoefkens, C.; Lyman, G.H., 2016:
Cost-Effectiveness Analysis of Prophylaxis Treatment Strategies to Reduce the Incidence of Febrile Neutropenia in Patients with Early-Stage Breast Cancer or Non-Hodgkin Lymphoma

Oddershede, L.; Walker, S.; Paton, N.; Stöhr, W.; Dunn, D.; Sculpher, M.J., 2014:
Cost-Effectiveness Analysis of Protease Inhibitor Monotherapy Verse Ongoing Triple-Therapy in the Long-Term Management of HIV Patients

Athanasakis, K.; Boubouchairopoulou, N.; Retsa, M.P.; Maiese, E.M.; Elbasha, E.H.; Kyriopoulos, J., 2014:
Cost-Effectiveness Analysis of Raltegravir in Hiv-Infected Treatment Naive Patients in Greece

Goldstein, D.A.; Ahmad, B.B.; Chen, Q.; Ayer, T.; Howard, D.H.; Lipscomb, J.; El-Rayes, B.F.; Flowers, C.R., 2016:
Cost-Effectiveness Analysis of Regorafenib for Metastatic Colorectal Cancer

Qian, L., 2015:
Cost-Effectiveness Analysis of Rituximab in Treatmenting Diffuse Large B-Cell Lymphoma in China

Dos Santos, R.F.; Vargas-Valencia, J.J.; Giannopoulou, A.; Campioni, M., 2015:
Cost-Effectiveness Analysis of Romiplostim for The Treatment of Adult Chronic Immune Thrombocytopenic Purpura (Itp) In Brazil

Fukuda, H.; Moriwaki, K., 2018:
Cost-Effectiveness Analysis of Safety-Engineered Devices

Chuluunbaatar, E., 2014:
Cost-Effectiveness Analysis of Screening Syphilis Among Pregnant Women

Nguyen, T-Phuong-Lan.; Wright, E.Pamela.; Nguyen, T-Trung.; Schuiling-Veninga, C.C.M.; Bijlsma, M.J.; Nguyen, T-Bach-Yen.; Postma, M.J., 2017:
Cost-Effectiveness Analysis of Screening for and Managing Identified Hypertension for Cardiovascular Disease Prevention in Vietnam

Lam, S.W.; Wai, M.; Lau, J.E.; McNamara, M.; Earl, M.; Udeh, B., 2016:
Cost-Effectiveness Analysis of Second-Line Chemotherapy Agents for Advanced Gastric Cancer

Klimes, J.; Mollon, P.; Graham, C.; Rajnoch, J.; Dostal, F.; Skalicky, D.; Jordan, P.; Depta, J., 2015:
Cost-Effectiveness Analysis of Secukinumab Compared to Ustekinumab In The Treatment of Moderate to Severe Plaque Psoriasis In The Czech Republic

Pantiri, K.; Westerhout, K.Y.; Obando, C.A., 2015:
Cost-Effectiveness Analysis of Simeprevir and Sofosbuvir Combination Therapy for the Treatment of Genotype 1 Hcv Patients in the Dominican Republic

Lapointe-Shaw, L.; Tran, K.L.; Coyte, P.C.; Hancock-Howard, R.L.; Powis, J.; Poutanen, S.M.; Hota, S., 2016:
Cost-Effectiveness Analysis of Six Strategies to Treat Recurrent Clostridium difficile Infection

Igarashi, A.; Goto, R.; Suwa, K.; Yoshikawa, R.; Ward, A.J.; Moller, Jörgen., 2016:
Cost-Effectiveness Analysis of Smoking Cessation Interventions in Japan Using a Discrete-Event Simulation

Kim, H.; Gill, B.; Beriwal, S.; Huq, M.Saiful.; Roberts, M.S.; Smith, K.J., 2017:
Cost-Effectiveness Analysis of Stereotactic Body Radiation Therapy Compared With Radiofrequency Ablation for Inoperable Colorectal Liver Metastases

Wu, D.B.C.; Hussain, S.; Mak, V.; Lee, K.K.C., 2014:
Cost-Effectiveness Analysis of Strontium Ranelate Verse Alendronate for Management of Osteoporosis Among Post-Menopausal Women in Malaysia Using A Markov Modelling Approach

Gachango, F.G.; Pedersen, S.M.; Kjaergaard, C., 2016:
Cost-Effectiveness Analysis of Surface Flow Constructed Wetlands (SFCW) for Nutrient Reduction in Drainage Discharge from Agricultural Fields in Denmark

Castañeda, E.; Sanz-Granda, Á.; Hidalgo, A.; Meza, D.F.; Marqueta, J.M.; Carreras, M., 2014:
Cost-Effectiveness Analysis of Surgical Management of Stress Urinary Incontinence With Single-Incision Mini-Sling Versus Tension-Free Vaginal Obturator in Spain

Tawiah, T.; Hansen, K.Schultz.; Baiden, F.; Bruce, J.; Tivura, M.; Delimini, R.; Amengo-Etego, S.; Chandramohan, D.; Owusu-Agyei, S.; Webster, J., 2016:
Cost-Effectiveness Analysis of Test-Based versus Presumptive Treatment of Uncomplicated Malaria in Children under Five Years in an Area of High Transmission in Central Ghana

Dyer, M.; Vereecken, W.; Worrall, J.; George, A.; Rahman, N., 2014:
Cost-Effectiveness Analysis of Testing for Brca Mutations in Women Diagnosed with Ovarian Cancer and their Female First-Degree Relatives: A Uk Health Service Perspective

Eccleston, A.; Bentley, A.; Dyer, M.; Vereecken, W.; George, A.; Rahman, N., 2015:
Cost-Effectiveness Analysis of Testing for Brca1 and Brca2 Mutations In Women Diagnosed With Ovarian Cancer and Their Female First- And Second Degree Relatives Using A Discrete Event Simulation: A Uk Health Service Perspective

Zhao, Y.Jiao.; Khoo, A.Leng.; Lin, L.; Teng, M.; Wu, T.Seng.; Chan, M.Y.; Lim, B.Peng., 2018:
Cost-Effectiveness Analysis of Ticagrelor and Prasugrel for the Treatment of Acute Coronary Syndrome

Athanasakis, K.; Tarantilis, F.; Skroumpelos, A.; Kyriopoulos, J., 2015:
Cost-Effectiveness Analysis of Tocilizumab Subcutaneous As First Line Biologic Monotherapy for Rheumatoid Arthritis Management In Greece

Bektur, C.; Kayir, F.; Nurgozhin, T., 2014:
Cost-Effectiveness Analysis of Tocilizumab Verse Infliximab for the Patients With Rheumatoid Arthritis in Kazakhstan

Hashemi-Meshkini, A.; Nikfar, S.; Glaser, E.; Jamshidi, A.; Hosseini, S.Alireza., 2018 :
Cost-Effectiveness Analysis of Tocilizumab in Comparison with Infliximab in Iranian Rheumatoid Arthritis Patients with Inadequate Response to tDMARDs: A Multistage Markov Model

Athanasakis, K.; Boubouchairopoulou, N.; Tarantilis, F.; Tsiantou, V.; Kontodimas, S.; Kyriopoulos, J., 2015:
Cost-Effectiveness Analysis of Topical Filed Treatment Therapies for The Treatment of Actinic Keratosis In Greece

Tallman, M.; Lo-Coco, F.; Barnes, G.; Kruse, M.; Wildner, R.; Martin, M.; Mueller, U.; Tang, B., 2016:
Cost-Effectiveness Analysis of Treating Acute Promyelocytic Leukemia Patients With Arsenic Trioxide and Retinoic Acid in the United States

Nerich, V.; Fleck, C.; Chaigneau, Lïc.; Isambert, N.; Borg, C.; Kalbacher, E.; Jary, M.; Simon, P.; Pivot, X.; Blay, J-Yves.; Limat, S., 2016:
Cost-Effectiveness Analysis of Tyrosine Kinase Inhibitors for Patients with Advanced Gastrointestinal Stromal Tumors

Butzke, B.; Oduncu, F.; Heinemann, V.; Pfeufer, A.; Giessen, C.; Stollenwerk, B.; Rogowski, W., 2014:
Cost-Effectiveness Analysis of Ugt1a1 Genotyping Before Colorectal Cancer Treatment with Irinotecan

Ismaila, A.; Roberts, G.; Punekar, Y.S.; O'Leary, M., 2014:
Cost-Effectiveness Analysis of Umeclidinium Bromide Compared to Tiotropium Bromide for Symptomatic Patients with COPD in the UK

Haeussler, K.; Marcellusi, A.; Mennini, F.Saverio.; Favato, G.; Picardo, M.; Garganese, G.; Bononi, M.; Costa, S.; Scambia, G.; Zweifel, P.; Capone, A.; Baio, G., 2016:
Cost-Effectiveness Analysis of Universal Human Papillomavirus Vaccination Using a Dynamic Bayesian Methodology: The BEST II Study

de Soárez, Pícia.Coelho.; Sartori, A.Marli.Christovam.; Freitas, A.Carvalho.; Nishikawa, Álvaro.Mitsunori.; Novaes, H.Maria.Dutilh., 2016:
Cost-Effectiveness Analysis of Universal Vaccination of Adults Aged 60 Years with 23-Valent Pneumococcal Polysaccharide Vaccine versus Current Practice in Brazil

Kolbin, A.; Vilum, I.; Kurylev, A.; Balykina, Y.; Proskurin, M., 2014 :
Cost-Effectiveness Analysis of Use of Dydrogesterone in Premenstrual Syndrome

Cromwell, I.; Regier, D.A.; Peacock, S.J.; Poh, C.F., 2018:
Cost-Effectiveness Analysis of Using Loss of Heterozygosity to Manage Premalignant Oral Dysplasia in British Columbia, Canada

Obando, C.A.; Desanvicente-Celis, Z.; Herrera, J.A.; Moreira, M.; De, C.J., 2014:
Cost-Effectiveness Analysis of Ustekinumab Compared With Etanercept for the Treatment of Moderate to Severe Psoriasis in Costa Rica

Kousoulakou, H.; Kalogeropoulou, M.; Panitti, E., 2015:
Cost-Effectiveness Analysis of Vildagliptin vs. Glimepiride as Add-On to Metformin in the Management of Type 2 Diabetes Mellitus in Greece

Shih, Y-Chen.Tina.; Chien, C-Ru.; Moguel, R.; Hernandez, M.; Hajek, R.A.; Jones, L.A., 2016:
Cost-Effectiveness Analysis of a Capitated Patient Navigation Program for Medicare Beneficiaries with Lung Cancer

Nguyen, K-Huong.; Smith, A.C.; Armfield, N.R.; Bensink, M.; Scuffham, P.A., 2016:
Cost-Effectiveness Analysis of a Mobile Ear Screening and Surveillance Service versus an Outreach Screening, Surveillance and Surgical Service for Indigenous Children in Australia

Vallejo-Torres, L.; Castilla, Ián.; Couce, Mía.L.; Pérez-Cerdá, C.; Martín-Hernández, E.; Pineda, Mé.; Campistol, J.; Arrospide, A.; Morris, S.; Serrano-Aguilar, P., 2015:
Cost-Effectiveness Analysis of a National Newborn Screening Program for Biotinidase Deficiency

Álvarez Pasquín, M.J.; Cisterna, R.; Gil de Miguel, A.; López-Belmonte, J.L.; Préaud, E.; Trejo, A., 2014:
Cost-Effectiveness Analysis of a Shingles Vaccination Program to Prevent Herpes Zoster And Post- Herpetic Neuralgia in the Spanish Setting

Kim, M.; Yoo, B-Kwang., 2016:
Cost-Effectiveness Analysis of a Television Campaign to Promote Seasonal Influenza Vaccination Among the Elderly

Maunoury, F.; Motrunich, A.; Palka-Santini, M.; Bernatchez, Séphanie.F.; Ruckly, Séphane.; Timsit, J-François., 2016:
Cost-Effectiveness Analysis of a Transparent Antimicrobial Dressing for Managing Central Venous and Arterial Catheters in Intensive Care Units

Green, W.; Taylor, M., 2016:
Cost-Effectiveness Analysis of d-Nav for People with Diabetes at High Risk of Neuropathic Foot Ulcers

Krysanov, I.; Krysanova, V., 2014:
Cost-Effectiveness Analysis of the Application of Ertapenem for the Treatment of Community-Acquired Complicated Intra-Abdominal Infections

Mlcoch, T.; Kruntoradova, K.; Mandelikova, M.; Dolezal, T., 2015:
Cost-Effectiveness Analysis of the Information Technology Aided Relaps Prevention Programme in Schizophrenia (Itareps) in the Czech Republic

Bogavac, S.N.; Petrovic, S.; Lakic, D.; Peco, A.A.; Vulicevic, I.; Ivanisevic, I.; Kotur, S.J.; Jelic-Ivanovic, Z., 2014:
Cost-Effectiveness Analysis of the New Biomarkers for Diagnosis of Acute Kidney Injury in Children After Cardiac Surgery

Kalyieva, S.; Minakova, N.; Yukhnevich-Nassonova, Y., 2014:
Cost-Effectiveness Analysis of the Original Drug Arglabin

Sakulsupsiri, A.; Sakthong, P.; Winit-Watjana, W., 2018:
Cost-Effectiveness Analysis of the Self-Management Program for Thai Patients with Metabolic Syndrome

Tuletova, A.; Dochshanova, A.; Skakova, R., 2014:
Cost-Effectiveness Analysis of the Therapy of Endometriosis

Leal, J.R.; Heitman, S.J.; Conly, J.M.; Henderson, E.A.; Manns, B.J., 2018:
Cost-Effectiveness Analysis of the Use of Probiotics for the Prevention of Clostridium difficile-Associated Diarrhea in a Provincial Healthcare System

Yang, Y.; Chen, H-Ning.; Wang, R.; Tang, Y-Jing.; Chen, X-Zu., 2016:
Cost-Effectiveness Analysis on Endoscopic Surveillance Among Western Patients With Barrett's Esophagus for Esophageal Adenocarcinoma Screening

Tapper, E.B.; Hunink, M.G.Myriam.; Afdhal, N.H.; Lai, M.; Sengupta, N., 2016:
Cost-Effectiveness Analysis: Risk Stratification of Nonalcoholic Fatty Liver Disease (NAFLD) by the Primary Care Physician Using the NAFLD Fibrosis Score

Rinde, H.; Genser, B.; Sonntag, D.; Kleber, M.E.; Stojakovic, T.; Scharnagl, H.; Maerz, W., 2014:
Cost-Effectiveness And Budget Impact Analyses Of Risk Stratification Of Patients With Moderate Risk Of Cardiovascular Events Using Lp-Pla2 Testing

Miquel-Cases, A.; Steuten, L.; Rigter, L.; van Harten, W.H., 2015:
Cost-Effectiveness and Feasibility of Implementing Mri-Guided Neoadjuvant Chemotherapy to Treat Er-Positive Her2-Negative Breast Cancers in the Netherlands

Lai, K.; Zhang, C.; Ke, W.; Gao, Y.; Zhou, S.; Liu, L.; Yang, Y., 2016:
Cost-Effectiveness Comparison Between the Response-Guided Therapies and Monotherapies of Nucleos(t)ide Analogues for Chronic Hepatitis B Patients in China

Ruffion, A.; Velard, M.; Loveman, C.; Khalaf, K.; Roze, S.; Pignata, M.; Stanisic, S.; Lister, J., 2014:
Cost-Effectiveness Comparison Of Botulinum Toxin Type A Plus Best Supportive Care Versus Best Supportive Care Alone In The Treatment Of Idiopathic Overactive Bladder With Urinary Incontinence Among Patients Not Adequately Managed By Anticholinergic Therapy In France

Meza-Torres, B.; Gay, J.G.; Jakouloff, D.E., 2014:
Cost-Effectiveness Evaluation of Brentuximab Vedotin for Refractory/Relapsed Hodgkin Lymphoma: A Comparative Analysis of the Results of Mexico and Venezuela

Johnson, J.A.; Lier, D.A.; Soprovich, A.; Al Sayah, F.; Qiu, W.; Majumdar, S.R., 2018:
Cost-Effectiveness Evaluation of Collaborative Care for Diabetes and Depression in Primary Care

Phillips, A.L.; Edwards, N.C.; Locklear, J.C., 2014:
Cost-Effectiveness Evaluation of Data from the Evidence (Evidence of Interferon Dose-Response: European North American Comparative Efficacy) Study

Ben-Assuli, O.; Ziv, A.; Sagi, D.; Ironi, A.; Leshno, M., 2017:
Cost-Effectiveness Evaluation of EHR: Simulation of an Abdominal Aortic Aneurysm in the Emergency Department

Shiragami, M.; Mizukami, A.; Leeuwenkamp, O.; Mrkvan, T.; Delgleize, E.; Kurono, Y.; Iwata, S., 2014:
Cost-Effectiveness Evaluation of the 10-Valent Pneumococcal Non-typeable Haemophilus influenzae Protein D Conjugate Vaccine and 13-Valent Pneumococcal Vaccine in Japanese Children

Graham, C.; Knox, H.; Hess, L.M.; Jen, M.; Cuyun Carter, G.; Chandrawansa, K.; Boye, M., 2015:
Cost-Effectiveness In The Second-Line Treatment Of Non-Small Cell Lung Cancer (Nsclc) In The Us

Slof, J.; Serrano, D.; Álvarez, M.; Álvarez López-Dóriga, M.; Marqués, T.; Benito, J.; Vidal, J., 2014:
Cost-Effectiveness Model Results of Intrathecal Baclofen Therapy Compared to Conventional Medical Management in Patients with Non-Focal Disabling Spasticity Who are Resistant or Intolerant to Oral Therapy at the Institut Guttmann

Becker, U.; Briggs, A.H.; Moreno, S.G.; Ray, J.A.; Ngo, P.; Samanta, K., 2017:
Cost-Effectiveness Model for Chemoimmunotherapy Options in Patients with Previously Untreated Chronic Lymphocytic Leukemia Unsuitable for Full-Dose Fludarabine-Based Therapy

Luime, J.J.; Buisman, L.R.; Oppe, M.; Hazes, J.M.W.; Rutten-van Mölken, M.P.M.H., 2017:
Cost-Effectiveness Model for Evaluating New Diagnostic Tests in the Evaluation of Patients With Inflammatory Arthritis at Risk of Having Rheumatoid Arthritis

Epinette, J.A.; Robert, J.; Rodriguez, J.; Lafuma, A., 2014:
Cost-Effectiveness Model of Dual-Mobility Cups for Total Hip Replacement in France

Saenz, A.S.A., 2014:
Cost-Effectiveness Model of Pertuzumab in Combination with Trastuzumab and Docetaxel Compared with Trastuzumab in Combination with Docetaxel for the 1st Line Treatment of HER2+ Metastatic Breast Cancer in Colombia

Maunoury, F.; Motrunich, A.; Palka-Santini, M., 2014:
Cost-Effectiveness Modeling Of Antimicrobial Dressings For Preventing Catheter-Related Bloodstream Infection: Homogeneous Verse Non-Homogeneous Markov Approaches

Garattini, L.; Ghislandi, F.; Da Costa, M.Rangel., 2016:
Cost-Effectiveness Modeling in Multiple Sclerosis: Playing Around with Non-Healthcare Costs?

Critchlow, S.; Hirst, M.; Sullivan, W.; Dunlop, W., 2015:
Cost-Effectiveness Modelling for Neuropathic Pain Treatments: An Exploration to Identify Comparative Importance of Model Parameters

Fraser, I.; Burger, J.; Lubbe, M.; Dranitsaris, G.; Sonderup, M.; Stander, T., 2017:
Cost-Effectiveness Modelling of Sofosbuvir-Containing Regimens for Chronic Genotype 5 Hepatitis C Virus Infection in South Africa

Hoogendoorn, M.; Feenstra, T.; Asukai, Y.; Borg, S.; Hansen, R.N.; Jansson, S.A.; Samyshkin, Y.; Wacker, M.; Briggs, A.; Lloyd, A.; Sullivan, S.D.; Rutten-van Mölken, M.P., 2014:
Cost-Effectiveness Models for Chronic Obstructive Pulmonary Disease (COPD): Cross-Model Comparison of Hypothetical Treatment Scenarios

Schmier, J.K.; Hulme-Lowe, C.K., 2017:
Cost-Effectiveness Models in Age-Related Macular Degeneration: Issues and Challenges

Rodríguez-GonzálezMoro, J.M.; Menendez, R.; Campins, M.; Lwoff, N.; Oyagüez, I.; Echave, M.; Rejas, J.; Antoñanzas, F., 2015:
Cost-Effectiveness Of A 13-Valent Conjugate Pneumococcal Vaccination Program In Copd Patients Aged 50+ Years In Spain

Toledo, A.; Llopis, A.; Mora, A.; Rubio-Terrés, C.; Rubio-Rodríguez, D.; Nazir, J., 2015:
Cost-Effectiveness Of A Fixed-Dose Combination Of Solifenacin Plus Tamsulosin Ocas For The Treatment Of Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia In Spain

Gor, D.; Kim, K.; Chumnumwat, S.; Galanter, W.L.; You, J.; Walton, S.M.; Garofalo, J.; Duarte, J.; Krishnan, J.A.; Bauman, J.L.; Nutescu, E.A., 2015:
Cost-Effectiveness Of A Novel Pharmacist Guided Warfarin Pharmacogenetic Service

Ho, K.; Ng, W.; You, J., 2015:
Cost-Effectiveness Of Active Surveillance Of Carbapenem-Resistant Enterobacteriaceae In Intensive Care Units In Hong Kong

Lanitis, T.; Hamilton, M.; Rublee, D.A.; Leipold, R.; Quon, P.; Browne, C.; Cohen, A.T., 2014:
Cost-Effectiveness Of Apixaban Compared To Other Anticoagulants For Lifetime Treatment And Prevention Of Recurrent Venous Thromboembolism

Rudakova, A.V.; Parfenov, V.A., 2014:
Cost-Effectiveness Of Apixaban Compared To Warfarin And Aspirin In Patients With Non-Valvular Atrial Fibrillation (Nvaf) In The Russian Federation

Chen, W.; Yang, Y.; Du, F.; Li, J.; Chen, Y., 2015:
Cost-Effectiveness Of Bortizomib For Multiple Myeloma: A Systematic Review

Saunders, R.; Erslon, M.G.; Vargo, J., 2015:
Cost-Effectiveness Of Capnography Monitoring During Gastrointestinal Endoscopy Targeting Moderate Sedation

Zhou, Z.; Hurry, M.; Zhang, J.; Fan, L.; Zhang, C.; Xie, J., 2015:
Cost-Effectiveness Of Ceritinib In Previously Treated Patients With Crizotinib In Anaplastic Lymphoma Kinase-Positive (Alk+) Non-Small Cell Lung Cancer In Canada

Zhou, Z.; Zhang, J.; Fan, L.; Zhang, C.; Xie, J., 2015:
Cost-Effectiveness Of Ceritinib In The Treatment Of Previously Treated Anaplastic Lymphoma Kinase-Positive (Alk+) Non-Small Cell Lung Cancer In The United Kingdom

Krol, M.; Ovcinnikova, O.; von Hohnhorst, P.; Jarrett, J., 2015:
Cost-Effectiveness Of Cetuximab In First-Line Treatment Of Patients With Metastatic Colorectal Cancer In Belgium And The Netherlands

Walter, E.; Bauer, M.; Ressl, S., 2015:
Cost-Effectiveness Of Combined Treatment With Alteplase (Rt-Pa) And Cerebrolysin In Acute Ischemic Hemispheric Stroke In Austria

Rosselli, D.; Rueda, J.D.; Wolowacz, S.; Brockbank, J.; Abeysinghe, S., 2014:
Cost-Effectiveness Of Dabigatran Compared With Warfarin, Apixaban, Rivaroxaban And Low Molecular Weight Heparins For The Treatment And Secondary Prevention Of Venous Thromboembolism In Colombia

Eggington, S.; Brandt, A.; Reimer Rasmussen, E.; Grifi, M.; Nyberg, J., 2015:
Cost-Effectiveness Of Deep Brain Stimulation (Dbs) In The Management Of Advanced Parkinson's Disease: A Swedish Payer Perspective

Mittmann, N.; Hassan, S.; Patel, J.; Tinmouth, J., 2015:
Cost-Effectiveness Of Directly Mailed Fobt Kits To Previous Responders Being Recalled For Screening

Giraldo Giraldo, N.Amparo.; Vásquez Velásquez, J.; Roldán Cano, P.Andrea.; Ospina Astudillo, C.; Sosa Cardona, Y.Paulina., 2017:
Cost-Effectiveness of Early Nutritional Therapy in Malnourished Adult Patients in a High Complexity Hospital

Sadique, Z.; Grieve, R.; Harrison, D.; Rowan, K., 2015:
Cost-Effectiveness Of Early Parenteral Versus Enteral Nutrition In Critically Ill Patients

Claxton, L.; Taylor, M.; Lewis, L.; Alexandre, A.F.; Harrington, A.E.; Bakhai, A.; Brueggenjuergen, B., 2015:
Cost-Effectiveness Of Edoxaban Compared With Other Licensed Noacs For The Prevention Of Stroke And Systemic Embolic Events In The Uk

Taylor, M.; Claxton, L.; Lewis, L.; Harrington, A.E.; Alexandre, A.F.; Bakhai, A.; Brueggenjuergen, B., 2015 :
Cost-Effectiveness Of Edoxaban Compared With Warfarin For The Prevention Of Stroke And Systemic Embolic Events In The Uk

Buriskova, K.; Rogalewicz, V.; Ostadal, P., 2014:
Cost-Effectiveness Of Extracorporeal Cardiopulmonary Resuscitation In Patients With Refractory Cardiac Arrest

Walter, E.; Bauer, M.; Ressl, S., 2015:
Cost-Effectiveness Of Ferric Carboxymaltose In Patients With Iron Deficiency And Chronic Heart Failure In Austria

Yang, M.C.; Tan, E., 2014:
Cost-Effectiveness Of First-Line Therapy For Advanced Non-Small Cell Lung Cancer (Nsclc)

Shin, M.; Shin, S.; Lee, J.Y.; Kim, J.; Park, J.; Kwon, H., 2015:
Cost-Effectiveness Of First-Line Tyrosine Kinase Inhibitors (Tkis) In Newly Diagnosed Chronic Myeloid Leukemia (Cml) Patients In Korea: Comparison Of Dasatinib (100mg), Nilotinib (600mg) And Imatinib (400mg)

Ramaekers, B.L.T.; Armstrong, N.; Joore, M.A.; Westwood, M.; Whiting, P.; Thokala, P.; Ross, J.; Kleijnen, J.; Severens, J.; van, A.A., 2014:
Cost-Effectiveness Of High-Sensitive Troponin Assays For The Early Rule-Out Or Diagnosis Of Acute Myocardial Infarction (Ami) In People With Acute Chest Pain: A Nice Diagnostic Assessment

Gouveia, M.; Silva, M.G.; Alarcão, J.; Fiorentino, F.; Carda, J.; Costa, R.; Mariz, J.M.; Raposo, J.; Costa, J.; Borges, M., 2015:
Cost-Effectiveness Of Idelalisib In Combination With Rituximab For The Treatment Of Relapsed/Refractory Chronic Lymphocytic Leukemia (Cll) In Portugal

Leleu, H.; Blachier, M.; Mealing, S.; Perard, R.; Baujat, C.; Pentel, J., 2015:
Cost-Effectiveness Of Idelalisib Plus Rituximab In Chronic Lymphocytic Leukaemia

Folse, H.J.; Rengarajan, B.; Goswami, D.; Budoff, M.; Kahn, R., 2014:
Cost-Effectiveness Of Ldl-P-Guided Statin Therapy

Almeida, J.; Vandewalle, B.; Félix, J., 2014:
Cost-Effectiveness Of Linaclotide: A Valuable Option In The Treatment Of Irritable Bowel Syndrome

Jenks, M.; Taylor, M.; Shore, J., 2015:
Cost-Effectiveness Of Local Insufflation Of Warm Humidified Co2 During Open And Laparoscopic Colorectal Surgery

Herschorn, S.; Vicente, C.; Nazir, J.; Ramos, B.; Hakimi, Z., 2014:
Cost-Effectiveness Of Mirabegron 50mg Compared To Tolterodine Er 4mg In The Treatment Of Patients With Overactive Bladder In Canada

Ruiz, M.C.I.; Ubiarco, L.V., 2014:
Cost-Effectiveness Of Mycophelonate Sodium On Patients With Renal Transplant At The Public Mexican Health Care System

Aiello, A.; Daniel, F.; D'Ausilio, A.; Snedecor, S.J.; Toumi, M., 2015:
Cost-Effectiveness Of Nilotinib In Patients With Chronic Myeloid Leukaemia Eligible To Start The Treatment-Free Remission Phase In Italy

Pearson, I.V.; Hawe, E.; Zuluaga, S.; Wolowacz, S.; Haiderali, A., 2015:
Cost-Effectiveness Of Ofatumumab Plus Chlorambucil In First-Line Chronic Lymphocytic Leukemia In The United Kingdom

Kanters, T.A.; Gertsen, K.; Hakkaart, L., 2015:
Cost-Effectiveness Of Omalizumab In Chronic Spontaneous Urticaria In The Netherlands

Majer, I.; Pichardo-Piña, C.A.; Sanchez-Casillas, J.L.; Schmidt, R.; Vo, P., 2015:
Cost-Effectiveness Of Palivizumab In Premature Infants And Children With Chronic Lung Disease In Mexico

Reis, A.Machado.Dos.; Kabke, Górgia.Brum.; Fruchtenicht, A.Valéria.Gonçalves.; Barreiro, T.Dias.; Moreira, L.Fernando., 2017:
Cost-Effectiveness of Perioperative Immunonutrition in Gastrointestinal Oncologic Surgery: a Systematic Review

Hou, C.; Siva, S.; Haas, M.; Viney, R., 2014:
Cost-Effectiveness of Post-Therapy Pet and Telephone Interview in the Clinical Follow-Up of Patients Treated with Locally Advanced Cervical Cancer

Shepherd, A.C.; Ortega-Ortega, M.; Gohel, M.S.; Epstein, D.; Brown, L.C.; Davies, A.H., 2017:
Cost-Effectiveness of Radiofrequency Ablation Versus Laser for Varicose Veins

Gorokhova, S.G.; Ryazhenov, V.V.; Gorokhov, V.D.; Maximkin, S.A., 2014:
Cost-Effectiveness Of Ranolazine For The Treatment Of Angina Pectoris In Russia

Araújo, M.; Pinto, C.G., 2014:
Cost-Effectiveness Of Routine Testing For Hla-B*5801 In Caucasian Patients Newly Diagnosed With Gout In Portuguese Nhs Hospitals

Basarir, H.; Brennan, A.; Jacques, R.; Pollard, D.; Stevens, K.; Freeman, J.; Wales, J.; Price, K., 2016:
Cost-Effectiveness of Structured Education in Children with Type-1 Diabetes Mellitus

Ren, H.; Zhang, J.; Dong, P., 2015:
Cost-Effectiveness Of Sunitinib As Second-Line Treatment For Gastrointestinal Stromal Tumor(Gist) In China

Costa, J.; Fiorentino, F.; Caldeira, D.; Inês, M.; Pereira, C.; Pinheiro, L.; Vaz Carneiro, A.; Gouveia, M.; Borges, M., 2015:
Cost-Effectiveness Of The Non-Vitamin K Antagonist Oral Anticoagulants For Atrial Fibrillation In Portugal

Echave, M.; Ojanguren, M.E.; Elías, I.; de Andrés-Nogales, F.; Oyagüez, I.; Casado, Má.; Crespo, C., 2015:
Cost-Effectiveness Of Tiotropium In The Treatment Of Patients With Asthma

Eklund, O.; Afzal, F.; Borgström, F.; Ojanguren, M.E.; Crespo, C.; Baldwin, M., 2015:
Cost-Effectiveness Of Tiotropium Vs Glycopyrronium In Moderate To Very Severe Copd In Spain

Poullié, A-Isabelle.; Cognet, M.; Gauthier, A.; Clementz, M.; Druais, S.; Späth, H-Martin.; Perrier, L.; Scemama, O.; Pichon, C.Rumeau.; Harousseau, J-Luc., 2017:
Cost-Effectiveness of Treatments for Mild-To-Moderate Obstructive Sleep Apnea in France

Miravitlles, M.; Galdiz, J.B.; Huerta, A.; Villacampa, A.; Carcedo, D.; García-Rio, F., 2015:
Cost-Effectiveness Of Umeclidinium/Vilanterol In Symptomatic Copd Spanish Patients

Jacobs, P., 2016:
Cost-Effectiveness Results for Early Psychosis Intervention Programs Are Influenced by the Perspective Taken

Kriza, C.; Jahn, B.; Hassan, C.; Kolominsky-Rabas, P.L., 2014:
Cost-Effectiveness Simulation of Colonography Versus Colonoscopy in Germany: Is Laxative-Free Colonography Cost-Effective?

Dolk, F.C.; Eichner, M.; Welte, R.; Anastassopoulou, A.; Van Bellinghen, L.; Poulsen Nautrup, B.; Van Vlaenderen, I.; Schmidt-Ott, R.; Schwehm, M.; Postma, M., 2015:
Cost-Effectiveness analysis of Quadrivalent Versus trivalent Influenza Vaccination In Germany - Linking a Dynamic Transmission Model with Health and Economic Outcomes

Hren, R., 2014:
Cost-Effectiveness and Budget-Impact Analysis of Braf Inhibitors in Patients With Metastatic Malignant Melanoma (MMM) in Slovenia

Garrison, L.P., 2016:
Cost-Effectiveness and Clinical Practice Guidelines: Have We Reached a Tipping Point?-An Overview

Toy, M.; Hutton, D.W.; So, S.K., 2016:
Cost-Effectiveness and Cost Thresholds of Generic and Brand Drugs in a National Chronic Hepatitis B Treatment Program in China

Fuchs, P.A.; Lal, L.; Fuchs, H.A.; Swint, J., 2015:
Cost-Effectiveness and Cost-Utility Analyses Comparing Strategies for Initial Treatment of Rheumatoid Arthritis Using Published Outcomes: Economic Lessons From The Tear Trial

Elías, I.; Ortega-Joaquín, N.; de la Cueva, P.; Del Pozo, L.J.; Moreno-Ramírez, D.; Boada, A.; Aguilar, M.; Mirada, A.; Mosquera, E.; Gibbons, C.; Oyagüez, I., 2017:
Cost-Effectiveness and Cost-Utility Analysis of Ingenol Mebutate Versus Diclofenac 3% and Imiquimod 5% in the Treatment of Actinic Keratosis in Spain

Zucco, F.; Ciampichini, R.; Lavano, A.; Costantini, A.; De Rose, M.; Poli, P.; Fortini, G.; Demartini, L.; De Simone, E.; Menardo, V.; Cisotto, P.; Meglio, M.; Scalone, L.; Mantovani, L.G., 2016:
Cost-Effectiveness and Cost-Utility Analysis of Spinal Cord Stimulation in Patients With Failed Back Surgery Syndrome: Results From the PRECISE Study

Kourlaba, G.; Palaka, E.; Papagiannopoulou, V.; Maniadakis, N., 2014:
Cost-Effectiveness and Cost-Utility of Granulocyte Colony-Stimulating Factors in the Primary Prophylaxis of Chemotherapy Induced Febrile Neutropenia (FN) in Breast Cancer Patients in Greece: A Comparative Analysis

van Barreveld, M.; Rutten, J.; Vlieger, A.; Frankenhuis, C.; George, E.; Groeneweg, M.; Norbruis, O.; Tjon A Ten, W.; van Wering, H.; Merkus, M.; Benninga, M.; Dijkgraaf, M., 2015:
Cost-Effectiveness and Cost-Utility of Home-Based Hypnotherapy Using Compact Disc Versus Individual Hypnotherapy By A Therapist for Pediatric Irritable Bowel Syndrome and Functional Abdominal Pain (Syndrome)

Mo, X.; Tobe, R.Gai.; Liu, X.; Mori, R., 2016:
Cost-Effectiveness and Health Benefits of Pediatric 23-Valent Pneumococcal Polysaccharide Vaccine, 7-Valent and Forecasting 13-Valent Pneumococcal Conjugate Vaccines in China

Cure, S.; Guerra, I., 2014:
Cost-Effectiveness and Long-Term Outcomes of Sovaldi (SOFOSBUVIR) for the Treatment of Chronic Hepatitis C Infected (HCV) Patients from a Swedish Societal Perspective

Raviotta, J.M.; Smith, K.J.; DePasse, J.; Brown, S.T.; Shim, E.; Nowalk, M.Patricia.; Zimmerman, R.K., 2016:
Cost-Effectiveness and Public Health Effect of Influenza Vaccine Strategies for U.S. Elderly Adults

Orlando, S.; Diamond, S.; Palombi, L.; Sundaram, M.; Shear Zimmer, L.; Marazzi, M.Cristina.; Mancinelli, S.; Liotta, G., 2017:
Cost-Effectiveness and Quality of Care of a Comprehensive ART Program in Malawi

Ogunniyi, A.; Dairo, M.David.; Dada-Adegbola, H.; Ajayi, I.O.; Olayinka, A.; Oyibo, W.A.; Fawole, O.I.; Ajumobi, O., 2016:
Cost-Effectiveness and Validity Assessment of Cyscope Microscope, Quantitative Buffy Coat Microscope, and Rapid Diagnostic Kit for Malaria Diagnosis among Clinic Attendees in Ibadan, Nigeria

Tuffaha, H.W.; Shelley, R.; Chaboyer, W.; Gordon, L.G.; Scuffham, P.A., 2014:
Cost-Effectiveness and Value of Information Analyses of Nutritional Support in Preventing Pressure Ulcers in High Risk Hospitalised Patients

Ting, J.; Tien Ho, P.; Xiang, P.; Sugay, A.; Abdel-Sattar, M.; Wilson, L., 2016:
Cost-Effectiveness and Value of Information of Erlotinib, Afatinib, and Cisplatin-Pemetrexed for First-Line Treatment of Advanced EGFR Mutation-Positive Non-Small-Cell Lung Cancer in the United States

Cai, S-Rong.; Zhu, H-Hong.; Huang, Y-Qin.; Li, Q-Long.; Ma, X-Yuan.; Zhang, S-Zhan.; Zheng, S., 2017:
Cost-Effectiveness between Double and Single Fecal Immunochemical Test(s) in a Mass Colorectal Cancer Screening

Sutton, J.M.; Hoehn, R.S.; Ertel, A.E.; Wilson, G.C.; Hanseman, D.J.; Wima, K.; Sussman, J.J.; Ahmad, S.A.; Shah, S.A.; Abbott, D.E., 2016:
Cost-Effectiveness in Hepatic Lobectomy: the Effect of Case Volume on Mortality, Readmission, and Cost of Care

Marbaix, S.; Sato, R.; Mignon, A.; Atwood, M.; Weycker, D., 2015:
Cost-Effectiveness of 13-Valent Pneumococcal Conjugate Vaccine Among Patients Aged 65-84 Years With Co-Morbidities or Immunosuppression In Belgium

Tichopad, A.; Pecen, L.; Roberts, C.S.; Uglesic, L.; Tesovic, G.; Rogier, K., 2014:
Cost-Effectiveness of 13-Valent Versus 10-Valent Pneumococcal Conjugate Vaccine Use in Croatia National Vaccination Program

Terlinden, A.; Poirrier, J.; Curran, D.; Haberl, M.; Hanley, R.; Moore, P., 2015:
Cost-Effectiveness of 18 Month Booster Dose of A Pertussis-Containing Vaccine on The Australian National Immunisation Program: A Dynamic Model-Based Analysis

Miquel-Cases, A.; Teixeira, S.; Retèl, V.; Steuten, L.; Valdés Olmos, R.; Rutgers, E.; van Harten, W.H., 2015:
Cost-Effectiveness of 18f-Fdg Pet/Ct for Screening Distant Metastasis in Stage Ii/Iii Breast Cancer Patients of the UK, the United States and the Netherlands

Hlavinkova, L.; Li, X.; Van Kriekinge, G.; Trnovec, P., 2014:
Cost-Effectiveness of 2-DOSE AS04-Adjuvanted Human Papillomavirus 16/18 Vaccination Schedule in Slovakia

Cheruvanky, A.; Kirn, T.J.; Weinstein, M.P., 2016:
Cost-Effectiveness of 30- Compared to 20-Milliliter Blood Cultures: a Retrospective Study

Amin, A.; Cruz González, I.; Reddy, V.; Holmes, D.; Berti, S.; Iñiguez Romo, A.; De Deppo, L.; Priest, V.; Simmonds, M.; Lee, C.; Wasserman, M.; Margonato, A., 2015:
Cost-Effectiveness of A Left Atrial Appendage Closure Device In Patients With Non-Valvular Atrial Fibrillation Unable or Unwilling to Tolerate Oral Anticoagulant Therapy In Italy And Spain

Wong, C.K.H.; Jiao, F.F.; Siu, S.C.; Fung, C.S.C.; Wong, K.W.; Lam, C.L.K., 2014:
Cost-Effectiveness of A Short Message Service (Sms) Intervention To Prevent Type 2 Diabetes Among Adults With Impaired Glucose Tolerance

Gaultney, J.; Nappi, C.; Benucci, M.; Iannazzo, S.; Sion, K.; Alemao, E.; Sabater, J., 2015:
Cost-Effectiveness of Abatacept Compared to Adalimumab In Italy Based on A Head-To-Head Outcomes Study In Rheumatoid Arthritis

Woo, C.Y.; Strandberg, E.J.; Schmiegelow, M.D.; Pitt, A.L.; Hlatky, M.A.; Owens, D.K.; Goldhaber-Fiebert, J.D., 2015:
Cost-Effectiveness of Adding Cardiac Resynchronization Therapy to an Implantable Cardioverter-Defibrillator Among Patients With Mild Heart Failure

Soni, A.; Chu, E., 2016:
Cost-Effectiveness of Adjuvant Chemotherapy in the Treatment of Early-Stage Colon Cancer

Eriksson, M.; Castelo-Branco, A.; Nilsson, J., 2014:
Cost-Effectiveness of Aflibercept in the Treatment of Macular Oedema Secondary to Central Retinal Vein Occlusion In Sweden

Gharibi, Z.; Ayvaci, M.U.S.; Hahsler, M.; Giacoma, T.; Gaston, R.S.; Tanriover, B., 2016:
Cost-Effectiveness of Antibody-Based Induction Therapy in Deceased Donor Kidney Transplantation in the United States

Hamza, M.; Idris, M.A.; Maiyaki, M.B.; Lamorde, M.; Chippaux, J-Philippe.; Warrell, D.A.; Kuznik, A.; Habib, A.G., 2016:
Cost-Effectiveness of Antivenoms for Snakebite Envenoming in 16 Countries in West Africa

Chen, W.; Tang, Z.; Wang, X.; Li, J.; Luo, Z., 2014:
Cost-Effectiveness of Antiviral Therapy for Chronic Hepatitis B: A Systematic Review

Lanitis, T.; Hamilton, M.; Quon, P.; Browne, C.; Masseria, C.; Cohen, A.T., 2015:
Cost-Effectiveness of Apixaban Compared to Low Molecular Weight Heparin/ Edoxaban for Treatment and Prevention of Recurrent Venous Thromboembolism

Fernández Ávila, Y.; Garcia, K.C.; Garrido Lecca, S.; Donato, B.M.; Juarez-Garcia, A., 2015:
Cost-Effectiveness of Apixaban Versus Other New Oral Anticoagulants And Warfarin for Stroke Prevention In Atrial Fibrillation In Venezuela

Tanaka, S.; Preto, M.C.; Bernardino, G.; Nogueira, F.; Ferreira, C.N.; Donato, B.M., 2015:
Cost-Effectiveness of Apixaban Versus Other Noacs And Warfarin, During Hospitalization In The Private Brazilian Health System

Li, X.; Tse, V.C.; Lau, W.C.Y.; Cheung, B.M.Y.; Lip, G.Y.H.; Wong, I.C.K.; Chan, E.W., 2017:
Cost-Effectiveness of Apixaban versus Warfarin in Chinese Patients with Non-Valvular Atrial Fibrillation: A Real-Life and Modelling Analyses

Mughal, F.; Cawston, H.; Kinahan, D.; Morris, J.; Tencer, T.; Zhang, F., 2015:
Cost-Effectiveness of Apremilast In Moderate to Severe Psoriasis In Scotland

Mughal, F.; Cawston, H.; Cure, S.; Morris, J.; Tencer, T.; Zhang, F., 2015:
Cost-Effectiveness of Apremilast In Psoriatic Arthritis In Scotland

Helal, M.; Elsisi, G., 2014:
Cost-Effectiveness of Aprepitant in Egyptian Patients Receiving Highly Emetogenic Therapy from the Third Party Payer Perspective

Dornan, G.J.; Katthagen, J.Christoph.; Tahal, D.S.; Petri, M.; Greenspoon, J.A.; Denard, P.J.; Burkhart, S.S.; Millett, P.J., 2016:
Cost-Effectiveness of Arthroscopic Rotator Cuff Repair Versus Reverse Total Shoulder Arthroplasty for the Treatment of Massive Rotator Cuff Tears in Patients With Pseudoparalysis and Nonarthritic Shoulders

Perez de Llano, L.A.; Villoro, R.; Hidalgo, A.; Merino, M., 2014:
Cost-Effectiveness of Asthma Management in a Hospital-Based Adult Asthma Clinic in Spain

Shah, G.L.; Winn, A.N.; Lin, P-Jung.; Klein, A.; Sprague, K.A.; Smith, H.P.; Buchsbaum, R.; Cohen, J.T.; Miller, K.B.; Comenzo, R.; Parsons, S.K., 2016:
Cost-Effectiveness of Autologous Hematopoietic Stem Cell Transplantation for Elderly Patients with Multiple Myeloma using the Surveillance, Epidemiology, and End Results-Medicare Database

Jha, S.; Ismail, N.; Clark, D.; Lewis, J.J.; Omar, S.; Dreyer, A.; Chihota, V.; Churchyard, G.; Dowdy, D.W., 2017:
Cost-Effectiveness of Automated Digital Microscopy for Diagnosis of Active Tuberculosis

McLawhorn, A.S.; Southren, D.; Wang, Y.Claire.; Marx, R.G.; Dodwell, E.R., 2016:
Cost-Effectiveness of Bariatric Surgery Prior to Total Knee Arthroplasty in the Morbidly Obese: A Computer Model-Based Evaluation

Salton, R., 2015:
Cost-Effectiveness of Bariatric Surgery for The Treatment of Obesity In Australia

Tang, Q.; Sun, Z.; Zhang, N.; Xu, G.; Song, P.; Xu, L.; Tang, W., 2017:
Cost-Effectiveness of Bariatric Surgery for Type 2 Diabetes Mellitus: A Randomized Controlled Trial in China

Waycaster, C.R.; Gilligan, A.M.; Motley, T.A., 2017:
Cost-Effectiveness of Becaplermin Gel on Diabetic Foot Ulcer HealingChanges in Wound Surface Area

Winters, D.; Casten, R.; Rovner, B.; Murchison, A.; Leiby, B.E.; Haller, J.A.; Hark, L.; Weiss, D.M.; Pizzi, L.T., 2016:
Cost-Effectiveness of Behavior Activation Versus Supportive Therapy on Adherence to Eye Exams in Older African Americans With Diabetes

Joensuu, J.T.; Aaltonen, K.J.; Aronen, P.; Sokka, T.; Puolakka, K.; Tuompo, R.; Korpela, M.; Vasala, M.; Ilva, K.; Nordström, D.; Blom, M., 2015:
Cost-Effectiveness of Biologics Compared to Conventional Disease-Modifying Antirheumatic Drugs for Treatment of Rheumatoid Arthritis in Finland

Sánchez-González, G.; Figueroa-Lara, A.; Elizondo-Cano, M.; Wilson, L.; Novelo-Garza, B.; Valiente-Banuet, L.; Ramsey, J.M., 2016:
Cost-Effectiveness of Blood Donation Screening for Trypanosoma cruzi in Mexico

Zafari, Z.; Sadatsafavi, M.; Marra, C.A.; Chen, W.; FitzGerald, J.Mark., 2016:
Cost-Effectiveness of Bronchial Thermoplasty, Omalizumab, and Standard Therapy for Moderate-to-Severe Allergic Asthma

Pititto, L.; Neslusan, C.; Teschemaker, A.R.; Johansen, P.; Willis, M.; Asano, E.; Puig, A., 2015:
Cost-Effectiveness of Canagliflozin (Cana) Versus Sitagliptin (Sita) As Add-On To Metformin Plus Sulfonylurea In Patients With Type 2 Diabetes Mellitus (T2dm) In Brazil

Patel, S.; Trueman, D.; Bentley, A.; Poole, C.; Chambers, C., 2014 :
Cost-Effectiveness of Capsaicin 8% Patch (Qutenza(tm)) Compared With Pregabalin for the Treatment of Patients With Peripheral Neuropathic Pain (Pnp) In Scotland

Mankowski, C.; Patel, S.; Trueman, D.; Bentley, A.; Poole, C., 2016:
Cost-Effectiveness of Capsaicin 8% Patch Compared with Pregabalin for the Treatment of Patients with Peripheral Neuropathic Pain in Scotland

Bhatt, N.; Turakhia, M.; Fogarty, T.J., 2016:
Cost-Effectiveness of Cardiac Radiosurgery for Atrial Fibrillation: Implications for Reducing Health Care Morbidity, Utilization, and Costs

Paladio-Hernández, Já.; Martínez-Morales, J., 2015:
Cost-Effectiveness of Cardioprotective Effect of Dexrazoxane (Cardioxane®) in Advanced/Metastatic Breast Cancer Patients Treated with Anthracycline-Based Chemotherapy in México

Gupta, A.; Mushlin, A.I.; Kamel, H.; Navi, B.B.; Pandya, A., 2016:
Cost-Effectiveness of Carotid Plaque MR Imaging as a Stroke Risk Stratification Tool in Asymptomatic Carotid Artery Stenosis

De, L.Juste.A.; Rejas, Gérrez.J.; Oteo, Álvaro.Á., 2014:
Cost-Effectiveness of Celecoxib and Non Selective Non Steroidal Anti-Inflammatory Drug (Nsaid) Therapy for the Treatment of Osteoarthritis in Spain: A Decision-Tree Model

Balu, S.; Cerezo-Camacho, O.; Smith, N.J.; Beckerman, R., 2015:
Cost-Effectiveness of Ceritinib Versus Current Therapies for Chemotherapy-Experienced Anaplastic Lymphoma Kinase Positive Non-Small Cell Lung Cancer Patients in Mexico

Caglayan, B.; Firidin, A.; Yildirim, N.; Tatar, M.; Essiz, M., 2015:
Cost-Effectiveness of Certolizumab Pegol for The Treatment of Axial Spondyloarthritis In Turkey

Codreanu, C.; Mogosanu, C.; Joita, M.; Purcaru, O., 2014:
Cost-Effectiveness of Certolizumab Pegol in the Treatment of Active Rheumatoid Arthritis, Axial Spondyloarthritis, and Psoriatic Arthritis In Romania

Shankaran, V.; Ortendahl, J.D.; Purdum, A.G.; Bolinder, B.; Anene, A.M.; Sun, G.H.; Bentley, T.G.K., 2015:
Cost-Effectiveness of Cetuximab as First-line Treatment for Metastatic Colorectal Cancer in the United States

Janmaat, V.T.; Bruno, M.J.; Polinder, S.; Lorenzen, S.; Lordick, F.; Peppelenbosch, M.P.; Spaander, M.C.W., 2016:
Cost-Effectiveness of Cetuximab for Advanced Esophageal Squamous Cell Carcinoma

Lairson, D.R.; Parikh, R.C.; Cormier, J.N.; Chan, W.; Du, X.L., 2016:
Cost-Effectiveness of Chemotherapy for Breast Cancer and Age Effect in Older Women

Pan, Y.; Wang, Y.L.; Liu, G.; Zhao, K.; Wang, Y., 2014:
Cost-Effectiveness of Clopidogrel-Aspirin Versus Aspirin Alone for Acute Tia and Minor Stroke

Shen, F.; Liu, H.; Yuan, J.; Han, B.; Cui, K.; Ding, Y.; Fan, X.; Cao, H.; Yao, S.; Suo, X.; Sun, Z.; Yun, X.; Hua, Z.; Chen, J., 2016:
Cost-Effectiveness of Coal Workers' Pneumoconiosis Prevention Based on Its Predicted Incidence within the Datong Coal Mine Group in China

Painter, J.T.; Fortney, J.C.; Gifford, A.L.; Rimland, D.; Monson, T.; Rodriguez-Barradas, M.C.; Pyne, J.M., 2016:
Cost-Effectiveness of Collaborative Care for Depression in HIV Clinics

Goodall, S.; Church, J., 2014:
Cost-Effectiveness of Colonic Stents for the Management of Malignant Large Bowel Obstruction

Burgos, J.L.; Patterson, T.L.; Graff-Zivin, J.S.; Kahn, J.G.; Rangel, M.Gudelia.; Lozada, M.Remedios.; Staines, H.; Strathdee, S.A., 2016:
Cost-Effectiveness of Combined Sexual and Injection Risk Reduction Interventions among Female Sex Workers Who Inject Drugs in Two Very Distinct Mexican Border Cities

Gilbert, J.A.; Shenoi, S.V.; Moll, A.P.; Friedland, G.H.; Paltiel, A.David.; Galvani, A.P., 2017:
Cost-Effectiveness of Community-Based TB/HIV Screening and Linkage to Care in Rural South Africa

Rosenheck, R.; Leslie, D.; Sint, K.; Lin, H.; Robinson, D.G.; Schooler, N.R.; Mueser, K.T.; Penn, D.L.; Addington, J.; Brunette, M.F.; Correll, C.U.; Estroff, S.E.; Marcy, P.; Robinson, J.; Severe, J.; Rupp, A.; Schoenbaum, M.; Kane, J.M., 2017:
Cost-Effectiveness of Comprehensive, Integrated Care for First Episode Psychosis in the NIMH RAISE Early Treatment Program

Bencina, G.; Van de Velde, N., 2015:
Cost-Effectiveness of Conjugate Pneumococcal Vaccination In Croatia

Preda, A.L.; Moise, M.; Delgleize, E.; Leeuwenkamp, O.R., 2014:
Cost-Effectiveness of Conjugate Pneumococcal Vaccination in Romania

Teitsson, S.; Bobula, J.; Hawes, C.; Moffatt, M.; Ohna, A.; Borgström, F., 2015:
Cost-Effectiveness of Conjugated Estrogens/Bazedoxifene for the Treatment of Vasomotor Symptoms in the United States

Marino, P.; Houvenaeghel, G.; Narducci, F.; Boyer-Chammard, Aès.; Ferron, Gël.; Uzan, C.; Bats, A-Sophie.; Mathevet, P.; Dessogne, P.; Guyon, Fédéric.; Rouanet, P.; Jaffre, I.; Carcopino, X.; Perez, T.; Lambaudie, E., 2016:
Cost-Effectiveness of Conventional vs Robotic-Assisted Laparoscopy in Gynecologic Oncologic Indications

Salata, B.M.; Hutton, D.W.; Levine, D.A.; Froehlich, J.B.; Barnes, G.D., 2016:
Cost-Effectiveness of Dabigatran (150 mg Twice Daily) and Warfarin in Patients ≥ 65 Years With Nonvalvular Atrial Fibrillation

van Leent, M.W.J.; Stevanović, J.; Jansman, F.G.; Beinema, M.J.; Brouwers, J.R.B.J.; Postma, M.J., 2016:
Cost-Effectiveness of Dabigatran Compared to Vitamin-K Antagonists for the Treatment of Deep Venous Thrombosis in the Netherlands Using Real-World Data

Galvani, G.; Grassetto, A.; Sterlicchio, S.; Themistoclakis, S.; Andrea, V.; Giampaolo, Z.; Domenico, M., 2015:
Cost-Effectiveness of Dabigatran Exilate in Treatment of Atrial Fibrillation

Charokopou, M.; Vioix, H.; Eddowes, L.A.; Griffiths, M.; Verheggen, B.G.; Gabriel, Z.; Tolley, K., 2014:
Cost-Effectiveness of Dapagliflozin Compared To Dpp-4 Inhibitors as Triple Therapy In Combination With Metformin and A Sulphonylurea In The Treatment Of Type 2 Diabetes Mellitus From A Uk Health Care Perspective

Charokopou, M.; Vioix, H.; Verheggen, B.; Eddowes, L.A.; Griffiths, M.; Gabriel, Z.; Tolley, K.; Franks, D., 2014:
Cost-Effectiveness of Dapagliflozin Versus Dpp-4 Inhibitors as Monotherapy in the Treatment of Type 2 Diabetes Mellitus From A Uk Health Care Perspective

Tzanetakos, C.; Tentolouris, N.; Kourlaba, G.; Maniadakis, N., 2016:
Cost-Effectiveness of Dapagliflozin as Add-On to Metformin for the Treatment of Type 2 Diabetes Mellitus in Greece

Tzanetakos, C.; Tentolouris, N.; Kourlaba, G.; Maniadakis, N., 2015:
Cost-Effectiveness of Dapagliflozin as Add-on to Metformin for the Treatment of Type 2 Diabetes in Greece

Gu, S.; Mu, Y.; Zhai, S.; Zeng, Y.; Zhen, X.; Dong, H., 2016:
Cost-Effectiveness of Dapagliflozin versus Acarbose as a Monotherapy in Type 2 Diabetes in China

Michaelidis, C.I.; Kern, M.S.; Smith, K.J., 2016:
Cost-Effectiveness of Decision Support Strategies in Acute Bronchitis

Pietzsch, J.B.; Garner, A.M.; Marks, W.J., 2016:
Cost-Effectiveness of Deep Brain Stimulation for Advanced Parkinson's Disease in the United States

Bektur, C.; Nurgozhin, T., 2014:
Cost-Effectiveness of Denosumab vs. Brand or Generic zoledronic Acid in Patients with Breast Cancer in Kazakhstan

Lee, L.; Mitmaker, E.J.; Chabot, J.A.; Lee, J.A.; Kuo, J.H., 2016:
Cost-Effectiveness of Diagnostic Lobectomy Versus Observation for Thyroid Nodules >4 cm

Yin, Z-Gang.; Zhang, J-Bing.; Gong, K-Tong., 2016:
Cost-Effectiveness of Diagnostic Strategies for Suspected Scaphoid Fractures

Nahvijou, A.; Daroudi, R.; Tahmasebi, M.; Amouzegar Hashemi, F.; Rezaei Hemami, M.; Akbari Sari, A.; Barati Marenani, A.; Zendehdel, K., 2017:
Cost-Effectiveness of Different Cervical Screening Strategies in Islamic Republic of Iran: A Middle-Income Country with a Low Incidence Rate of Cervical Cancer

Rosen, J.; Sancheti, P.; Fierlinger, A.; Niazi, F.; Johal, H.; Bedi, A., 2017:
Cost-Effectiveness of Different Forms of Intra-Articular Injections for the Treatment of Osteoarthritis of the Knee

Olsen, J.; Wiren, A., 2015:
Cost-Effectiveness of Dimethyl Fumarate Treatment for Relapsing-Remitting Multiple Sclerosis From A Danish Perspective

Salazar, J.; Saxena, V.; Kahn, J.G.; Roberts, J.P.; Mehta, N.; Volk, M.; Lai, J.C., 2016:
Cost-Effectiveness of Direct-Acting Antiviral Treatment in Hepatitis C-Infected Liver Transplant Candidates With Compensated Cirrhosis and Hepatocellular Carcinoma

Tsiachristas, A.; Burgers, L.; Rutten-van Mölken, M.P.M.H., 2016:
Cost-Effectiveness of Disease Management Programs for Cardiovascular Risk and COPD in The Netherlands

Pialoux, G.; Marcelin, A-Geneviève.; Despiégel, N.; Espinas, C.; Cawston, Hélène.; Finkielsztejn, L.; Laurisse, A.; Aubin, Céline., 2016:
Cost-Effectiveness of Dolutegravir in HIV-1 Treatment-Experienced (TE) Patients in France

Despiégel, N.; Anger, D.; Martin, M.; Monga, N.; Cui, Q.; Rocchi, A.; Pulgar, S.; Gilchrist, K.; Refoios Camejo, R., 2015:
Cost-Effectiveness of Dolutegravir in HIV-1 Treatment-Naive and Treatment-Experienced Patients in Canada

Despiégel, N.; Marcellin, A.G.; Aubin, C.; Espinas, C.; Laurisse, A.; Pialoux, G., 2014:
Cost-Effectiveness of Dolutegravir, a New Generation Integrase Inhibitor, in Hiv-1 Treatment Experienced Patients in France

Pialoux, G.; Marcelin, A.; Cawston, H.; Guilmet, C.; Laurisse, A.; Finkielsztejn, L.; Aubin, C., 2015:
Cost-Effectiveness of Dolutegravir/Abacavir/Lamivudine in Hiv-1 Treatment Naive Patients in France

Posso, M.; Carles, Mòrdia.; Rué, M.; Puig, T.; Bonfill, X., 2017:
Cost-Effectiveness of Double Reading versus Single Reading of Mammograms in a Breast Cancer Screening Programme

Xiridou, M.; Lugnér, A.; de Vries, H.J.C.; van Bergen, J.E.A.M.; Götz, H.M.; van Benthem, B.H.B.; Wallinga, J.; van der Sande, M.A.B., 2017:
Cost-Effectiveness of Dual Antimicrobial Therapy for Gonococcal Infections Among Men Who Have Sex With Men in the Netherlands

Raibouaa, A.; Borgeke, H.; Alexiou, D.; Lowin, J.; Norrbacka, K., 2015:
Cost-Effectiveness of Dulaglutide 1.5mg Once Weekly for the Treatment of Patients with Type Two Diabetes Mellitus in Sweden

Allen, R.; Bryden, P.; Grotzinger, K.M.; Stapelkamp, C.; Woods, B., 2017:
Cost-Effectiveness of Eltrombopag versus Romiplostim for the Treatment of Chronic Immune Thrombocytopenia in England and Wales

Aguiar-Ibáñez, R.; Palencia, R.; Kandaswamy, P.; Li, L., 2014:
Cost-Effectiveness of Empagliflozin (Jardiance®) 10 Mg And 25 Mg Administered As An Add-On To Metformin And Sulfonilurea (Met+Su) Compared To Other Sodium-Glucose Co-Transporter 2 Inhibitors (Sglt2is) in Patients with Type 2 Diabetes Mellitus (T2dm) In The Uk

Aguiar-Ibáñez, R.; Palencia, R.; Kandaswamy, P.; Li, L., 2014:
Cost-Effectiveness of Empagliflozin (Jardiance®) 10 Mg And 25 Mg Administered As An Add-on To Metformin Compared To Other Sodium-Glucose Co-Transporter 2 Inhibitors (Sglt2is) for Patients With Type 2 Diabetes Mellitus (T2dm) In The UK

Pietzsch, J.B.; Garner, A.M.; Herth, F.J., 2014 :
Cost-Effectiveness of Endobronchial Valve Therapy for Severe Emphysema: A Model-Based Projection Based on the Vent Study

Salisbury, A.C.; Li, H.; Vilain, K.R.; Jaff, M.R.; Schneider, P.A.; Laird, J.R.; Cohen, D.J., 2017:
Cost-Effectiveness of Endovascular Femoropopliteal Intervention Using Drug-Coated Balloons Versus Standard Percutaneous Transluminal Angioplasty: Results From the IN.PACT SFA II Trial

Kunz, W.G.; Hunink, M.G.Myriam.; Sommer, W.H.; Beyer, S.E.; Meinel, F.G.; Dorn, F.; Wirth, S.; Reiser, M.F.; Ertl-Wagner, B.; Thierfelder, K.M., 2016:
Cost-Effectiveness of Endovascular Stroke Therapy: A Patient Subgroup Analysis From a US Healthcare Perspective

Ademi, Z.; Pasupathi, K.; Liew, D., 2017:
Cost-Effectiveness of Eplerenone Compared to Usual Care in Patients With Chronic Heart Failure and NYHA Class II Symptoms, an Australian Perspective

Furneri, G.; Santoni, L.; Ricella, C.; Prosperini, L., 2015:
Cost-Effectiveness of Escalating to Natalizumab or Switching Among Immunomodulators In Relapsing-Remitting Multiple Sclerosis In Italy

Wójcik, P.; Chudziak, D.; Macioch, T.; Niewada, M., 2015:
Cost-Effectiveness of Esomeprazole Compared With Other Ppis Currently Reimbursed In Poland In The Treatment of Gerd

Mendes, L.R.; Haddad, L.; D'albuquerque, L.A., 2015:
Cost-Effectiveness of Everolimus In Liver Transplantation

Malhan, S.; Güler, S.; Yetkin, I.; Baeten, S.; Verheggen, B., 2014:
Cost-Effectiveness of Exenatide Twice Daily (Bid) Added To Basal Insulin Compared To A Bolus Insulin Add-On In Turkey

Zowall, H.; Brewer, C.; Deutsch, A., 2014:
Cost-Effectiveness of Fecal Microbiota Transplant in Treating Clostridium Difficile Infection in Canada

Brodszky, V.; Strbák, B.; Baji, P.; Péntek, M.; Gulacsi, L., 2014:
Cost-Effectiveness of Fidaxomicin Therapy for Clostridium Difficile Infection in Hungary

Van Engen, A.; Lie, X.; Norén, T.; Nordling, S.; Nørgaard, K., 2014:
Cost-Effectiveness of Fidaxomicin for the Treatment of Clostridium Difficile Infection (CDI) in Sweden

Newgard, C.D.; Yang, Z.; Nishijima, D.; McConnell, K.John.; Trent, S.A.; Holmes, J.F.; Daya, M.; Mann, N.Clay.; Hsia, R.Y.; Rea, T.D.; Wang, N.Ewen.; Staudenmayer, K.; Delgado, M.Kit., 2017:
Cost-Effectiveness of Field Trauma Triage among Injured Adults Served by Emergency Medical Services

Henderson, C.; Knapp, M.; Yeeles, K.; Bremner, S.; Eldridge, S.; David, A.S.; O'Connell, N.; Burns, T.; Priebe, S., 2016:
Cost-Effectiveness of Financial Incentives to Promote Adherence to Depot Antipsychotic Medication: Economic Evaluation of a Cluster-Randomised Controlled Trial

Soini, E.J.; Joutseno, J.; Sumelahti, M., 2015:
Cost-Effectiveness of First-Line Disease-Modifying Therapies (Dmts) For Relapsing-Remitting Ms (Rrms)

Pennington, M.; Grieve, R.; Black, N.; van der Meulen, J.H., 2016:
Cost-Effectiveness of Five Commonly Used Prosthesis Brands for Total Knee Replacement in the UK: A Study Using the NJR Dataset

Hornberger, J.; Michalopoulos, S.; Dai, M.; Andrade, P.; Dilla, T.; Happich, M., 2015:
Cost-Effectiveness of Florbetapir-PET in Alzheimer's Disease: A Spanish Societal Perspective

Hutchinson, A.B.; Farnham, P.G.; Sansom, S.L.; Yaylali, E.; Mermin, J.H., 2016:
Cost-Effectiveness of Frequent HIV Testing of High-Risk Populations in the United States

Saab, S.; Virabhak, S.; Parisé, Hélène.; Johnson, S.; Wang, A.; Misurski, D.; Gonzalez, Y.Sanchez.; Juday, T., 2017 :
Cost-Effectiveness of Genotype 1 Chronic Hepatitis C Virus Treatments in Patients Coinfected with Human Immunodeficiency Virus in the United States

Miller, J.D.; Lenhart, G.M.; Bonafede, M.M.; Lukes, A.S.; Laughlin-Tommaso, S.K., 2016:
Cost-Effectiveness of Global Endometrial Ablation vs. Hysterectomy for Treatment of Abnormal Uterine Bleeding: US Commercial and Medicaid Payer Perspectives

Costa-Scharplatz, M.; Ställberg, Börn.; Goyal, P.; Asukai, Y.; Gruenberger, J-Bernard.; Price, D., 2016:
Cost-Effectiveness of Glycopyrronium Bromide Compared with Tiotropium in Patients with Chronic Obstructive Pulmonary Disease in Sweden

De Bruin, E.J.; van Steensel, F.J.A.; Meijer, A.Marie., 2017:
Cost-Effectiveness of Group and Internet Cognitive Behavioral Therapy for Insomnia in Adolescents: Results from a Randomized Controlled Trial

Geue, C.; Wu, O.; Xin, Y.; Heggie, R.; Hutchinson, S.; Martin, N.K.; Fenwick, E.; Goldberg, D.; Vickerman, P.; Miners, A.; Hickman, M.; Jones, L.; Semaille, C.; Larson, C.; Duffell, E.; Amato, A.; Lim, T-Ang.; van de Laar, M., 2016:
Cost-Effectiveness of HBV and HCV Screening Strategies--A Systematic Review of Existing Modelling Techniques

Bernard, C.L.; Brandeau, M.L.; Humphreys, K.; Bendavid, E.; Holodniy, M.; Weyant, C.; Owens, D.K.; Goldhaber-Fiebert, J.D., 2016:
Cost-Effectiveness of HIV Preexposure Prophylaxis for People Who Inject Drugs in the United States

van Santen, Dëla.K.; de Vos, A.S.; Matser, A.; Willemse, S.B.; Lindenburg, K.; Kretzschmar, M.E.E.; Prins, M.; de Wit, G.Ardine., 2017:
Cost-Effectiveness of Hepatitis C Treatment for People Who Inject Drugs and the Impact of the Type of Epidemic; Extrapolating from Amsterdam, the Netherlands

Suwantika, A.A.; Beutels, P.; Postma, M.J., 2014:
Cost-Effectiveness of Hepatitis a Vaccination in Indonesia

Le, P.; Rothberg, M.B., 2016:
Cost-Effectiveness of Herpes Zoster Vaccine for Persons Aged 50 Years

Beby, A.Trisia.; Cornelis, T.; Zinck, R.; Liu, F.Xiaoqing., 2016:
Cost-Effectiveness of High Dose Hemodialysis in Comparison to Conventional In-Center Hemodialysis in the Netherlands

Nguyen, E.; Egri, F.; Mearns, E.S.; White, C.M.; Coleman, C.I., 2017:
Cost-Effectiveness of High-Dose Edoxaban Compared with Adjusted-Dose Warfarin for Stroke Prevention in Non-Valvular Atrial Fibrillation Patients

Ting, J.; Smith, J.S.; Myers, E.R., 2016:
Cost-Effectiveness of High-Risk Human Papillomavirus Testing With Messenger RNA Versus DNA Under United States Guidelines for Cervical Cancer Screening

Méndez, A.B.; Ordonez-Llanos, J.; Farrero, M.; Mirabet, S.; Brossa, V.; López, L.; Bonet, R.; Sionis, A.; Pérez-Villa, F.; Roig, E., 2016:
Cost-Effectiveness of Highly Sensitive Cardiac Troponin T to Rule Out Acute Rejection After Heart Transplantation

Hammond, D.A.; Kathe, N.; Shah, A.; Martin, B.C., 2016:
Cost-Effectiveness of Histamine 2 Receptor Antagonists Versus Proton Pump Inhibitors for Stress Ulcer Prophylaxis in Critically Ill Patients

Westra, T.A.; Postma, M.J., 2014:
Cost-Effectiveness of Human Papillomavirus Vaccination Programmes Parallel to Current Routine Vaccination of Young Teenage Girls

Morton, T.D.; Ernst, F.; Mealing, S.; Eaton, J.; Hawkins, N.S.; Thompson, J.C.; Amrane, M., 2015:
Cost-Effectiveness of Ikervis® In Severe Dry Eye Disease In The Uk [Update

Gariepy, A.M.; Duffy, J.Y.; Xu, X., 2015:
Cost-Effectiveness of Immediate Compared With Delayed Postpartum Etonogestrel Implant Insertion

Bachert, C.; Noergaard Andreasen, J., 2016:
Cost-Effectiveness of Immunotherapy in the Treatment of Seasonal Allergic Rhinitis: Identifying Product-Specific Parameters of Relevance for Health Care Decision-Makers and Clinicians

Sandhu, A.T.; Goldhaber-Fiebert, J.D.; Owens, D.K.; Turakhia, M.P.; Kaiser, D.W.; Heidenreich, P.A., 2017:
Cost-Effectiveness of Implantable Pulmonary Artery Pressure Monitoring in Chronic Heart Failure

Holtzer-Goor, K.M.; Gaultney, J.G.; van Houten, P.; Wagg, A.S.; Huygens, S.A.; Nielen, M.M.J.; Albers-Heitner, C.P.; Redekop, W.K.; Rutten-van Mölken, M.P.; Al, M.J., 2016:
Cost-Effectiveness of Including a Nurse Specialist in the Treatment of Urinary Incontinence in Primary Care in the Netherlands

Tilden, D.; Guarnieri, C., 2016:
Cost-Effectiveness of Incobotulinumtoxin-A with Flexible Treatment Intervals Compared to Onabotulinumtoxin-A in the Management of Blepharospasm and Cervical Dystonia

Akın, L.; Macabéo, Bérengère.; Caliskan, Z.; Altinel, S.; Satman, I., 2016:
Cost-Effectiveness of Increasing Influenza Vaccination Coverage in Adults with Type 2 Diabetes in Turkey

Macabeo, B.; Akin, L.; Caliskan, Z.; Altinel, S.; Satman, I., 2015:
Cost-Effectiveness of Increasing the Influenza Vaccination Rate in Adults with Type 2 Diabetes in Turkey

Lee, J.Y.; Park, D.J., 2014:
Cost-Effectiveness of Infant Vaccination with 13-Valent Versus 10-Valent Pneumococcal Conjuvate Vaccine in Korea

Naidoo, K.; Grobler, A.C.; Deghaye, N.; Reddy, T.; Gengiah, S.; Gray, A.; Abdool Karim, S., 2015:
Cost-Effectiveness of Initiating Antiretroviral Therapy at Different Points in TB Treatment in HIV-TB Coinfected Ambulatory Patients in South Africa

Jackson, H.; Mandell, K.; Johnson, K.; Chatterjee, D.; Vanness, D.J., 2016:
Cost-Effectiveness of Injectable Extended-Release Naltrexone Compared With Methadone Maintenance and Buprenorphine Maintenance Treatment for Opioid Dependence

Evans, M.; Gundgaard, J.; Hansen, B.Bekker., 2016:
Cost-Effectiveness of Insulin Degludec/Insulin Aspart Versus Biphasic Insulin Aspart in Patients with Type 2 Diabetes from a Danish Health-Care Perspective

Barnett, P.G.; Jeffers, A.; Smith, M.W.; Chow, B.K.; McFall, M.; Saxon, A.J., 2016:
Cost-Effectiveness of Integrating Tobacco Cessation Into Post-Traumatic Stress Disorder Treatment

Gregory, S.; Kuntz, K.; Sainfort, Fçois.; Kharbanda, A., 2016:
Cost-Effectiveness of Integrating a Clinical Decision Rule and Staged Imaging Protocol for Diagnosis of Appendicitis

Marques, Aéa.; Lourenço, Óscar.; Ortsäter, G.; Borgström, F.; Kanis, J.A.; da Silva, Jé.António.P., 2018:
Cost-Effectiveness of Intervention Thresholds for the Treatment of Osteoporosis Based on FRAX(®) in Portugal

Ignatyeva, V.; Avxentyeva, M.; Galstyan, G.R.; Bregovskiy, V.; Udovichenko, O., 2014:
Cost-Effectiveness of Interventions Aimed at Decreasing The Number of Amputations Among Patients With Diabetes Mellitus

Leppert, M.H.; Campbell, J.D.; Simpson, J.R.; Burke, J.F., 2015:
Cost-Effectiveness of Intra-Arterial Treatment as an Adjunct to Intravenous Tissue-Type Plasminogen Activator for Acute Ischemic Stroke

Janković, S.M.; Kostić, M., 2018:
Cost-Effectiveness of Introducing Point-of-Care Test for Detection of Level of Glycogen Phosphorylase in Early Diagnostic Algorithm of Acute Coronary Syndrome

Lépine, Aélia.; Nundy, N.; Kilbourne-Brook, M.; Siapka, M.; Terris-Prestholt, F., 2016:
Cost-Effectiveness of Introducing the SILCS Diaphragm in South Africa

Aceituno, S.; Canal, C.; Paz, S.; Gonzalez, P.; Marquez-Rodas, I., 2014:
Cost-Effectiveness of Ipilimumab for Previously Untreated Patients with Advanced Metastatic Melanoma in Spain

Barzey, V.; Asukai, Y.; Gueron, B.; Holmberg, C.; Kotapati, S., 2014:
Cost-Effectiveness of Ipilimumab in Previously Untreated Patients for Advanced Melanoma in Sweden

Kansal, A.R.; Cowie, M.R.; Kielhorn, A.; Krotneva, S.; Tafazzoli, A.; Zheng, Y.; Yurgin, N., 2017:
Cost-Effectiveness of Ivabradine for Heart Failure in the United States

Taieb, A.; Stein Gold, L.; Feldman, S.R.; Dansk, V.; Bertranou, E., 2017:
Cost-Effectiveness of Ivermectin 1% Cream in Adults with Papulopustular Rosacea in the United States

Gandra, S.R.; Villa, G.; Fonarow, G.C.; Lothgren, M.; Lindgren, P.; Somaratne, R.; van Hout, B., 2017:
Cost-Effectiveness of LDL-C Lowering With Evolocumab in Patients With High Cardiovascular Risk in the United States

Rutstein, S.E.; Siedhoff, M.T.; Geller, E.J.; Doll, K.M.; Wu, J.M.; Clarke-Pearson, D.L.; Wheeler, S.B., 2016:
Cost-Effectiveness of Laparoscopic Hysterectomy With Morcellation Compared With Abdominal Hysterectomy for Presumed Myomas

Siedhoff, M.T.; Rutstein, S.E.; Wheeler, S.B.; Geller, E.J.; Doll, K.M.; Wu, J.M.; Clarke-Pearson, D.L., 2016:
Cost-Effectiveness of Laparoscopic Hysterectomy With Morcellation Compared to Abdominal Hysterectomy for Presumed Benign Leiomyomata

Hop, M.Jenda.; Stekelenburg, C.M.; Hiddingh, J.; Kuipers, H.C.; Middelkoop, E.; Nieuwenhuis, M.K.; Polinder, S.; van Baar, M.E.; Beerthuizen, G.I.J.M.; Boekema, B.K.; Breederveld, R.S.; Dokter, J.; Hofland, H.W.C.; Oen, I.M.M.H.; Penninga-Puister, U.; Scholten-Jaegers, S.M.; Tempelman, F.R.H.; Trommel, N.; Tuinebreijer, W.E.; van der Vlies, C.H.; Vloemans, J.F.; van der Wal, M.B.A., 2016:
Cost-Effectiveness of Laser Doppler Imaging in Burn Care in The Netherlands: A Randomized Controlled Trial

Hop, M.J.; Stekelenburg, C.; Hiddingh, J.; Kuipers, H.; Goei, H.; Middelkoop, E.; Nieuwenhuis, M.; Polinder, S.; van, B.M.E., 2014:
Cost-Effectiveness of Laser Doppler Imaging in Burn Care in The Netherlands; A Randomised Controlled Trial

Howells, R.; Treharne, C., 2015:
Cost-Effectiveness of Ledipasvir/Sofosbuvir for the Treatment of Genotype 1 Or 4 Chronic Hepatitis C in England and Wales

Saw, J.; Bennell, M.C.; Singh, S.M.; Wijeysundera, H.C., 2016:
Cost-Effectiveness of Left Atrial Appendage Closure for Stroke Prevention in Atrial Fibrillation Patients With Contraindications to Anticoagulation

Pokorney, S.D.; Mark, D.B., 2018:
Cost-Effectiveness of Left Atrial Appendage Occlusion: A Case Based on Facts Not in Evidence?

Vandewalle, B.; Félix, J.; Almeida, J.; Valeska, A.; Yeo, R., 2014:
Cost-Effectiveness of Lenalidomide-Plus-Dexamethasone in Multiple Myeloma Patients Who Have Received at Least One Prior Therapy: A South Korean Perspective

Edwards, S.J.; Nherera, L.; Trevor, N.; Wakefield, V., 2014:
Cost-Effectiveness of Lithium Versus an Atypical Anti-Psychotic (AAP) used to Augment Treatment with a Selective Serotonin Reuptake Inhibitor (SSRI) in Treatment Resistant Depression (TRD)

Rosenheck, R.A.; Leslie, D.L.; Sint, K.J.; Lin, H.; Li, Y.; McEvoy, J.P.; Byerly, M.J.; Hamer, R.M.; Swartz, M.S.; Stroup, T.Scott., 2016:
Cost-Effectiveness of Long-Acting Injectable Paliperidone Palmitate Versus Haloperidol Decanoate in Maintenance Treatment of Schizophrenia

Wu, J.X.; Beni, C.E.; Zanocco, K.A.; Sturgeon, C.; Yeh, M.W., 2016:
Cost-Effectiveness of Long-Term Every Three-Year Versus Annual Postoperative Surveillance for Low-Risk Papillary Thyroid Cancer

Fischer, C.R.; Cassilly, R.; Dyrszka, M.; Trimba, Y.; Peters, A.; Goldstein, J.A.; Spivak, J.; Bendo, J.A., 2018:
Cost-Effectiveness of Lumbar Spondylolisthesis Surgery at 2-Year Follow-up

Takura, T.; Nakanishi, T.; Kawanishi, H.; Nitta, K.; Akizawa, T.; Hiramatsu, M.; Kawasaki, T.; Kukita, K.; Soejima, H.; Hirakata, H.; Yoshida, T.; Miyamoto, T.; Takahashi, S., 2016:
Cost-Effectiveness of Maintenance Hemodialysis in Japan

van Dongen, J.M.; Groeneweg, R.; Rubinstein, S.M.; Bosmans, J.E.; Oostendorp, R.A.; Ostelo, R.W.; van Tulder, M.W., 2015:
Cost-Effectiveness of Manual Therapy Versus Physical Therapy In Patients With Sub-Acute and Chronic Neck Pain: A Randomized Controlled Trial

Wera, E.; Mourits, M.C.M.; Siko, M.M.; Hogeveen, H., 2016:
Cost-Effectiveness of Mass Dog Vaccination Campaigns against Rabies in Flores Island, Indonesia

Poirrier, J.E.; Mungall, B.; Lee, I.H.; Terlinden, A.; Curran, D., 2014:
Cost-Effectiveness of Maternal Immunisation for Pertussis in New Zealand

Simon, M.S.; Weiss, D.; Geevarughese, A.; Kratz, M.M.; Cutler, B.; Gulick, R.M.; Zucker, J.R.; Varma, J.K.; Schackman, B.R., 2016:
Cost-Effectiveness of Meningococcal Vaccination Among Men Who Have Sex With Men in New York City

Nazir, J.; Maman, K.; Neine, M-Elmoctar.; Briquet, B.; Odeyemi, I.A.O.; Hakimi, Z.; Garnham, A.; Aballéa, S., 2016:
Cost-Effectiveness of Mirabegron Compared with Antimuscarinic Agents for the Treatment of Adults with Overactive Bladder in the United Kingdom

Bar-Zeev, N.; Tate, J.E.; Pecenka, C.; Chikafa, J.; Mvula, H.; Wachepa, R.; Mwansambo, C.; Mhango, T.; Chirwa, G.; Crampin, A.C.; Parashar, U.D.; Costello, A.; Heyderman, R.S.; French, N.; Atherly, D.; Cunliffe, N.A.; Beard, J.; Iturriza-Gomara, M.; Jere, K.; King, C.; Lewycka, S.; Nakagomi, O.; Phiri, T.; Verani, J.R.; Whitney, C.G., 2016:
Cost-Effectiveness of Monovalent Rotavirus Vaccination of Infants in Malawi: A Postintroduction Analysis Using Individual Patient-Level Costing Data

Moriwaki, K.; Yoshimura, M.; Izumi, R.; Noto, S., 2014:
Cost-Effectiveness of Multiple Anti-Osteoporotic Therapies for Secondary Fracture Prevention in Japan

Naudet, F.; Granger, B.; Braillon, A., 2017:
Cost-Effectiveness of Nalmefene: Exaggerated Expectations or Fallacy?

Poonawalla, I.B.; Lairson, D.R.; Chan, W.; Piller, L.B.; Du, X.L., 2015:
Cost-Effectiveness of Neoadjuvant Chemotherapy versus Primary Surgery in Elderly Patients with Advanced Ovarian Cancer

Cortesi, P.A.; Mantovani, L.G.; Ciaccio, A.; Rota, M.; Mazzarelli, C.; Cesana, G.; Strazzabosco, M.; Belli, L.S., 2016:
Cost-Effectiveness of New Direct-Acting Antivirals to Prevent Post-Liver Transplant Recurrent Hepatitis

Boix, B.; Figueras, M.; Riera, M., 2015:
Cost-Effectiveness of New Therapies for Multiple Sclerosis In Spain

Lafuma, A.; Agostini, A.; Linet, T.; Robert, J.; Levy-Bachelot, L.; Godard, C., 2015:
Cost-Effectiveness of Nexplanon® (Etonogestrel Implant) Compared to other Reimbursed Contraceptive Methods in France Based on Real Life Data

Essex, H.N.; Parrott, S.; Wu, Q.; Li, J.; Cooper, S.; Coleman, T., 2015:
Cost-Effectiveness of Nicotine Patches for Smoking Cessation in Pregnancy: A Placebo Randomized Controlled Trial (SNAP)

Andronis, L.; Kinghorn, P.; Qiao, S.; Whitehurst, D.G.T.; Durrell, S.; McLeod, H., 2016:
Cost-Effectiveness of Non-Invasive and Non-Pharmacological Interventions for Low Back Pain: a Systematic Literature Review

Singh, S.M.; Wijeysundera, H.C., 2016:
Cost-Effectiveness of Novel Oral Anticoagulants for Stroke Prevention in Non-Valvular Atrial Fibrillation

Simmons, S.F.; Keeler, E.; An, R.; Liu, X.; Shotwell, M.S.; Kuertz, B.; Silver, H.J.; Schnelle, J.F., 2016:
Cost-Effectiveness of Nutrition Intervention in Long-Term Care

Herring, W.; Pearson, I.; Purser, M.; Nakhaipour, H.R.; Haiderali, A.; Wolowacz, S.; Jayasundara, K., 2014:
Cost-Effectiveness of Ofatumumab Plus Chlorambucil in First Line Chronic Lymphocytic Leukemia in Canada

Sinkey, R.G.; Odibo, A.O., 2017:
Cost-Effectiveness of Old and New Technologies for Aneuploidy Screening

Tatar, M.; Sezen, S.; Senturk, A.; Balp, M.M.; Saylan, M.; Keskinaslan, A., 2014:
Cost-Effectiveness of Omalizumab in Chronic Idiopathic Urticaria Refractory to H1-Antihistamines in Turkey

Gaultney, J.; de Knegt, R.J.; Fassler, P.; Visser, S.; Johnson, S., 2015:
Cost-Effectiveness of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir for Patients With Chronic Hcv in the Netherlands

Owusu-Edusei, K.; Hoover, K.W.; Gift, T.L., 2018:
Cost-Effectiveness of Opt-Out Chlamydia Testing for High-Risk Young Women in the U.S

Shah, A.; Shewale, A.; Hayes, C.J.; Martin, B.C., 2017:
Cost-Effectiveness of Oral Anticoagulants for Ischemic Stroke Prophylaxis Among Nonvalvular Atrial Fibrillation Patients

Leal, J.; Gray, A.M.; Hawley, S.; Prieto-Alhambra, D.; Delmestri, A.; Arden, N.K.; Cooper, C.; Javaid, M.Kassim.; Judge, A., 2016:
Cost-Effectiveness of Orthogeriatric and Fracture Liaison Service Models of Care for Hip Fracture Patients: A Population-Based Study

Nayak, S.; Greenspan, S.L., 2017:
Cost-Effectiveness of Osteoporosis Screening Strategies for Men

Straub, N.; Bauer, E.; Agarwal, S.; Meybohm, P.; Zacharowski, K.; Hanke, A.A.; Weber, C.F., 2016:
Cost-Effectiveness of POC Coagulation Testing Using Multiple Electrode Aggregometry

Doutriaux, A.; Cognet, M.; Druais, S.; Lançon, C.; Samalin, L.; Levy, P.; Godet, A.; Guillon, P., 2014:
Cost-Effectiveness of Paliperidone Palmitate Versus other Antipsychotics for the Treatment of Schizophrenia in France

Majer, I.; Pichardo-Piña, C.A.; Sanchez-Casillas, J.L.; Schmidt, R.; Vo, P., 2015:
Cost-Effectiveness of Palivizumab In Children With Congenital Heart Disease In Mexico

Fernandes, R.R.A., 2014:
Cost-Effectiveness of Palivizumab Use in High Risk Children From Brazilian Health System Perspective

Hahl, J.; Kurki, S.; Miettinen, T.; Snicker, K., 2015:
Cost-Effectiveness of Pasireotide Long-Acting in a Treatment of Acromegaly in Finland. Economic Evaluation Based on Finnish Auria Biobank Data on Health Care Resource Utilization

Chola, L.; Fadnes, L.T.; Engebretsen, I.M.S.; Nkonki, L.; Nankabirwa, V.; Sommerfelt, H.; Tumwine, J.K.; Tylleskar, T.; Robberstad, B.; Tylleskär, T.; Van de Perre, P.; Ekström, E-Charlotte.; Meda, N.; Tumwine, J.K.; Kankasa, C.; Jackson, D.; Tylleskär, T.; Engebretsen, I..M.S.; Fadnes, L.Thore.; Fjeld, E.; Fylkesnes, K.; Klungsøyr, Jørn.; Nordrehaug-Åstrøm, A.; Olsen, Øystein.Evjen.; Robberstad, B.; Sommerfelt, H.; Van de Perre, P.; Ekström, E-Charlotte.; Nor, B.; Meda, N.; Diallo, A.., 2016:
Cost-Effectiveness of Peer Counselling for the Promotion of Exclusive Breastfeeding in Uganda

Goyal, A.; Murray, J.M., 2016:
Cost-Effectiveness of Peg-Interferon, Interferon and Oral Nucleoside Analogues in the Treatment of Chronic Hepatitis B and D Infections in China

Marriott, E.; Praet, C.; Aguiar-Ibáñez, R.; Pellissier, J.; Xu, R.; Wang, J., 2015:
Cost-Effectiveness of Pembrolizumab for Unresectable Metastatic Melanoma After Progression with Ipilimumab in England

Lasalvia, P.; Barahona, J.; Romero, D.; Gil, S.; Castañeda-Cardona, C.; Bayona, J.G.; Triana, J.J.; Laserna, A.; Restrepo, P.; Mejía, M.; Rosselli, D., 2015:
Cost-Effectiveness of Pen Devices For Nph Insulin Administration Compared With Syringe And Vial In Adult Patients With Diabetes Mellitus In Colombia

Lai, A.Y.H., 2014:
Cost-Effectiveness of Percent Free Psa for Prostate Cancer Detection in Chinese Men with a Total Psa of 4.0-10.0 Ng/Ml

Freeman, J.V.; Hutton, D.W.; Barnes, G.D.; Zhu, R.P.; Owens, D.K.; Garber, A.M.; Go, A.S.; Hlatky, M.A.; Heidenreich, P.A.; Wang, P.J.; Al-Ahmad, A.; Turakhia, M.P., 2017:
Cost-Effectiveness of Percutaneous Closure of the Left Atrial Appendage in Atrial Fibrillation Based on Results From PROTECT AF Versus PREVAIL

Atkins, K.E.; Fitzpatrick, M.C.; Galvani, A.P.; Townsend, J.P., 2017:
Cost-Effectiveness of Pertussis Vaccination During Pregnancy in the United States

Durkee, B.Y.; Qian, Y.; Pollom, E.L.; King, M.T.; Dudley, S.A.; Shaffer, J.L.; Chang, D.T.; Gibbs, I.C.; Goldhaber-Fiebert, J.D.; Horst, K.C., 2016:
Cost-Effectiveness of Pertuzumab in Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer

Plöthner, M.; Ribbentrop, D.; Hartman, J-Phillipp.; Frank, M., 2017:
Cost-Effectiveness of Pharmacogenomic and Pharmacogenetic Test-Guided Personalized Therapies: A Systematic Review of the Approved Active Substances for Personalized Medicine in Germany

Aumann, I.; Rozanski, K.; Damm, K.; Graf von der Schulenburg, J-M., 2016:
Cost-Effectiveness of Pharmacological Smoking Cessation Therapies - A Systematic Literature Review

Bürge, E.; Monnin, D.; Berchtold, Aé.; Allet, L., 2017:
Cost-Effectiveness of Physical Therapy Only and of Usual Care for Various Health Conditions: Systematic Review

Kuhlmann, A.; Treskova, M.; Ultsch, B.; Weidemann, F.; Wichmann, O.; Falkenhorst, G.; Graf von der Schulenburg, J., 2015:
Cost-Effectiveness of Pneumococcal Vaccination of Elderly In Germany

Iannazzo, S.; Chiroli, S.; Rowntree, C.; McGarry, L.; Briggs, A., 2015:
Cost-Effectiveness of Ponatinib Followed By Stem Cell Transplant Versus Best Supportive Care For Uk Patients With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukaemia After Failure of Dasatinib

Junjarunee, S.; Numuang, K.; Lerdlitruangsin, S.; Itzler, R., 2014:
Cost-Effectiveness of Posaconazole Versus Fluconazole or Itraconazole in the Prophylaxis of Invasive Fungal Infections Among Neutropenic Patients in Thailand

Price, J.T.; Wheeler, S.B.; Stranix-Chibanda, L.; Hosek, S.G.; Watts, D.Heather.; Siberry, G.K.; Spiegel, H.M.L.; Stringer, J.S.; Chi, B.H., 2017:
Cost-Effectiveness of Pre-exposure HIV Prophylaxis During Pregnancy and Breastfeeding in Sub-Saharan Africa

Plessow, R.; Arora, N.Kumar.; Brunner, B.; Wieser, S., 2016:
Cost-Effectiveness of Price Subsidies on Fortified Packaged Infant Cereals in Reducing Iron Deficiency Anemia in 6-23-Month-Old-Children in Urban India

Fritz, J.M.; Kim, M.; Magel, J.S.; Asche, C.V., 2016:
Cost-Effectiveness of Primary Care Management With or Without Early Physical Therapy for Acute Low Back Pain: Economic Evaluation of a Randomized Clinical Trial

Jin, X.Wen.; Lipold, L.; Foucher, J.; Sikon, A.; Brainard, J.; Belinson, J.; Schramm, S.; Nottingham, K.; Hu, B.; Rothberg, M.B., 2016:
Cost-Effectiveness of Primary HPV Testing, Cytology and Co-testing as Cervical Cancer Screening for Women Above Age 30 Years

Takabayashi, N.; Murata, K.; Tanaka, S.; Kawakami, K., 2016:
Cost-Effectiveness of Proton Pump Inhibitor Co-Therapy in Patients Taking Aspirin for Secondary Prevention of Ischemic Stroke

Sluiter, R.; Chau, S.H.; Kievit, W.; Teichert, M.; Hugtenburg, J., 2015:
Cost-Effectiveness of Proton Pump Inhibitor Initiation Aimed to Prevent Upper Gastrointestinal Toxicity in Patients Using Low-Dose Acetylsalicylic Acid

Roldos, M.I.; Espinoza, I., 2015:
Cost-Effectiveness of Quadrivalent Human Papilloma Virus (Hpv6/11/16/18) Vaccination In Ecuador

De Boer, P.T.; Pitman, R.J.; Macabeo, B.; Chit, A.; Postma, M.J.; Crépey, P., 2014:
Cost-Effectiveness of Quadrivalent Versus Trivalent Influenza Vaccine in the United States

Brandes, A.; Koerber, F.; Schwarzkopf, L.; Hunger, M.; Waidelich, R.; Rogowski, W., 2014:
Cost-Effectiveness of Radical Prostatectomy, Radiation Therapy and Active Surveillance for the Treatment of Localized Prostate Cancer - A Claims Data Analysis

Rodriguez, B.Cruz.; Leal, S.; Calvimontes, G.; Hutton, D., 2015:
Cost-Effectiveness of Radiofrequency Ablation for Supraventricular Tachycardia in Guatemala: Patient outcomes and economic analysis from a low-middle-income country

Haig, J.; Regnier, S.A.; Malcom, W.; Xue, W., 2014:
Cost-Effectiveness of Ranibizumab Verse Aflibercept in Treatment of Treatment of Visual Impairment Due to Diabetic Macular Oedema (Dmo)

Adedokun, L.; Burke, C., 2016:
Cost-Effectiveness of Ranibizumab Versus Aflibercept for Macular Edema Secondary to Branch Retinal Vein Occlusion: A UK Healthcare Perspective

Feng, S.; Ying, X.; Qi, F.; Chang, J., 2014:
Cost-Effectiveness of Ranibizumab Versus Photodynamic Therapy for the Treatment of Neovascluar Age-Related Macular Degeneration Based in China Cost Setting

Ruiz, M.C.I.; Ubiarco, L.V., 2014:
Cost-Effectiveness of Ranibizumab on Patients With Diffuse Diabetic Macular Edema Within the Public Mexican Health Care System

Saunders, R.; Boye, K.S.; van Brunt, K.; Pollock, R.F.; Valentine, W.J., 2015:
Cost-Effectiveness of Rapid-Acting Analog Insulin for Type 1 Diabetes In The Uk Setting

Goossens, L.M.A.; Vasbinder, E.C.; Van den Bemt, P.M.L.A.; Rutten-van Mölken, M.P.M.H., 2014:
Cost-Effectiveness of Real-Time Medication Monitoring in Children with Asthma

Rossaint, R.; Christensen, M.C.; Choong, P.Iau.Tsau.; Boffard, K.D.; Riou, B.; Rizoli, S.; Kluger, Y.; Lefering, R.; Morris, S., 2007:
Cost-Effectiveness of Recombinant Activated Factor VII as Adjunctive Therapy for Bleeding Control in Severely Injured Trauma Patients in Germany

Arakawa, I.; Momoeda, M.; Osuga, Y.; Ota, I.; Tanaka, E.; Adachi, K.; Koga, K., 2015:
Cost-Effectiveness of Recommended Medical Intervention for Treatment of Dysmenorrhea and Endometriosis in Japan Setting

Simons, P.A.M.; Ramaekers, B.; Hoebers, F.; Kross, K.W.; Marneffe, W.; Pijls-Johannesma, M.; Vandijck, D., 2016:
Cost-Effectiveness of Reduced Waiting Time for Head and Neck Cancer Patients due to a Lean Process Redesign

Nguyen, K-Huong.; Gordon, L.G., 2016:
Cost-Effectiveness of Repetitive Transcranial Magnetic Stimulation versus Antidepressant Therapy for Treatment-Resistant Depression

Makhni, E.C.; Swart, E.; Steinhaus, M.E.; Mather, R.C.; Levine, W.N.; Bach, B.R.; Romeo, A.A.; Verma, N.N., 2017:
Cost-Effectiveness of Reverse Total Shoulder Arthroplasty Versus Arthroscopic Rotator Cuff Repair for Symptomatic Large and Massive Rotator Cuff Tears

Vargas-Valencia, J.; Garcia Perlaza, J., 2015:
Cost-Effectiveness of Romiplostim As First-Line Primary Immune Thrombocytopenia (Itp) Treatment in Adult Splenectomised Patients Who are Refractory to Other Treatments and As Second-Line Itp Treatment in Adult Non-Splenectomised Patients Where Surgery is Contraindicated in Colombia

Augusto, M.; Gouveia, M.; Borges, M.; Campioni, M., 2014:
Cost-Effectiveness of Romiplostim for the Treatment of Chronic Immune Thrombocytopenia In Portugal

Shakerian, S.; Moradi Lakeh, M.; Esteghamati, A.; Zahraei, M.; Yaghoubi, M., 2015:
Cost-Effectiveness of Rotavirus Vaccination for Under-Five Children in Iran

Yamin, D.; Atkins, K.E.; Remy, V.; Galvani, A.P., 2017:
Cost-Effectiveness of Rotavirus Vaccination in France-Accounting for Indirect Protection

Hahl, J.; Kurki, S.; Miettinen, T.; Snicker, K., 2015:
Cost-Effectiveness of Ruxolitinib for The Treatment of Myelofibrosis In Finland. Economic Evaluation Based on Finnish Auria Biobank Data on Health Care Resource Utilization

King, J.B.; Shah, R.U.; Bress, A.P.; Nelson, R.E.; Bellows, B.K., 2017:
Cost-Effectiveness of Sacubitril-Valsartan Combination Therapy Compared With Enalapril for the Treatment of Heart Failure With Reduced Ejection Fraction

Sandhu, A.T.; Ollendorf, D.A.; Chapman, R.H.; Pearson, S.D.; Heidenreich, P.A., 2016:
Cost-Effectiveness of Sacubitril-Valsartan in Patients With Heart Failure With Reduced Ejection Fraction

Charokopou, M.; Vioix, H.; Verheggen, B.; Eddowes, L.A.; Griffiths, M.; Gabriel, Z.; Tolley, K.; Sibartie, M., 2014:
Cost-Effectiveness of Saxagliptin Compared To Glp-1 Analogues As An Add-On To Insulin in the Treatment of Type 2 Diabetes Mellitus From A Uk Health Care Perspective

Gu, S.; Zeng, Y.; Yu, D.; Hu, X.; Dong, H., 2017:
Cost-Effectiveness of Saxagliptin versus Acarbose as Second-Line Therapy in Type 2 Diabetes in China

Deogan, C.; Zarabi, N.; Stenström, N.; Högberg, P.; Skärstrand, E.; Manrique-Garcia, E.; Neovius, K.; Månsdotter, A., 2016:
Cost-Effectiveness of School-Based Prevention of Cannabis Use

Wingate, L'Marcus.T.; Coleman, M.S.; Posey, D.L.; Zhou, W.; Olson, C.K.; Maskery, B.; Cetron, M.S.; Painter, J.A., 2016:
Cost-Effectiveness of Screening and Treating Foreign-Born Students for Tuberculosis before Entering the United States

Nelson, S.; Kim, J.; Wilson, F.A.; Soliman, A.S.; Ngoma, T.; Kahesa, C.; Mwaiselage, J., 2018:
Cost-Effectiveness of Screening and Treatment for Cervical Cancer in Tanzania: Implications for other Sub-Saharan African Countries

Maceira, D.; Espinola, N.; Palacios, A., 2015:
Cost-Effectiveness of Screening for Colorectal Cancer In Argentina

Chan, C.K.W.; Gangwani, R.A.; McGhee, S.M.; Lian, J.; Wong, D.S.H., 2016:
Cost-Effectiveness of Screening for Intermediate Age-Related Macular Degeneration during Diabetic Retinopathy Screening

Lubitz, C.C.; Economopoulos, K.P.; Sy, S.; Johanson, C.; Kunzel, H.E.; Reincke, M.; Gazelle, G.Scott.; Weinstein, M.C.; Gaziano, T.A., 2016:
Cost-Effectiveness of Screening for Primary Aldosteronism and Subtype Diagnosis in the Resistant Hypertensive Patients

Costa-Scharplatz, M.; Lang, A.; Gustavsson, A.; Fasth, A., 2015:
Cost-Effectiveness of Secukinumab Compared to Ustekinumab In Patients With Psoriasis From A Swedish Health Care Perspective

Roze, Séphane.; Smith-Palmer, J.; Valentine, W.; Payet, V.; de Portu, S.; Papo, N.; Cucherat, M.; Hanaire, H., 2016:
Cost-Effectiveness of Sensor-Augmented Pump Therapy with Low Glucose Suspend Versus Standard Insulin Pump Therapy in Two Different Patient Populations with Type 1 Diabetes in France

Horn, E.K.; Verheul, R.; Thunnissen, M.; Delimon, J.; Goorden, M.; Hakkaart-van Roijen, L.; Soons, M.; Meerman, A.M.M.A.; Ziegler, U.M.; Rossum, B.V.; Stijnen, T.; Emmelkamp, P.M.G.; Busschbach, J.J.V., 2017:
Cost-Effectiveness of Short-Term Inpatient Psychotherapy Based on Transactional Analysis in Patients With Personality Disorder

Bektur, C.; Nurgozhin, T.; Abdukhakimova, D., 2015:
Cost-Effectiveness of Simeprevir Vs. Telaprevir for The Triple Therapy of Hepatitis C In Kazakhstan

Sweet, D.E.; Altice, F.L.; Cohen, C.J.; Vandewalle, Börn., 2016:
Cost-Effectiveness of Single- Versus Generic Multiple-Tablet Regimens for Treatment of HIV-1 Infection in the United States

Kim, Y.J.; Ko, S.K.; Lee, C.W., 2014:
Cost-Effectiveness of Single-Pill Combination Therapy of Amlodipine/Atorvastatin Compared with Concurrent Two-Pill Therapy in Patients with Hypertension

Athanasakis, K.; Zhuo, J.; Chen, J.; Boubouchairopoulou, N.; Tarantilis, F.; Papageorgiou, M.; Retsa, P.; Brandtmüller, A.; Tunceli, K.; Karokis, A.; Kyriopoulos, J., 2015:
Cost-Effectiveness of Sitagliptin Compared to Sulphonylurea as an Add-on to Metformin in the Treatment of Type 2 Diabetes in Greece

Chen, J.; Radican, L.; Shankar, R.; Hiver, M.; Qiu, Y., 2014:
Cost-Effectiveness of Sitagliptin Versus Sulfonylurea As An Add-On Therapy To Metformin In Patients With Type 2 Diabetes In A Belgium Setting

Leleu, H.; Blachier, M.; Hauvespre, A.; Pentel, J., 2015:
Cost-Effectiveness of Sofosbuvir and Ledipasvir In The Treatment of Patients With Hepatitis C

Kiel, M.A.; Röder, E.; Gerth van Wijk, R.; Rutten-Van Mölken, M.P.M.H., 2014:
Cost-Effectiveness of Subcutaneous Immunothereapy in Allergic Rhinitis Using One or More Allergens - An Analysis Long Overdue

Phillips, A.L.; Edwards, N.C.; Locklear, J.C., 2014:
Cost-Effectiveness of Subcutaneous Interferon Beta-1A in a Sub-Population of Multiple Sclerosis Patients (Kurtzke Expanded Disability Status Scale [EDSS]: >3.5-5.0)

Silverio, N.; Sequeira, L.; Meletiche, D., 2014:
Cost-Effectiveness of Subcutaneous Verse Intramuscular Interferon Beta-1A In Portugal Based on the Findings of Cochrane Collaboration Review of First-Line Treatments for Relapsing-Remitting Multiple Sclerosis

Lester-Coll, N.H.; Rutter, C.E.; Bledsoe, T.J.; Goldberg, S.B.; Decker, R.H.; Yu, J.B., 2017:
Cost-Effectiveness of Surgery, Stereotactic Body Radiation Therapy, and Systemic Therapy for Pulmonary Oligometastases

McCarthy, I.; Hostin, R.; O'Brien, M.; Fleming, N.; Ogola, G.; Kudyakov, R.; Richter, K.; Saigal, R.; Berven, S.; Deviren, V.; Ames, C., 2013:
Cost-Effectiveness of Surgical Treatment for Adult Spinal Deformity: A Comparison of Dollars per Quality of Life Improvement Across Health Domains

Aras, E.Levent.; Bunger, C.; Hansen, E.Stender.; Søgaard, R., 2016:
Cost-Effectiveness of Surgical Versus Conservative Treatment for Thoracolumbar Burst Fractures

Penno, E.C.; Baird, S.J.; Crump, J.A., 2016:
Cost-Effectiveness of Surveillance for Bloodstream Infections for Sepsis Management in Low-Resource Settings

Amler, N.; Becker, T.; Bierbaum, M.; Schöffski, O., 2014:
Cost-Effectiveness of Targeted Pharmacotherapy - A Systematic Review of the Literature

Bongiovanni-Delarozière, I.; Le, G-Pronost.M.; Rapp, T., 2014:
Cost-Effectiveness of Telemedicine: Lessons To Learn From An International Review

Biz, A.N.; Schluckebier, L.F.; Bastos, C.R.; Silva, R.M.; Braga, J.U.; Caetano, R., 2015:
Cost-Effectiveness of The Use of 18fdg-Pet/Ct In The Detection of Recurrent Differentiated Thyroid Cancer

Zsólyom, A.; Nagy, B.; Nagyjánosi, L.; Dessewffy, Z.; Steiner, T.; Kaló, Z.; Vokó, Z., 2014:
Cost-Effectiveness of Theintroduction of A National Adherence Program for Type 2 Diabetes In Hungary

Velasco, A.; Chung, O.; Raza, F.; Pandey, A.; Brinker, S.; Arbique, D.; Price, A.; Lotan, Y.; Das, S.R.; Vongpatanasin, W., 2016:
Cost-Effectiveness of Therapeutic Drug Monitoring in Diagnosing Primary Aldosteronism in Patients With Resistant Hypertension

Haghighat, S.; Akbari, M.Esmaeil.; Yavari, P.; Javanbakht, M.; Ghaffari, S., 2016:
Cost-Effectiveness of Three Rounds of Mammography Breast Cancer Screening in Iranian Women

Pan, Y.; Wang, Y.L.; Liu, G.; Zhao, K.; Wang, Y., 2014:
Cost-Effectiveness of Thrombolysis Within 4.5 Hours of Acute Ischemic Stroke in China

Rama, M.; Miraci, M.; Balla, I.; Petrela, E.; Malaj, L.; Koleci, A., 2016:
Cost-Effectiveness of Thrombolytic Therapy, Compared with Anticoagulants Therapy in the Treatment of Acute Myocardial Infarction in Albania

Kalra, V.B.; Wu, X.; Haas, B.M.; Forman, H.P.; Philpotts, L.E., 2016:
Cost-Effectiveness of Tomosynthesis in Annual Screening Mammography

Reynolds, M.R.; Lei, Y.; Wang, K.; Chinnakondepalli, K.; Vilain, K.A.; Magnuson, E.A.; Galper, B.Z.; Meduri, C.U.; Arnold, S.V.; Baron, S.J.; Reardon, M.J.; Adams, D.H.; Popma, J.J.; Cohen, D.J., 2016:
Cost-Effectiveness of Transcatheter Aortic Valve Replacement With a Self-Expanding Prosthesis Versus Surgical Aortic Valve Replacement

Busca, R.; Geisler, B.P.; Pietzsch, J.B., 2015:
Cost-Effectiveness of Transcatheter Aortic Valve Replacement: Current Decision-Analytic Models and Future Opportunities

Gao, L.; Li, S.C., 2014:
Cost-Effectiveness of Treating Acute Coronary Syndrome Patients with Rivaroxban in Australia

Chevalier, J.; Chamoux, C.; Hammès, F.; Chicoye, A., 2016:
Cost-Effectiveness of Treatments for Relapsing Remitting Multiple Sclerosis: A French Societal Perspective

Tempelaar, S.; Stephens, S.; Schouten, J., 2015:
Cost-Effectiveness of Treatments for Wet Age-Related Macular Degeneration (Wamd) In The Netherlands, The Case of Intravitreal Aflibercept (Ivt-Afl) and Ranibizumab

Jalal, H.; O'Dell, J.R.; Bridges, S.Louis.; Cofield, S.; Curtis, J.R.; Mikuls, T.R.; Moreland, L.W.; Michaud, K., 2016:
Cost-Effectiveness of Triple Therapy Versus Etanercept Plus Methotrexate in Early Aggressive Rheumatoid Arthritis

Tatar, M.; Senturk, A.; Dalgali, Y., 2014:
Cost-Effectiveness of Use of Barricaid® In Lumbar Discectomy Surgery in Turkey

Väätäinen, S.; Soini, E.J.; Valgardsson, V.S.; Mälkönen, T., 2015:
Cost-Effectiveness of Ustekinumab In The Treatment of Psoriasis In Finland

van Hoek, A.Jan.; Miller, E., 2016:
Cost-Effectiveness of Vaccinating Immunocompetent ≥65 Year Olds with the 13-Valent Pneumococcal Conjugate Vaccine in England

Rosselli, D.; Castañeda-Cardona, C.; Bayona, J.G.; Díaz Toro, Y.R.; Saenz Ariza, S.A., 2015:
Cost-Effectiveness of Vemurafenib Vs Ipilimumab Plus Dacarbacine in the Treatment of Non-Resectable Metastasic Melanoma with Braf600e Mutation in Colombia

Rubio-Terrés, C.; Orofino, J.; Armas, J.; Parra, J.; Rubio-Rodríguez, D.; Grau, S., 2015:
Cost-Effectiveness of Vemurafenib as a First-Line Treatment in Patients with Braf V600 Mutation-Positive Unresectable or Metastatic Melanoma in Spain

Mikudina, B.; Péter, T.; Nagy, B.; Horváth, K., 2014:
Cost-Effectiveness of Vismodegib Verse Standard of Care Therapy in the Treatment of Locally-Advanced or Symptomatic Metastatic Basal Cell Carcinoma in Hungary - A Global Cost-Effectiveness Model Adaptation

Elmansy, H.; Metry, A.B.; Eldessouki, R.; Elsisi, G., 2015:
Cost-Effectiveness of Zoledronic Acid Versus Alendronic Acid In The Treatment of Osteoporosis In Postmenopausal Egyptian Patients: Decision Analysis

van Bakelen, N.B.; Vermeulen, K.M.; Buijs, G.J.; Jansma, J.; de Visscher, J.G.A.M.; Hoppenreijs, T.J.M.; Bergsma, J.E.; Stegenga, B.; Bos, R.R.M., 2016:
Cost-Effectiveness of a Biodegradable Compared to a Titanium Fixation System in Maxillofacial Surgery: A Multicenter Randomized Controlled Trial

Roth, J.A.; Ramsey, S.D.; Carlson, J.J., 2016:
Cost-Effectiveness of a Biopsy-Based 8-Protein Prostate Cancer Prognostic Assay to Optimize Treatment Decision Making in Gleason 3 + 3 and 3 + 4 Early Stage Prostate Cancer

Boland, M.R.S.; Kruis, A.; Tsiachristas, A.; Assendelft, W.; Gussekloo, J.; Blom, C.; Chavannes, N.; Rutten van-Molken, M., 2014:
Cost-Effectiveness of a COPD Disease Management Program in Primary Care: The Recode Cluster Randomized Trial

van Leeuwen, K.M.; Bosmans, J.E.; Jansen, A.P.D.; Hoogendijk, E.O.; Muntinga, M.E.; van Hout, H.P.J.; Nijpels, G.; van der Horst, H.E.; van Tulder, M.W., 2015:
Cost-Effectiveness of a Chronic Care Model for Frail Older Adults in Primary Care: Economic Evaluation Alongside a Stepped-Wedge Cluster-Randomized Trial

Celano, C.M.; Healy, B.; Suarez, L.; Levy, D.E.; Mastromauro, C.; Januzzi, J.L.; Huffman, J.C., 2016:
Cost-Effectiveness of a Collaborative Care Depression and Anxiety Treatment Program in Patients with Acute Cardiac Illness

Zwerink, M.; Effing, T.; Kerstjens, H.A.M.; van der Valk, P.; Brusse-Keizer, M.; Zielhuis, G.; van der Palen, J., 2017:
Cost-Effectiveness of a Community-Based Exercise Programme in COPD Self-Management

Hsieh, H-Min.; Gu, S-Mao.; Shin, S-Jang.; Kao, H-Yun.; Lin, Y-Chieh.; Chiu, H-Chia., 2016:
Cost-Effectiveness of a Diabetes Pay-For-Performance Program in Diabetes Patients with Multiple Chronic Conditions

Levy, D.E.; Klinger, E.V.; Linder, J.A.; Fleegler, E.W.; Rigotti, N.A.; Park, E.R.; Haas, J.S., 2016:
Cost-Effectiveness of a Health System-Based Smoking Cessation Program

Byrnes, J.; Carrington, M.; Chan, Y-Kai.; Pollicino, C.; Dubrowin, N.; Stewart, S.; Scuffham, P.A., 2016 :
Cost-Effectiveness of a Home Based Intervention for Secondary Prevention of Readmission with Chronic Heart Disease

Jayaraman, S.P.; Jiang, Y.; Resch, S.; Askari, R.; Klompas, M., 2017:
Cost-Effectiveness of a Model Infection Control Program for Preventing Multi-Drug-Resistant Organism Infections in Critically Ill Surgical Patients

Graves, N.; Page, K.; Martin, E.; Brain, D.; Hall, L.; Campbell, M.; Fulop, N.; Jimmeison, N.; White, K.; Paterson, D.; Barnett, A.G., 2016:
Cost-Effectiveness of a National Initiative to Improve Hand Hygiene Compliance Using the Outcome of Healthcare Associated Staphylococcus aureus Bacteraemia

Jensen, Jørgen.Dejgård.; Saxe, H.; Denver, S., 2016:
Cost-Effectiveness of a New Nordic Diet as a Strategy for Health Promotion

Brown, N.J.; David, M.; Cuttle, L.; Kimble, R.M.; Rodger, S.; Higashi, H., 2016:
Cost-Effectiveness of a Nonpharmacological Intervention in Pediatric Burn Care

Polgreen, L.A.; Han, J.; Carter, B.L.; Ardery, G.P.; Coffey, C.S.; Chrischilles, E.A.; James, P.A., 2016:
Cost-Effectiveness of a Physician-Pharmacist Collaboration Intervention to Improve Blood Pressure Control

Wong, C.K.H.; Jiao, F-Fang.; Siu, S-Chung.; Fung, C.S.C.; Fong, D.Y.T.; Wong, K-Wai.; Yu, E.Y.T.; Lo, Y.Y.C.; Lam, C.L.K., 2016:
Cost-Effectiveness of a Short Message Service Intervention to Prevent Type 2 Diabetes from Impaired Glucose Tolerance

Tanajewski, L.; Franklin, M.; Gkountouras, G.; Berdunov, V.; Edmans, J.; Conroy, S.; Bradshaw, L.E.; Gladman, J.R.F.; Elliott, R.A., 2016:
Cost-Effectiveness of a Specialist Geriatric Medical Intervention for Frail Older People Discharged from Acute Medical Units: Economic Evaluation in a Two-Centre Randomised Controlled Trial (AMIGOS)

Michaud, T.L.; Abraham, J.; Jalal, H.; Luepker, R.V.; Duval, S.; Hirsch, A.T., 2016:
Cost-Effectiveness of a Statewide Campaign to Promote Aspirin Use for Primary Prevention of Cardiovascular Disease

Schremser, K.; Rogowski, W.H.; Adler-Reichel, S.; Tufman, A.L.H.; Huber, R.M.; Stollenwerk, Börn., 2016:
Cost-Effectiveness of an Individualized First-Line Treatment Strategy Offering Erlotinib Based on EGFR Mutation Testing in Advanced Lung Adenocarcinoma Patients in Germany

Bektur, C.; Nurgozhin, T., 2014:
Cost-Effectiveness of denosumab vs. Brand or generic zoledronic acid in patients with prostate cancer in kazakhstan

Zang, X.; Tang, H.; Min, J.Eun.; Gu, D.; Montaner, J.S.G.; Wu, Z.; Nosyk, B., 2017:
Cost-Effectiveness of the 'One4All' HIV Linkage Intervention in Guangxi Zhuang Autonomous Region, China

Fischer, L.; Arnold, M.; Kirsch, F.; Leidl, R., 2015:
Cost-Effectiveness of the 21 Gene Assay in Patients with Node-Positive Breast Cancer

Roque, M.; Valle, M.; Guimarães, F.; Sampaio, M.; Geber, S., 2015:
Cost-Effectiveness of the Freeze-All Policy

Groessl, E.J.; Sklar, M.; Laurent, D.D.; Lorig, K.; Ganiats, T.G.; Ho, S.B., 2016:
Cost-Effectiveness of the Hepatitis C Self-Management Program

Obradovic, M.; Vanden, B.H.; Liedgens, H., 2014:
Cost-Effectiveness of the Lidocaine 5% Medicated Plaster Verse Pregabalin and Amitriptyline for the Treatment of Post-Herpetic Neuralgia In the Netherlands

Chen, X.F.; Huang, S.T.; Zhu, W.F., 2014:
Cost-Effectiveness of the Treatment of Respiratory Diseases of Xiyanping Injection : A Systematic Review

Walter, E.; Kasper, D.C., 2014:
Cost-Effectiveness-Analysis of The New-Born Screening in Austria

Ding, Y.; Thompson, J.D.; Kobrynski, L.; Ojodu, J.; Zarbalian, G.; Grosse, S.D., 2017:
Cost-Effectiveness/Cost-Benefit Analysis of Newborn Screening for Severe Combined Immune Deficiency in Washington State

Vujicic, Z., 2015:
Cost-Effectivness Analysis of Shizophrenia Treatment With Haloperidol , Olanzapine And Risperidone In Bosnia and Hercegovina ,Republic of Srpska By Application of The Markov Model

Mleşniţe, M.; Bocşan, I.Stelian., 2016:
Cost-Efficiency Analysis of a Multi-Pavilion Hospital in Cluj County

Covens, A.; Köhler, C.; Nam, J-Hyun.; Naumann, R.Wendel.; Obermair, A.; Querleu, D., 2016:
Cost-Efficiency of Robotic Surgery

Alomi, Y.A.; Almudaiheem, H.Y.; Alarnous, T.; Alshurei, S.; Alsharafa, A.; Alzahrani, T.; Albassri, H.; Alenizi, K.; Alreshedi, M.; Alathan, M.; Aljohany, N., 2015:
Cost-Efficiency of of National Drug Information Center Through Ministry of Healh Hotline Calling Services (937) in Saudi Arabia: Application of a Mercian Model

Zhang, P.; Li, W.; Sun, H., 2017:
Cost-Efficient and Multi-Functional Secure Aggregation in Large Scale Distributed Application

Kolochenko, I., 2016:
Cost-Justifying Security

Djordjevic, J.; Mitrovic, M.; Marinkovic, V.; Tasic, L.; Krajnovic, D., 2014:
Cost-Minimisation Analysis of Colistimethate Sodium in Serbia- off Label Use Approach

Vioix, H.; Eddowes, L.A.; Griffiths, M.; Gabriel, Z., 2014:
Cost-Minimisation Analysis of Dapagliflozin Compared To Lixisenatide As An Add-On To Insulin In The Treatment of Type 2 Diabetes Mellitus From A Uk Health Care Perspective

Athanazio, R.; Maldini, P.; Roa, S.; Turunen, H.; Silva, C., 2015:
Cost-Minimisation Analysis of Dexmedetomidine Versus Propofol in Mechanical Ventilated Patients at Icu

Quintero, J.; Oyagüez, I.; González, B.; Cuervo-Arango, I.; García, I.; Casado, M.Angel., 2016:
Cost-Minimisation Analysis of Paliperidone Palmitate Long-Acting Treatment versus Risperidone Long-Acting Treatment for Schizophrenia in Spain

Vioix, H.; Eddowes, L.A.; Griffiths, M.; Gabriel, Z., 2014:
Cost-Minimisation Analysis of Saxagliptin Compared to Sitagliptin And Linagliptin As Triple Therapy In Combination With Metformin And A Sulphonylurea In The Treatment Of Type 2 Diabetes Mellitus From A Uk Health Care Perspective

Pichardo-Piña, C.A.; Sánchez-Casillas, J.L.; Pozos-Espíndola, J.C., 2015:
Cost-Minimization Analyses of Adalimumab Compared with Selective Immunosuppressive Cytokines Blockers and Inhibitors of Tumor Necrosis Factor Alpha Indicated for the Treatment of Rheumatoid Arthritis, Psoriasis and Crohn's Disease in the Private Market in Mexico

Ravasio, R.; Pisarra, P.; Comaschi, M., 2015:
Cost-Minimization Analysis (CMA) of Canagliflozin Compared to Glimepiride and Sitagliptin as Dual Therapy in Combination with Metformin

Piedade, A.; Paladini, L.; Tobaruella, F.; Nakada, C., 2015:
Cost-Minimization Analysis Of Rivaroxaban In Comparison To Enoxaparin Plus Warfarin For The Treatment Of Venous Thromboembolism (Vte) Under The Private Healthcare System Perspective

Menezes, F.G.; Chibana, V., 2015:
Cost-Minimization Analysis and Total Cost Analysis for A Weight Range In Crohn's Disease Treatment With Anti-Tnf Biologics Under Brazilian Private Health Care System Perspective

Tsuchiya, C.T.; Kim, H.S.J.; Maximo, M.F.M.; Ramos, L.A., 2014:
Cost-Minimization Analysis of Bevacizumab Verse Cetuximab in First-Line Treatment for Metastatic Colorectal Cancer in Kras Wild-Type Patients in the Supplementary Health Care System in Brazil

Murra Anton, Z.A., 2015:
Cost-Minimization Analysis of Intravitreal Aflibercept Compared with Ranibizumab on-Label In Patients with wet Age-Related Macular Degeneration (Wamd)

Soto, M.H.; Sanchez, K.; Constanzo, A.; Escobar, Járez.Y.; Fernandez, Z.; Melendez, C., 2014:
Cost-Minimization Analysis of Methadona Opioid Analgesic for Mexican Patients With Acute and Chronic Secondary Cancer As Rotation Option In Severe Pain

Zhang, S.; Vora, M.; Harris, A.H.S.; Baker, L.; Curtin, C.; Kamal, R.N., 2017:
Cost-Minimization Analysis of Open and Endoscopic Carpal Tunnel Release

Mylonas, C.; Kourlaba, G.; Fountzilas, G.; Skroumpelos, A.; Maniadakis, N., 2014:
Cost-Minimization Analysis of Trastuzumab Intravenous Versus Trastuzumab Subcutaneous for the Treatment of Patients With HER2+ Early Breast Cancer And Metastatic Breast Cancer in Greece

Pimentel, M.; Purdy, C.; Magar, R., 2015:
Cost-Minimization For A Novel Ibs Diagnostic Blood Panel Versus Standard Exclusionary Diagnostic Testing For Diarrhea Predominant Irritable Bowel Syndrome: A United States Perspective

Hren, R.; Stynes, G., 2014:
Cost-Minimization and Budget-Impact Analysis of Fixed-Dose Combination Inhalers in Treatment of Copd in Slovenia

Hren, R.; Trkman, M.; Stynes, G., 2014:
Cost-Minimization and Budget-Impact Analysis of Fixed-Dose ICS/LABA Combination Inhalers in the Treatment of Asthma in Slovenia

Blumberg, D.M.; Prager, A.J.; Liebmann, J.M.; Cioffi, G.A.; De Moraes, C.Gustavo., 2015:
Cost-Related Medication Nonadherence and Cost-Saving Behaviors Among Patients With Glaucoma Before and After the Implementation of Medicare Part D

Moores, B.Michael., 2017:
Cost-Risk-Benefit Analysis in Diagnostic Radiology: a Theoretical and Economic Basis for Radiation Protection of the Patient

Cámara, R.J.A.; Merz, C.; Wegmann, B.; Stauber, S.; von Känel, R.; Egloff, N., 2016:
Cost-Saving Early Diagnosis of Functional Pain in Nonmalignant Pain: A Noninferiority Study of Diagnostic Accuracy

Markowski, M.C.; Frick, K.D.; Eshleman, J.R.; Luo, J.; Antonarakis, E.S., 2016:
Cost-Savings Analysis of AR-V7 Testing in Patients With Metastatic Castration-Resistant Prostate Cancer Eligible for Treatment With Abiraterone or Enzalutamide

Parikh, K.R.; Davenport, M.S.; Viglianti, B.L.; Hubers, D.; Brown, R.K.J., 2017:
Cost-Savings Analysis of Renal Scintigraphy, Stratified by Renal Function Thresholds: Mercaptoacetyltriglycine Versus Diethylene Triamine Penta-Acetic Acid

Peters, R.DeV.; Petrunka, K.; Khan, S.; Howell-Moneta, A.; Nelson, G.; Pancer, S.Mark.; Loomis, C., 2016:
Cost-Savings Analysis of the Better Beginnings, Better Futures Community-Based Project for Young Children and Their Families: A 10-Year Follow-up

Pugliese, L., 2015:
Cost-Savings And Cost-Utility Of An Ehr System Smartphone App In A Trauma Intensive Care Unit

Goede, S.L.; Kuntz, K.M.; van Ballegooijen, M.; Knudsen, A.B.; Lansdorp-Vogelaar, I.; Tangka, F.K.; Howard, D.H.; Chin, J.; Zauber, A.G.; Seeff, L.C., 2015:
Cost-Savings to Medicare From Pre-Medicare Colorectal Cancer Screening

Lu, J.; Liong, V.Erin.; Zhou, J., 2016:
Cost-Sensitive Local Binary Feature Learning for Facial Age Estimation

Kumudha, P.; Venkatesan, R., 2017:
Cost-Sensitive Radial Basis Function Neural Network Classifier for Software Defect Prediction

Sinaiko, A.D.; Mehrotra, A.; Sood, N., 2016 :
Cost-Sharing Obligations, High-Deductible Health Plan Growth, and Shopping for Health Care: Enrollees With Skin in the Game

Liu, J.; Zhao, W., 2017:
Cost-Sharing of Ecological Construction Based on Trapezoidal Intuitionistic Fuzzy Cooperative Games

Ma, Y.; Huang, J.; Zhu, B.; Sun, Q.; Miao, Y.; Zou, H., 2016:
Cost-Utility Analyses of Cataract Surgery in Advanced Age-Related Macular Degeneration

Soini, E.; Hallinen, T.; Sokka, A.L.; Saarinen, K., 2014:
Cost-Utility Analysis (Cua) of First-Line Actinic Keratosis (Ak) Treatments in Finland

Soini, E.; Asseburg, C.; Sumelahti, M.L., 2014:
Cost-Utility Analysis (cua) Of First-Line Disease-Modifying Treatments (DMT) Versus Best Supportive Care (Bsc) In Finnish Relapsing-Remitting Multiple Sclerosis (RRMS) Patients

Paragò, V.; El, H.M.; Bonamonte, D.; Diociaiuti, A.; Teruzzi, C., 2014:
Cost-Utility Analysis Comparing Propranolol With Corticosteroids in the Treatment of Proliferating Infantile Hemangioma in Italy

Stern, S.; Cotte, F.; Minacori, R.; Gosden, T.; Hamilton, M.; Phatak, H.; Quon, P., 2015:
Cost-Utility Analysis Of Apixaban In The Acute Treatment And Prevention Of Venous Thromboembolism In France

Oh, S.H.; You, J.H.; Lee, J.Y.; Park, J.J.; Shin, S., 2014:
Cost-Utility Analysis Of Carotid Artery Stenting Versus Endarterectomy For Symptomatic Carotid Stenosis Patients

O'Day, K.; Campbell, D.J., 2015:
Cost-Utility Analysis Of Chocolate Consumption For Prevention Of Cardiometabolic Disease

Vicente, C.; Loblaw, A.; North, S.; Kassouf, W.; Naidoo, S.; Husein, F.; Nakhaipour, H.R., 2015 :
Cost-Utility Analysis Of Enzalutamide For Patients With Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer (Mcrpc) After Failure Of Androgen Deprivation Therapy (Adt)

Petryszyn, P.; Well, A., 2014:
Cost-Utility Analysis Of Fidaxomicin Compared To Vancomycin In The Management Of Severe Clostridium Difficile Infection In Poland

Stawowczyk, E.; Holko, P.; Kawalec, P.; Borowiec, L.; Filipiak, K.J., 2014:
Cost-Utility Analysis Of Hypertensive Treatment With Indapamide And Amlodipine Single-Pill Combination In The Polish Setting

Castro Jaramillo, Héctor.Eduardo.; Moreno Viscaya, M.; Mejia, A.E., 2016:
Cost-Utility Analysis of Primary Prophylaxis, Compared with On-Demand Treatment, for Patients with Severe Hemophilia Type a in Colombia

Zhang, E.; Wartelle-Bladou, C.; Lepanto, L.; Lachaine, J.; Cloutier, G.; Tang, A., 2014:
Cost-Utility Analysis Of Screening Strategies For Nonalcoholic Steatohepatitis

Igarashi, A.; Tang, W.; Cure, S.; Guerra, I.; Lopresti, M.; Tsutani, K., 2014:
Cost-Utility Analysis Of Sofosbuvir For Treatment Of Genotype2 Chronic Hepatitis C In Japan

Haasis, M.A.; Ceria, J.A., 2014:
Cost-Utility Analysis of 10- and 13-Valent Pneumocococcal Conjugate Vaccines in the Philippines

Jódar-Sánchez, F.; Malet-Larrea, A.; Martín, J.; Garcia, L.; López, D.Amo.M.P.; Martínez-Martínez, F.; Gastelurrutia-Garralda, M.A.; Garcia-Cárdenas, M.V.; Sabater-Hernández, D.; Benrimoj, S.I., 2014:
Cost-Utility Analysis of A Medication Review With Follow-Up for Older People With Polypharmacy in Community Pharmacies in Spain: Consigue Program

Wang, S.; Yang, H.; Yang, M.; Bao, Y., 2015:
Cost-Utility Analysis of Adalimumab for The Treatment of Moderate-To-Severe Ulcerative Colitis In Patients In Spain

Alvin, M.D.; Lubelski, D.; Abdullah, K.G.; Whitmore, R.G.; Benzel, E.C.; Mroz, T.E., 2016:
Cost-Utility Analysis of Anterior Cervical Discectomy and Fusion With Plating (ACDFP) Versus Posterior Cervical Foraminotomy (PCF) for Patients With Single-level Cervical Radiculopathy at 1-Year Follow-up

Tagliaferri, A.; Coppola, A.; Amoresano, S.; Aiello, A.; D'Ausilio, A.; Toumi, M., 2015:
Cost-Utility Analysis of Antihemophilic Factor Rfviii-Fs for Secondary Prophylaxis Vs on-Demand Therapy In Severe Haemophilia A In Italy

Barbieri, M.; Capri, S.; Oskar, B., 2015:
Cost-Utility Analysis of Apremilast for The Treatment of Moderate to Severe Plaque Psoriasis In The Italian Setting

Carrascosa, J.M.; Vanaclocha, F.; Caloto, T.; Echave, M.; Oyagüez, I.; Tencer, T., 2015:
Cost-Utility Analysis of Apremilast for The Treatment of Moderate to Severe Psoriasis In Spain

Capri, S.; Barbieri, M.; Oskar, B., 2015:
Cost-Utility Analysis of Apremilast for The Treatment of Psoriatic Arthritis In The Italian Setting

Gonzalez, C.M.; Almodóvar, R.; Caloto, T.; Echave, M.; Elías, I.; Tencer, T., 2015:
Cost-Utility Analysis of Apremilast for The Treatment of Psoriatic Arthritis Patients In Spain

Paquete, A.T.; Inês, M.; Duarte, I.; Almeida, A.; Esteves, S.; Miguel, L.S., 2014:
Cost-Utility Analysis of Bosutinib for Previously Treated Chronic Myeloid Leukemia (Cml) In Portugal

Winn, A.N.; Ekwueme, D.U.; Guy, G.P.; Neumann, P.J., 2016:
Cost-Utility Analysis of Cancer Prevention, Treatment, and Control: A Systematic Review

Xu, X.; Ma, Y-Yan.; Zou, H-Dong., 2017:
Cost-Utility Analysis of Cataract Surgery in Advanced Glaucoma Patients

Tzanetakos, C.; Maniadakis, N.; Kourlaba, G.; Tzioufas, A.; Goules, A.; Theodoratou, T.; Christou, P., 2014:
Cost-Utility Analysis of Certolizumab Pegol Plus Methotrexate for the Treatment of Moderate-To-Severe Active Rheumatoid Arthritis In Greece

Tzanetakos, C.; Vassilopoulos, D.; Kourlaba, G.; Christou, P.; Maniadakis, N., 2015:
Cost-Utility Analysis of Certolizumab Pegol for the Treatment of Active Psoriatic Arthritis in GREECE

Foteff, C.; Kennedy, S.; Milton, A.Hasnat.; Deger, M.; Payk, F.; Sanderson, G., 2017:
Cost-Utility Analysis of Cochlear Implantation in Australian Adults

Quitian, H.; Gomez, A.M.; Garcia Peña, A.A.; Arciniegas, J.; Iragorri, N.; Mantilla, B.; Gomez-Restrepo, C.; Rosselli, D., 2015:
Cost-Utility Analysis of Continuous Infusion Pump With Integrated Monitoring Compared With Multiple Daily Injection Treatment for Patients 15-Years or Older With Type 1 Diabetes Mellitus In Colombia

Silva Miguel, L.; de Sá, J.; Pinheiro, B.; Acosta, C., 2015:
Cost-Utility Analysis of Delayed-Release Dimethyl Fumerate For The Treatment of Relapsing-Remitting Multiple Sclerosis In Portugal

Stetka, R.; Psenkova, M.; Ondrusova, M.; Hlavinkova, L.; Trnovec, P., 2014:
Cost-Utility Analysis of Dolutegravir Compared to Raltegravir in Treatment Naive and Treatment Experienced Patients in Slovak Settings

Parrondo, J.; Moreno, S.; Losa, J.E.; Berenguer, J.; Martinez-Sesmero, J.M.; Grasset, E.; Cenoz-Gomis, S., 2015:
Cost-Utility Analysis of Dolutegravir/Abacavir/Lamivudine (Dtg/Abc/3tc) as a Single Tablet Treatment of Naïve Hiv Infected Patientss

Tongpak, P., 2014:
Cost-Utility Analysis of First-Line Regimen Between Cisplatin Plus Pemetrexed and Carboplatin Plus Paclitaxel In Advanced Non-Squamous Non-Small-Cell Lung Cancer in Thailand

Setiawan, D.; Dolk, F.Christiaan.; Suwantika, A.A.; Westra, T.Arend.; WIlschut, J.C.; Postma, M.Jacobus., 2018:
Cost-Utility Analysis of Human Papillomavirus Vaccination and Cervical Screening on Cervical Cancer Patient in Indonesia

Hatam, N.; Dehghani, M.; Habibian, M.; Jafari, A., 2015:
Cost-Utility Analysis of IEV Drug Regimen Versus ESHAP Drug Regimen for the Patients With Relapsed and Refractory Hodgkin and Non-Hodgkin's Lymphoma in Iran

Stawowczyk, E.; Kawalec, Pł.; Pilc, A., 2017:
Cost-Utility Analysis of Infliximab with Standard Care versus Standard Care Alone for Induction and Maintenance Treatment of Patients with Ulcerative Colitis in Poland

Elias, I.; Ortega-Joaquin, N.; Aguilar, M.; Moreno, D.; Boada, A.; Del Pozo, L.J.; de la Cueva, P.; Mirada, A.; Mosquera, E.; Gibbons, C.; Oyagüez, I., 2015:
Cost-Utility Analysis of Ingenol Mebutate Versus Diclofenac 3% for Actinic Keratosis Treatment In Spain

Ortega-Joaquin, N.; Elías, I.; de la Cueva, P.; Del Pozo, L.J.; Boada, A.; Moreno, D.; Aguilar, M.; Mosquera, E.; Mirada, A.; Gibbons, C.; Oyagüez, I., 2015:
Cost-Utility Analysis of Ingenol Mebutate Versus Imiquimod 5% for Actinic Keratosis Treatment In Spain

Alvin, M.D.; Lubelski, D.; Abdullah, K.G.; Whitmore, R.G.; Benzel, E.C.; Mroz, T.E., 2016:
Cost-Utility Analysis of Instrumented Fusion Versus Decompression Alone for Grade I L4-L5 Spondylolisthesis at 1-Year Follow-up: A Pilot Study

Rosselli, D.; Quitian, H.; Gomez, A.M.; Garcia Peña, A.A.; Arciniegas, J.; Iragorri, N.; Mantilla, B.; Gomez-Restrepo, C., 2015:
Cost-Utility Analysis of Insulin Analogues Compared with Multiple Daily Injections of Human Insulin for the Treatment of 15 Years Old or Older Patients with Type 1 Diabetes Mellitus in Colombia

Altawalbeh, S.M.; Thorpe, J.M.; Thorpe, C.T.; Smith, K.J., 2017:
Cost-Utility Analysis of Long-Acting Beta Agonists versus Leukotriene Receptor Antagonists in Older Adults with Persistent Asthma Receiving Concomitant Inhaled Corticosteroid Therapy

Kolek, M.; Duba, J.; Vesela, S.; Pasztor, B.; Doleckova, J., 2014:
Cost-Utility Analysis of Long-Acting Paliperidone in Comparison with Oral Risperidone, Oral Paliperidone and Long-Acting Risperidone in the Maintenance Treatment of Schizophrenia in the Czech Republic

Rajagopalan, K.; Trueman, D.; Crowe, L.; Squirrell, D.; Loebel, A., 2017:
Cost-Utility Analysis of Lurasidone Versus Aripiprazole in Adults with Schizophrenia

Parody, E.; Pedraza, S.; García-Gil, Mía.M.; Crespo, C.; Serena, Jín.; Dávalos, A., 2016:
Cost-Utility Analysis of Magnetic Resonance Imaging Management of Patients with Acute Ischemic Stroke in a Spanish Hospital

Ganesalingam, J.; Pizzo, E.; Morris, S.; Sunderland, T.; Ames, D.; Lobotesis, K., 2015:
Cost-Utility Analysis of Mechanical Thrombectomy Using Stent Retrievers in Acute Ischemic Stroke

Nee, R.; Rivera, I.; Little, D.J.; Yuan, C.M.; Abbott, K.C., 2015:
Cost-Utility Analysis of Mycophenolate Mofetil versus Azathioprine Based Regimens for Maintenance Therapy of Proliferative Lupus Nephritis

Alves, J.; Machado, M., 2015:
Cost-Utility Analysis of Natalizumab as First-Line Treatment of Highly-Active Relapsing-Remitting Multiple Sclerosis in the Brazilian Public Healthcare System

Wu, D.B.C.; Chaiyakunapruk, N.; Pratoomsoot, C.; Lee, K.K.C.; Chong, H.Y.; Nelson, R.E.; Smith, P.F.; Kirkpatrick, C.; Kamal, M.A.; Nieforth, K.; Dall, G.; Toovey, S.; Kong, D.C.; Kamauu, A.; Rayner, C., 2014:
Cost-Utility Analysis of Optimal Dosing of Oseltamivir Under Pandemic Influenza Using a Novel Approach: Linking Health Economics and Transmission Dynamic Models

Wajanavisit, W.; Woratanarat, P.; Sawatriawkul, S.; Lertbusayanukul, C.; Ongphiphadhanakul, B., 2015:
Cost-Utility Analysis of Osteoporotic Hip Fractures in Thais

Espinosa, J.; González-Larriba, J.L.; Maroto, P.; Méndez-Vidal, M.J.; Díaz-Cerezo, S., 2014:
Cost-Utility Analysis of Pazopanib Verse Sunitinib as First-Line Treatment of Metastatic Renal Cell Carcinoma (MRCC) iN Spain

Lee, H-Dong.; Jeon, C-Hoon.; Chung, N-Su.; Seo, Y-Wook., 2016:
Cost-Utility Analysis of Pedicle Screw Removal After Successful Posterior Instrumented Fusion in Thoracolumbar Burst Fractures

Pitter, J.G.; Vokó, Z.; Halmos, Á.; Józwiak, Á., 2015:
Cost-Utility Analysis of Potential Campylobacter Control Measures in the Food Chain of Indoor Broiler Chicken in the Eu

Belousov, D.; Afanasieva, E., 2015:
Cost-Utility Analysis of Pramipexole Extended Release Monotherapy In Early Parkinson`S Disease

Brettschneider, C.; Luck, T.; Fleischer, S.; Roling, G.; Beutner, K.; Sesselmann, Y.; Luppa, M.; Behrens, J.; Riedel-Heller, S.; König, H.H., 2014:
Cost-Utility Analysis of Preventive Home Visits in Older Adults

Ying, X.; Feng, S.; Wu, W.; Chang, J., 2014:
Cost-Utility Analysis of Recommended Ranibizumab Regimen for Age-Related Macular Degeneration in China

Pochopien, M.; Plisko, R.; Drzal, R.; Baran, M.; Sekiewicz, B.; Dudding, T.; Knowles, C.; Grifi, M.; Valyi, A., 2015:
Cost-Utility Analysis of Sacral Nerve Stimulation for The Treatment of Fecal Incontinence Refractory to Conservative Treatment: Looking for Optimal Treatment Path

Kim, S-Won.; Kang, G-Won., 2016:
Cost-Utility Analysis of Screening Strategies for Diabetic Retinopathy in Korea

Westerhout, K.Y.; Treur, M.; Mehnert, A.; Pascoe, K.; Ladha, I.; Belsey, J., 2014:
Cost-Utility Analysis of Simeprevir With Peginterferon + Ribavirin (SMV/PR) in the Management of Genotype 1 (G1) and 4 (G4) Hepatitis C Virus (HCV) Infection; from the Perspective of the Uk National Health Service (NHS)

Hofer, F.; Achelrod, D.; Stargardt, T., 2016:
Cost-Utility Analysis of Telemonitoring Interventions for Patients with Chronic Obstructive Pulmonary Disease (COPD) in Germany

Jain, K.M.; Zulliger, R.; Maulsby, C.; Kim, J.Janet.; Charles, V.; Riordan, M.; Holtgrave, D., 2017:
Cost-Utility Analysis of Three U.S. HIV Linkage and Re-engagement in Care Programs from Positive Charge

Nguyen, T.T.C.; Nguyen, T.T.T., 2014:
Cost-Utility Analysis of Trastuzumab in Treatment Of Metastatic Her2-Positive Breast Cancer in Vietnam

Park, D.J.; Kim, Y.H.; Kim, E.J., 2014:
Cost-Utility Analysis of Varenicline Versus Existing Smoking Cessation Strategies in Korea

Kidholm, K.; Rasmussen, M.Kjær.; Andreasen, J.Jesper.; Hansen, J.; Nielsen, G.; Spindler, H.; Dinesen, B., 2017:
Cost-Utility Analysis of a Cardiac Telerehabilitation Program: The Teledialog Project

Chatterjee, A.; Macarios, D.; Griffin, L.; Kosowski, T.; Pyfer, B.J.; Offodile, A.C.; Driscoll, D.; Maddali, S.; Attwood, J., 2016:
Cost-Utility Analysis: Sartorius Flap versus Negative Pressure Therapy for Infected Vascular Groin Graft Managment

Homer, T.; Vale, L.; Shen, J.; Hilton, P., 2014:
Cost-Utility And Value Of Information (Voi) Analyses On The Feasibility Of A Future Randomised Controlled Trial (Rct) Of Invasive Urodynamic Testing Prior To Surgery For Stress Urinary Incontinence In Women

Kourlaba, G.; Vlachopoulos, C.; Parissis, J.; Kanakakis, J.; Gourzoulidis, G.; Maniadakis, N., 2015:
Cost-Utility Of Ranolazine For The Symptomatic Treatment Of Patients With Chronic Angina Pectoris In Greece

Luque, A.; Nobre, M.R.; Abrahão, M.T., 2015:
Cost-Utility Of Statin In Secondary Prevention: A Propensity Score Method Of Administrative Database

Rajagopalan, K.; Trueman, D.; Crowe, L.; Patel, P.; Loebel, A., 2015:
Cost-Utility and Budget Impact Analyses Comparing Lurasidone with Aripiprazole in Adults with Schizophrenia in Scotland

Cuperus, N.; van den Hout, W.B.; Hoogeboom, T.J.; van den Hoogen, F.H.J.; Vliet Vlieland, T.P.M.; van den Ende, C.H.M., 2016:
Cost-Utility and Cost-Effectiveness Analyses of Face-to-Face Versus Telephone-Based Nonpharmacologic Multidisciplinary Treatments for Patients With Generalized Osteoarthritis

Borisenko, O.; Burdukova, E.; Hargreaves, J.; Adam, D.; Funch-Jensen, P., 2015:
Cost-Utility of Bariatric Surgery In Belgium, Denmark, and Italy

Borisenko, O.; Burdukova, E.; Hargreaves, J.; Adam, D., 2015:
Cost-Utility of Bariatric Surgery In France And Germany

T T T, N.; T T H, T., 2014:
Cost-Utility of Bevacizumab with PC Regimen in Non-Small Cell Lung Cancer Treatment

Smulders, Y.E.; van Zon, A.; Stegeman, I.; van Zanten, G.A.; Rinia, A.B.; Stokroos, R.J.; Free, R.H.; Maat, B.; Frijns, J.H.M.; Mylanus, E.A.M.; Huinck, W.J.; Topsakal, V.; Grolman, W., 2016:
Cost-Utility of Bilateral Versus Unilateral Cochlear Implantation in Adults: A Randomized Controlled Trial

Meads, D.M.; McCabe, C.; Hulme, C.T.; Edlin, R.; Kharroubi, S.A.; Browne, C.; Ford, H.; Dunn, J.; Marshall, A., 2014:
Cost-Utility of Cancer Therapies - the 'Cost' of Different Utility Generation Strategies

Relakis, I.; Patrikos, D.; Kourlaba, G.; Christou, P.; Maniadakis, N., 2015:
Cost-Utility of Certolizumab Pegol for The Treatment of Axial Spondyloarthritis In Greece

Kusel, J.; Maruszczak, M.; Adlard, N., 2015:
Cost-Utility of Fingolimod Compared With Dimethyl Fumarate (Dmf) In Highly Active Relapsing Remitting Multiple Sclerosis (Rrms) In England: Comparison of A Markov and Discrete Event Simulation Model

Jablonowski, Z.; Konecki, T.; Ziobro, M.; Haldas, M.; Wolski, Z.; Marteau, F.; Sosnowski, M., 2015:
Cost-Utility of Hexaminolevulinate Blue Light Cystoscopy (Hal) Assisted Transurethral Resection of The Bladder Tumour (Turb) Compared to Turb With White Light Cystoscopy (Wlc) Alone In Patients With Non-Muscle Invasive Bladder Cancer (Nimbc) In Poland

Graham, J.; McBride, D.; Stull, D.; Halliday, A.; Alexopoulos, S.T.; Balp, M.; Griffiths, M.; Agirrezabal, I.; Brennan, A., 2015:
Cost-Utility of Omalizumab Compared With Standard of Care for The Treatment of Chronic Spontaneous Urticaria (Csu)

Dolk, C.; Eichner, M.; Welte, R.; Anastassopoulou, A.; Van Bellinghen, L-Anne.; Poulsen Nautrup, B.; Van Vlaenderen, I.; Schmidt-Ott, R.; Schwehm, M.; Postma, M., 2016:
Cost-Utility of Quadrivalent Versus Trivalent Influenza Vaccine in Germany, Using an Individual-Based Dynamic Transmission Model

Kourlaba, G.; Relakis, J.; Mahon, R.; Kalogeropoulou, M.; Pantelopoulou, G.; Kousidou, O.; Maniadakis, N., 2015:
Cost-Utility of Ranibizumab Versus Aflibercept for Treating Visual Impairment Due to Diabetic Macular Edema In Greece

Jansen, F.; Krebber, A.M.H.; Coupé, V.M.H.; Cuijpers, P.; de Bree, R.; Becker-Commissaris, A.; Smit, E.F.; van Straten, A.; Eeckhout, G.M.; Beekman, A.T.F.; Leemans, C.René.; Verdonck-de Leeuw, I.M., 2016:
Cost-Utility of Stepped Care Targeting Psychological Distress in Patients With Head and Neck or Lung Cancer

Kitwitee, P.; Unnwongse, K.; Srikijvilaikul, T.; Yadee, T.; Limwattananon, C., 2016:
Cost-Utility of Video-Electroencephalography Monitoring Followed by Surgery in Adults with Drug-Resistant Focal Epilepsy in Thailand

Soini, E.J.; Hallinen, T.; Brignone, M.; Despiégel, N.; Aalto-Setälä, M.; Danchenko, N.; Kolasa, K., 2014 :
Cost-Utility of Vortioxetine in the Treatment of Major Depressive Disorder: Comparison with Agomelatine, Bupropion, Sertraline and Venlafaxine in the Finnish Setting

Stenehjem, D.D.; Bellows, B.K.; Yager, K.M.; Jones, J.; Kaldate, R.; Siebert, U.; Brixner, D.I., 2016:
Cost-Utility of a Prognostic Test Guiding Adjuvant Chemotherapy Decisions in Early-Stage Non-Small Cell Lung Cancer

Hatam, N.; Askarian, M.; Javan-Noghabi, J.; Ahmadloo, N.; Mohammadianpanah, M., 2016:
Cost-Utility of "Doxorubicin and Cyclophosphamide" versus "Gemcitabine and Paclitaxel" for Treatment of Patients with Breast Cancer in Iran

Karnon, J.; Partington, A., 2016:
Cost-Value Analysis and the SAVE: A Work in Progress, But an Option for Localised Decision Making?

Huynh, L.; Yermakov, S.; Davis, M.; Campbell, R.; Cleveland, M.; Farraye, F.A.; Yenikomshian, M., 2017:
Cost-analysis model of colonoscopy preparation using split-dose reduced-volume oral sulfate solution (OSS) and polyethylene glycol with electrolytes solution (PEG-ELS)

Herling, S.F.; Palle, C.; Møller, A.M.; Thomsen, T.; Sørensen, J., 2016:
Cost-analysis of robotic-assisted laparoscopic hysterectomy versus total abdominal hysterectomy for women with endometrial cancer and atypical complex hyperplasia

Mariño, R.; Tonmukayakul, U.; Manton, D.; Stranieri, A.; Clarke, K., 2017:
Cost-analysis of teledentistry in residential aged care facilities

Gardner, K.N.; Diefenderfer, L.A.; Nelson, L.Anne.; Iuppa, C.; Elliott, E.; Kleinhesselink, K.; Sass, D.; Sommi, R.W., 2016:
Cost-avoidance and qualitative analysis of clinical pharmacy interventions by psychiatric pharmacy residents at state psychiatric facilities

Cho, S-Yeon.; Lee, D-Gun.; Choi, J-Ki.; Lee, H-Jin.; Kim, S-Hyun.; Park, S-Hee.; Choi, S-Mi.; Choi, J-Hyun.; Yoo, J-Hong.; Kim, Y-Jin.; Kim, H-Je.; Min, W-Sung.; Back, H.; Kang, S.; Lee, E-Kyung., 2016:
Cost-benefit Analysis of Posaconazole Versus Fluconazole or Itraconazole as a Primary Antifungal Prophylaxis in High-risk Hematologic Patients: A Propensity Score-matched Analysis

Söderqvist, T.; Brinkhoff, P.; Norberg, T.; Rosén, L.; Back, Pär-Erik.; Norrman, J., 2016:
Cost-benefit analysis as a part of sustainability assessment of remediation alternatives for contaminated land

McKinnell, J.A.; Bartsch, S.M.; Lee, B.Y.; Huang, S.S.; Miller, L.G., 2015:
Cost-benefit analysis from the hospital perspective of universal active screening followed by contact precautions for methicillin-resistant Staphylococcus aureus carriers

Diel, R.; Nienhaus, A.; Hillemann, D.; Richter, E., 2016:
Cost-benefit analysis of Xpert MTB/RIF for tuberculosis suspects in German hospitals

Joliat, G-R.; Labgaa, I.; Petermann, D.; Hübner, M.; Griesser, A-C.; Demartines, N.; Schäfer, M., 2016:
Cost-benefit analysis of an enhanced recovery protocol for pancreaticoduodenectomy

Karki, S.; Lupiani, B.; Budke, C.M.; Karki, N.P.S.; Rushton, J.; Ivanek, R., 2016:
Cost-benefit analysis of avian influenza control in Nepal

Zhou, J.; Ma, X., 2015:
Cost-benefit analysis of craniocerebral surgical site infection control in tertiary hospitals in China

Dowell, J.D.; Shah, S.H.; Cooper, K.J.; Yıldız, V.; Pan, X., 2016:
Cost-benefit analysis of establishing an inferior vena cava filter clinic

Keall, M.D.; Pierse, N.; Howden-Chapman, P.; Guria, J.; Cunningham, C.W.; Baker, M.G., 2016:
Cost-benefit analysis of fall injuries prevented by a programme of home modifications: a cluster randomised controlled trial

Jemberu, W.T.; Mourits, M.; Rushton, J.; Hogeveen, H., 2017 :
Cost-benefit analysis of foot and mouth disease control in Ethiopia

Deng, L.; White, A.S.; Pawlowska, M.; Pottinger, B.; Aydin, J.; Chow, N.; Tildesley, H.D., 2015:
Cost-benefit analysis of internet therapeutic intervention on patients with diabetes

Butts, C.Caleb.; Sahawneh, J.; Duffy, A.; Curtis, R.; Mishra, N.; Frotan, M.Amin.; Hodge, J.; Luterman, A.; Gulati, S., 2015:
Cost-benefit analysis of outcomes from the use of fibrin sealant for fixation of skin grafts in small-size burns compared to staples as historical controls: a retrospective review

Lahiri, S., 2017:
Cost-benefit analysis of overhead lift use peer coaching

Hassan, M.; Miao, Y.; Lincoln, J.; Ricci, M., 2015:
Cost-benefit analysis of robotic versus nonrobotic minimally invasive mitral valve surgery

Bergevin, A.; Zick, C.D.; McVicar, S.Browning.; Park, A.H., 2016:
Cost-benefit analysis of targeted hearing directed early testing for congenital cytomegalovirus infection

Langabeer, J.R.; Champagne-Langabeer, T.; Alqusairi, D.; Kim, J.; Jackson, A.; Persse, D.; Gonzalez, M., 2016:
Cost-benefit analysis of telehealth in pre-hospital care

Badii, B.; Staderini, F.; Foppa, C.; Tofani, L.; Skalamera, I.; Fiorenza, G.; Qirici, E.; Cianchi, F.; Perigli, G., 2016:
Cost-benefit analysis of the intraoperative parathyroid hormone assay in primary hyperparathyroidism

Tozluoglu, M.; Mao, Y.; Bates, P.A.; Sahai, E., 2016:
Cost-benefit analysis of the mechanisms that enable migrating cells to sustain motility upon changes in matrix environments

Wald, N.J.; Luteijn, J.Michiel.; Morris, J.K.; Taylor, D.; Oppenheimer, P., 2017 :
Cost-benefit analysis of the polypill in the primary prevention of myocardial infarction and stroke

Groenendaal, H.; Zagmutt, F.J.; Patton, E.A.; Wells, S.J., 2017:
Cost-benefit analysis of vaccination against Mycobacterium avium ssp. paratuberculosis in dairy cattle, given its cross-reactivity with tuberculosis tests

Purtle, J.; Rich, L.J.; Bloom, S.L.; Rich, J.A.; Corbin, T.J., 2015:
Cost-benefit analysis simulation of a hospital-based violence intervention program

Gabbett, H.T.; Windt, J.; Gabbett, T.J., 2016:
Cost-benefit analysis underlies training decisions in elite sport

Khneisser, I.; Adib, S.; Assaad, S.; Megarbane, A.; Karam, P., 2016:
Cost-benefit analysis: newborn screening for inborn errors of metabolism in Lebanon

Beresniak, A.; Schmidt, A.; Proeve, J.; Bolanos, E.; Patel, N.; Ammour, N.; Sundgren, M.; Ericson, M.; Karakoyun, Töresin.; Coorevits, P.; Kalra, D.; De Moor, G.; Dupont, D., 2016:
Cost-benefit assessment of using electronic health records data for clinical research versus current practices: Contribution of the Electronic Health Records for Clinical Research (EHR4CR) European Project

Wan, X.; Lei, M.; Chen, T., 2018:
Cost-benefit calculation of phytoremediation technology for heavy-metal-contaminated soil

Jazwa, A.; Coleman, M.S.; Gazmararian, J.; Wingate, L'Marcus.T.; Maskery, B.; Mitchell, T.; Weinberg, M., 2015:
Cost-benefit comparison of two proposed overseas programs for reducing chronic Hepatitis B infection among refugees: is screening essential?

Pedersen, K., 2015:
Cost-benefit considerations in screening for cervical cancer

Kirkness, C.S.; Asche, C.V.; Ren, J.; Kim, M.; Rainville, E.C., 2017:
Cost-benefit evaluation of liposomal bupivacaine in the management of patients undergoing total knee arthroplasty

Patterson, J.A.; Holdford, D.A.; Saxena, K., 2016:
Cost-benefit of appointment-based medication synchronization in community pharmacies

Pellacani, G.; Witkowski, A.; Cesinaro, A.M.; Losi, A.; Colombo, G.L.; Campagna, A.; Longo, C.; Piana, S.; De Carvalho, N.; Giusti, F.; Farnetani, F., 2016:
Cost-benefit of reflectance confocal microscopy in the diagnostic performance of melanoma

Fernández-Cano, Mía.Isabel.; Armadans Gil, Lís.; Campins Martí, M., 2015:
Cost-benefit of the introduction of new strategies for vaccination against pertussis in Spain: cocooning and pregnant vaccination strategies

Zhang, Y.; Zhang, J.; Wang, C.; Cao, P.; Yuan, W., 2015:
Cost-benefit of vertebral augmentation: how to assess the benefit

Peisley, R.K.; Saunders, M.E.; Luck, G.W., 2016:
Cost-benefit trade-offs of bird activity in apple orchards

Mardiguian, S.; Kivikko, M.; Heringlake, M.; Smare, C.; Bertranou, E.; Apajasalo, M.; Pollesello, P., 2017:
Cost-benefits of incorporating levosimendan into cardiac surgery practice: German base case

Verma, V.; Shah, C.; Rwigema, J-Claude.M.; Solberg, T.; Zhu, X.; Simone, C.B., 2017:
Cost-comparativeness of proton versus photon therapy

Schwarzkopf, L.; Wacker, M.; Holle, R.; Leidl, R.; Günster, C.; Adler, Jürgen-Bernhard.; Huber, R.Maria., 2016:
Cost-components of lung cancer care within the first three years after initial diagnosis in context of different treatment regimens

Khaku, A.; Hollenbeak, C.S.; Soybel, D.I., 2017:
Cost-conscious decisions in the timing of operation for minimally symptomatic inguinal hernias in male patients

Ylijoki-Sørensen, S.; Boldsen, J.Lier.; Lalu, K.; Sajantila, A.; Baandrup, U.; Boel, L.Warner.Thorup.; Ehlers, L.Holger.; Bøggild, H., 2014:
Cost-consequence analysis of cause of death investigation in Finland and in Denmark

Schinco, P.; Cultrera, D.; Valeri, F.; Borchiellini, A.; Mantuano, M.; Gorla, F.; Savarese, A.; Teruzzi, C., 2015:
Cost-consequence analysis of long-term prophylaxis in the treatment of von Willebrand disease in the Italian context

Sorzano, C.Oscars.S.; Pérez-De-La-Cruz Moreno, M.Angeles.; Burguet-Castell, J.; Montejo, C.; Ros, A.Aguilar., 2016:
Cost-constrained optimal sampling for system identification in pharmacokinetics applications with population priors and nuisance parameters

Bonnechère, B.; Jansen, B.; Van Sint Jan, S., 2016:
Cost-effective (gaming) motion and balance devices for functional assessment: Need or hype?

Ma, J.; Wang, Z.; Zhang, J.; Waite, T.David.; Wu, Z., 2016:
Cost-effective Chlorella biomass production from dilute wastewater using a novel photosynthetic microbial fuel cell (PMFC)

Sun, S.X.; Kulaylat, A.N.; Hollenbeak, C.S.; Soybel, D.I., 2017:
Cost-effective Decisions in Detecting Silent Common Bile Duct Gallstones During Laparoscopic Cholecystectomy

Date, A.; Date, R.S., 2016:
Cost-effective Decisions in Managing Silent Common Bile Duct Stones Should Include All the Management Options to Help Decision Makers

Robinson, J.K.; Halpern, A.C., 2016:
Cost-effective Melanoma Screening

Osterberg, E.Charles.; Murphy, G.; Harris, C.R.; Breyer, B.N., 2017:
Cost-effective Strategies for the Management and Treatment of Urethral Stricture Disease

Lee, D.; Kwon, W-Bae.; Chae, C-Joon.; Park, C-Soo., 2015:
Cost-effective TCM-based WDM-PON for highly asymmetric traffic conditions

Nguyen, M.Hiep.; Yu, H.; Kiew, T.Yi.; Hadinoto, K., 2016:
Cost-effective alternative to nano-encapsulation: Amorphous curcumin-chitosan nanoparticle complex exhibiting high payload and supersaturation generation

Elad, S.; Thierer, T., 2017:
Cost-effective analysis of topical chlorhexidine in hematologic patients at risk for oral mucositis

Kaur, A.; Singh, A.; Dua, A.; Mahajan, R., 2016:
Cost-effective and concurrent production of industrially valuable xylano-pectinolytic enzymes by a bacterial isolate Bacillus pumilus AJK

Bruno, C.J.; Glass, K.M., 2016:
Cost-effective and low-technology options for simulation and training in neonatology

Kim, H-Je.; Myung-Sik, L.; Gopi, C.V.V.M.; Venkata-Haritha, M.; Rao, S.Srinivasa.; Kim, S-Kyoung., 2015:
Cost-effective and morphology controllable PVP based highly efficient CuS counter electrodes for high-efficiency quantum dot-sensitized solar cells

Fu, G.; Sanjay, S.T.; Li, X., 2018:
Cost-effective and sensitive colorimetric immunosensing using an iron oxide-to-Prussian blue nanoparticle conversion strategy

Li, Q.; Huang, B.; Chen, X.; Shi, Y., 2015:
Cost-effective bioregeneration of nitrate-laden ion exchange brine through deliberate bicarbonate incorporation

Luo, M.; Hu, R.; Li, W.; Yang, Q.; Yu, S., 2016 :
Cost-effective coherent ONU transceiver based on single directly modulated laser

Li, M.; Hu, R.; Xia, J.; Yang, Q.; Xiao, X.; Li, C.; Li, X.; Yu, S., 2015:
Cost-effective coherent PON using silicon Mach-Zehnder modulator and digital carrier regeneration

Rose, L.E.; Heard, G.W.; Chee, Y.En.; Wintle, B.A., 2016:
Cost-effective conservation of an endangered frog under uncertainty

Zinsstag, J.; Abakar, M.F.; Ibrahim, M.; Tschopp, R.; Crump, L.; Bonfoh, B.; Schelling, E., 2017:
Cost-effective control strategies for animal and zoonotic diseases in pastoralist populations

Yang, J.; Zhou, M.; Hu, Y.; Yang, W., 2016:
Cost-effective copper removal by electrosorption powered by microbial fuel cells

Suwannasing, W.; Imai, T.; Kaewkannetra, P., 2017:
Cost-effective defined medium for the production of polyhydroxyalkanoates using agricultural raw materials

Lehtola, S.; Parkhill, J.; Head-Gordon, M., 2016:
Cost-effective description of strong correlation: Efficient implementations of the perfect quadruples and perfect hextuples models

Tasnim, F.; Phan, D.; Toh, Y-Chin.; Yu, H., 2016:
Cost-effective differentiation of hepatocyte-like cells from human pluripotent stem cells using small molecules

Sun, Y.; Chakrabartty, A., 2016:
Cost-effective elimination of lipofuscin fluorescence from formalin-fixed brain tissue by white phosphor light emitting diode array

Ramzani, P.Muhammad.Adnan.; Khalid, M.; Anjum, S.; Khan, W-Ud-Din.; Ali, S.; Hannan, F.; Iqbal, M., 2016:
Cost-effective enhanced iron bioavailability in rice grain grown on calcareous soil by sulfur mediation and its effect on heavy metals mineralization

Reanpang, P.; Themsirimongkon, S.; Saipanya, S.; Chailapakul, O.; Jakmunee, J., 2016:
Cost-effective flow injection amperometric system with metal nanoparticle loaded carbon nanotube modified screen printed carbon electrode for sensitive determination of hydrogen peroxide

Anonymous, 2016:
Cost-effective flu prevention

Tu, H-Z.; Lin, Y.E.; Tseng, M-R.; Huang, T-S.; Chen, Y-S., 2016:
Cost-effective identification of Mycobacterium tuberculosis complex using microscopic morphology and rapid tests

Subochev, P., 2016:
Cost-effective imaging of optoacoustic pressure, ultrasonic scattering, and optical diffuse reflectance with improved resolution and speed

Sun, G-Ying.; Wang, C.; Luo, Y-Qin.; Zhao, Y-Xin.; Yang, J.; Liu, Z-Sheng.; Aisa, H.Akber., 2018:
Cost-effective imprinting combining macromolecular crowding and a dummy template for the fast purification of punicalagin from pomegranate husk extract

Cai, H.; Qiao, Y.; Huang, X.; Sun, M.; Luo, Q.; Yuan, X.; Yang, Y.; Mao, W.; Lv, Z., 2016:
Cost-effective initial assessment strategies for thyroid nodules in iodine-adequate areas

Pedersen, K.; Burger, E.A.; Sy, S.; Kristiansen, I.S.; Kim, J.J., 2016:
Cost-effective management of women with minor cervical lesions: Revisiting the application of HPV DNA testing

Foerster, F.; Wörns, M.A.; Galle, P.R.; Schattenberg, J.M., 2016:
Cost-effective medical therapy of hepatitis C employing novel compensation models - pay for cure